Λίστα δημοσιεύσεων μελών ΚΕΟ & Μετακαλούμενων Ερευνητών
Ερευνητική Ομάδα 1
Μουρελάτος Διονύσιος
Συντονιστής & Υπεύθυνος Ομάδας
1. Title: FETAL HEMOGLOBIN MODULATION BY NOVEL ALKYLATING AGENTS IN
HUMAN ERYTHROID CELLS; SYNERGISTIC EFFECTS WITH ESTABLISHED HBFINDUCING AGENTS
Author(s): Chiotoglou I, Samara M, Paterakis G, et al.
Conference Information: 14th Annual Meeting of the European-Hematology-Association, JUN 04-07,
2009 Berlin, GERMANY
Source: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL Volume: 94 Pages: 71-71
Supplement: Suppl. 2 Meeting Abstract: 0186 Published: JUN 2009
Times Cited: 0
2. Title: Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized
antitumour steroidal esters
Author(s): Karapidaki I, Bakopoulou A, Papageorgiou A, et al.
Source: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL
MUTAGENESIS Volume: 675 Issue: 1-2 Pages: 51-59 Published: APR 30 2009
Times Cited: 0
3. Title: Cytogenetic Activity of Diazepam in Normal Human Lymphocyte Cultures
Author(s): Akritopoulou K, Iakovidou-Kritsi Z, Mioglou-Kalouptsi E, et al.
Source: GENETIC TESTING AND MOLECULAR BIOMARKERS Volume: 13 Issue: 2 Pages:
227-231 Published: APR 2009
Times Cited: 0
4. Title: Synthesis, characterization, toxicity, cytogenetic and in vivo antitumor
studies of 1,1-dithiolate Cu(II) complexes with di-, tri-, tetra- amines and 1,3-thiazoles. Structureactivity correlation
Author(s): Bolos CA, Chaviara AT, Mourelatos D, et al.
Source: BIOORGANIC & MEDICINAL CHEMISTRY Volume: 17 Issue: 8 Pages: 3142-3151
Published: APR 15 2009
Times Cited: 1
5. Title: Genotoxic and cytotoxic effects of different types of dental cement on
normal cultured human lymphocytes
Author(s): Bakopoulou A, Mourelatos D, Tsiftsoglou AS, et al.
Source: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL
MUTAGENESIS Volume: 672 Issue: 2 Pages: 103-112 Published: JAN 31 2009
Times Cited: 0
6. Title: Induction of fetal hemoglobin (HbF) by novel alkylating agents in human
erythroid cells; synergistic effects with established HbF-inducing agents
Author(s): Chiotoglou I, Samara M, Likousi S, et al.
Conference Information: 4th Conference on Stem Cell Gene Therapy, SEP 13-17, 2007 Thessaloniki,
GREECE
Source: BLOOD CELLS MOLECULES AND DISEASES Volume: 40 Issue: 2 Pages: 260-261
Meeting Abstract: 21 Published: MAR-APR 2008
Times Cited: 0
7. Title: Sister-chromatid exchange, chromosomal aberrations and delays in cell-cycle
kinetics in human lymphocytes induced by dental composite resin eluates
Author(s): Bakopoulou A, Mourelatos D, Tsiftsoglou AS, et al.
Source: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL
MUTAGENESIS Volume: 649 Issue: 1-2 Pages: 79-90 Published: JAN 8 2008
Times Cited: 5
8. Title: Structure-anti leukemic activity relationship study of B- and D-ring modified
and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a
comparative study
Author(s): Fousteris MA, Koutsourea AI, Arsenou ES, et al.
Source: ANTI-CANCER DRUGS Volume: 18 Issue: 9 Pages: 997-1004 Published: OCT 2007
Times Cited: 2
9. Title: Synergistic antitumor activity of oxaliplatin in combination with gemcitabine
in pancreatic tumor-bearing mice
Author(s): Moschidis A, Papageorgiou A, Atmatzidis K, et al.
Source: CHEMOTHERAPY Volume: 53 Issue: 3 Pages: 153-159 Published: 2007
Times Cited: 3
10. Title: Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic
and antineoplastic activity
Author(s): Hussein A, Mioglou-Kalouptsi E, Papageorgiou A, et al.
Source: IN VIVO Volume: 21 Issue: 2 Pages: 389-395 Published: MAR-APR 2007
Times Cited: 0
11. Title: Antileukemic and cytogenetic activity by triple administration of three modified
steroidal derivatives of nitrogen mustards
Author(s): Fousteris MA, Papageorgiou A, Arsenou ES, et al.
Source: CHEMOTHERAPY Volume: 53 Issue: 2 Pages: 118-126 Published: 2007
Times Cited: 3
12. Title: Elevation of fetal hemoglobin (HbF) by novel alkylating agents in human
erythroid cells; Synergistic effects with established HbF-inducing agents.
Author(s): Chiotoglou I, Samara M, Likousi S, et al.
Conference Information: 48th Annual Meeting of the American-Society-of-Hematology, DEC 09-12,
2006 Orlando, FL
Source: BLOOD Volume: 108 Issue: 11 Pages: 29B-29B Part: Part 2 Meeting Abstract: 3815
Published: NOV 16 2006
Times Cited: 0
13. Title: Structure-anti-leukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of chlorambucil
Author(s): Fousteris MA, Koutsourea AI, Arsenou ES, et al.
Source: ANTI-CANCER DRUGS Volume: 17 Issue: 5 Pages: 511-519 Published: JUN 2006
Times Cited: 4
14. Title: Structure-anti-leukemic activity relationship study of B- and D-ring
modified and non-modified steroidal esters of chlorambucil's active metabolite
Author(s): Papageorgiou A, Koutsourea AI, Arsenou ES, et al.
Source: ANTI-CANCER DRUGS Volume: 16 Issue: 10 Pages: 1075-1082 Published: NOV
2005
Times Cited: 7
15. Title: Synthesis and cytogenetic studies of structure-biological activity
relationship of esters of Hecogenin and aza-homo-Hecogenin with N,N-bis(2chloroethyl)aminocinnamic acid isomers
Author(s): Camoutsis C, Mourelatos D, Pairas G, et al.
Source: STEROIDS Volume: 70 Issue: 9 Pages: 586-593 Published: AUG 2005
Times Cited: 1
16. Title: Preclinical studies on NSC290205 aza-steroid alkylator activity in
combination with adriamycin against lymphoid leukaemia
Author(s): Trafalis DTP, Tsavdaridis D, Camoutsis C, et al.
Source: BRITISH JOURNAL OF HAEMATOLOGY Volume: 128 Issue: 3 Pages: 343-350
Published: FEB 2005
Times Cited: 1
17. Title: CYTOGENETIC EFFECTS OF 7-OXIDIZED STEROIDAL ESTERS OF
NITROGEN MUSTARDS
Author(s): Mourelatos D, Mioglou E, Iakovidou Z, et al.
Source: ANTICANCER RESEARCH Volume: 24 Issue: 5D Pages: 3520-3521 Meeting
Abstract: 226 Published: SEP-OCT 2004
Times Cited: 0
18. Title: The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of
chlorambucil's active metabolite steroidal esters
Author(s): Arsenou ES, Fousteris MA, Koutsourea AI, et al.
Source: ANTI-CANCER DRUGS Volume: 15 Issue: 10 Pages: 983-990 Published: NOV 2004
Times Cited: 13
19. Title: A new approach for evaluating in vivo anti-leukemic activity using the SCE
assay - An application on three newly synthesised anti-tumour steroidal esters
Author(s): Karayianni V, Mioglou E, Iakovidou Z, et al.
Source: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL
MUTAGENESIS Volume: 535 Issue: 1 Pages: 79-86 Published: FEB 5 2003
Times Cited: 10
20. Title: 7-Keto hybrid steroidal esters of nitrogen mustard: cytogenetic and
antineoplastic effects
Author(s): Karayianni V, Papageorgiou A, Mioglou E, et al.
Source: ANTI-CANCER DRUGS Volume: 13 Issue: 6 Pages: 637-643 Published: JUL 2002
Times Cited: 14
21. Title: Antileukemic and cytogenetic effects of modified and nonmodified esteric steroidal
derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA)
Author(s): Fousteris MA, Koutsourea AI, Arsenou ES, et al.
Source: ANTICANCER RESEARCH Volume: 22 Issue: 4 Pages: 2293-2299 Published: JULAUG 2002
Times Cited: 10
22. Title: Synthesis and cytogenetic effects of aminoquinone derivatives with a di- and a
tripeptide
Author(s): Pachatouridis C, Iakovidou Z, Myoglou E, et al.
Source: ANTI-CANCER DRUGS Volume: 13 Issue: 4 Pages: 367-372 Published: APR 2002
Times Cited: 1
23. Title: Comparative study of sister chromatid exchange induction and antitumor
effects by homo-aza-steroidal esters of {p-[bis(2-chloroethyl)amino]phenyl}butyric acid
Author(s): Camoutsis C, Catsoulacos D, Karayianni V, et al.
Source: CANCER DETECTION AND PREVENTION Volume: 25 Issue: 6 Pages: 558-564
Published: 2001
Times Cited: 4
24. Title: A comparative study on cytogenetic and antineoplastic effects induced by two
modified steroidal alkylating agents
Author(s): Papageorgiou A, Tsavdaridis D, Geromichalos GD, et al.
Source: CANCER DETECTION AND PREVENTION Volume: 25 Issue: 4 Pages: 369-374
Published: 2001
Times Cited: 1
25. Title: Platinum(II) and palladium(II) complexes with 2-acetylpyridine thiosemicarbazone:
cytogenetic and antineoplastic effects
Author(s): Iakovidou Z, Papageorgiou A, Demertzis MA, et al.
Source: ANTI-CANCER DRUGS Volume: 12 Issue: 1 Pages: 65-70 Published: JAN 2001
Times Cited: 35
26. Title: Synergistic antineoplastic and cytogenetic effects by the combined action of
two homo-aza-steroidal esters of nitrogen mustards on P388 and L1210 leukaemias in vivo and in
vitro
Author(s): Nikolaropoulos S, Tsavdaridis D, Arsenou E, et al.
Source: ANTICANCER RESEARCH Volume: 20 Issue: 4 Pages: 2745-2751 Published: JULAUG 2000
Times Cited: 9
27. Title: Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and
antineoplastics
Author(s): Karaberis E, Mourelatos D
Source: TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS Volume: 20 Issue: 3
Pages: 141-146 Published: 2000
Times Cited: 2
28. Title: New antitumor agents: Cytostatic and cytogenetic activity of two modified
steroidal alkylating agents
Author(s): Papageorgiou A, Chrysogelou E, Tsavdaridis D, et al.
Source: EUROPEAN JOURNAL OF CANCER Volume: 35 Pages: S196-S196 Supplement:
Suppl. 4 Meeting Abstract: 759 Published: SEP 1999
Times Cited: 0
29. Title: Lack of genotoxicity of silver iodide in the SCE assay in vitro, in vivo, and
in the Ames/microsome test
Author(s): Eliopoulos P, Mourelatos D
Source: TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS Volume: 18 Issue: 6
Pages: 303-308 Published: 1998
Times Cited: 2
30. Title: Enhanced cytogenetic and antineoplastic effects by the combined action of
two esteric steroidal derivatives of nitrogen mustards
Author(s): Papageorgiou A, Nikolaropoulos SS, Arsenou ES, et al.
Source: CHEMOTHERAPY Volume: 45 Issue: 1 Pages: 61-67 Published: JAN-FEB 1999
Times Cited: 9
31. Title: Antineoplastic and cytogenetic effects of platinum(II) and palladium(II) complexes with
pyridine-2-carboxyaldehyde-thiosemicarbazone
Author(s): Kovala-Demertzi D, Demertzis MA, Varagi V, et al.
Source: CHEMOTHERAPY Volume: 44 Issue: 6 Pages: 421-426 Published: NOV-DEC 1998
Times Cited: 40
32. Title: A comparative study of the cytogenetic and antineoplasmatic effects
induced by carboplatin in combination with Niacin in human lymphocytes in vitro and in Ehrlich
ascites tumor cells in vivo
Author(s): Mylonaki-Charalambours E, Mourelatos D, Kotsis A
Source: CHEMOTHERAPY Volume: 44 Issue: 2 Pages: 121-128 Published: MAR-APR 1998
Times Cited: 6
33. Title: Antitumor and cytogenetic effects of esteric (ASE) and amidic (ASA)
steroidal derivative of p-bis (2-chloroethyl) amino phenylacetic acid (CAPA). A comparative study
Author(s): Nikolaropoulos SS, Arsenou ES, Papageorgiou A, et al.
Source: ANTICANCER RESEARCH Volume: 17 Issue: 6D Pages: 4525-4529 Published: NOVDEC 1997
Times Cited: 16
34. Title: Antineoplastic and cytogenetic effects of complexes of Pd(II) with 4N-substituted
derivatives of 2-acetyl-pyridine-thiosemicarbazone
Author(s): Papageorgiou A, Iakovidou Z, Mourelatos D, et al.
Source: ANTICANCER RESEARCH Volume: 17 Issue: 1A Pages: 247-251 Published: JANFEB 1997
Times Cited: 39
35. Title: A comparative study of the cytogenetic and antineoplastic effects induced by steroidal
amidoesters of p-N,N-bis (2-chloroethyl) aminophenylbutyric acid (chlorambucil)
Author(s): Papageorgiou A, Catsoulacos P, Catsoulacos D, et al.
Source: CANCER JOURNAL Volume: 9 Issue: 4 Pages: 203-206 Published: JUL-AUG 1996
Times Cited: 2
36. Title: Chromosomes study as predictor of chemoresponse of tumours
Author(s): Mourelatos D
Source: CANCER JOURNAL Volume: 9 Issue: 3 Pages: 136-141 Published: MAY-JUN 1996
Times Cited: 28
37. Title: LACK OF MUTAGENICITY OF METABOLIC PRODUCTS OF ICE
NUCLEATION BACTERIA IN SALMONELLA-TYPHIMURIUM
Author(s): MOURELATOS D, ELIOPOULOS P, LIARALIS T, et al.
Source: MUTAGENESIS Volume: 10 Issue: 3 Pages: 261-262 Published: MAY 1995
Times Cited: 0
38. Title: COMPARATIVE-STUDY OF SCE INDUCTION AND CYTOSTATIC
EFFECTS BY HOMO-AZASTEROIDAL ESTERS OF N,N-BIS(2-CHLOROETHYL)
AMINOBENZOIC ACID IN HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, MYLONAKI E, PAPAGEORGIOU A, et al.
Source: MUTATION RESEARCH LETTERS Volume: 346 Issue: 3 Pages: 129-133 Published:
MAR 1995
Times Cited: 5
39. Title: COMPARATIVE-STUDY ON SALMONELLA MUTAGENICITY AND
ON CYTOGENETIC AND ANTINEOPLASTIC EFFECTS INDUCED BY
CYCLOPHOSPHAMIDE AND 3-AMINOBENZAMIDE IN CELLS OF 3 TRANSPLANTABLE
TUMORS IN-VIVO
Author(s): ELIOPOULOS P, MOURELATOS D, DOZIVASSILIADES J
Source: MUTATION RESEARCH-GENETIC TOXICOLOGY Volume: 342 Issue: 3-4 Pages:
141-146 Published: APR 1995
Times Cited: 9
40. Title: ENHANCEMENT OF CYTOGENETIC DAMAGE AND OF
ANTINEOPLASTIC EFFECT IN LYMPHOID L1210 LEUKEMIA-CELLS TREATED WITH
PROSTAGLANDIN-E2 AND CYCLOPHOSPHAMIDE IN-VIVO
Author(s): MOURELATOS D, MIOGLOU E, KRISTI Z, et al.
Source: MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF
MUTAGENESIS Volume: 326 Issue: 1 Pages: 125-129 Published: JAN 1995
Times Cited: 1
41. Title: COMPARATIVE-STUDY ON CYTOGENETIC DAMAGE-INDUCED BY HOMOAZA-STEROIDAL ESTERS IN HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, PAPAGEORGIOU A, BOUTIS L, et al.
Source: MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED
SUBJECTS Volume: 334 Issue: 1 Pages: 19-22 Published: FEB 1995
Times Cited: 2
42. Title: ENHANCEMENT OF ANTINEOPLASTIC EFFECT AND
ATTENUATION OF SISTER-CHROMATID EXCHANGES BY PROSTAGLANDIN E(2) IN
EHRLICH ASCITES TUMOR-CELLS TREATED WITH CYCLOPHOSPHAMIDE IN-VIVO
Author(s): MOURELATOS D, KRITSI Z, MIOGLOU E, et al.
Source: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS Volume: 49
Issue: 3 Pages: 707-710 Published: SEP 1993
Times Cited: 1
43. Title: COMPARISON OF CURRENT ALKYLATING-AGENTS WITH A
HOMO-AZA-STEROIDAL ESTER FOR ANTINEOPLASTIC ACTIVITY
Author(s): CATSOULACOS P, PAPAGEORGIOU A, MARGARITY E, et al.
Source: ONCOLOGY Volume: 51 Issue: 1 Pages: 74-78 Published: JAN-FEB 1994
Times Cited: 12
44. Title: 4-AROYL-1-NITROSOHYDRAZINECARBOXAMIDES - SYNTHESIS,
INVIVO AND INVITRO ANTITUMOR-ACTIVITY
Author(s): GUGOVA RG, PAPAGEORGIOU A, TAKSIROV SI, et al.
Source: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY Volume: 27 Issue: 8 Pages:
745-750 Published: NOV 1992
Times Cited: 6
45. Title: CYTOGENETIC DAMAGE BY MELPHALAN AND HYPERTHERMIA
IN PATIENTS WITH AN INITIAL EPILEPTIC ATTACK
Author(s): PETRIDOU M, MOURELATOS D, TSOLAKI M, et al.
Source: MUTATION RESEARCH Volume: 280 Issue: 2 Pages: 143-148 Published: AUG 1992
Times Cited: 1
46. Title: FREQUENCIES OF CHROMOSOMAL-ABERRATIONS IN PESTICIDE
SPRAYERS WORKING IN PLASTIC GREEN HOUSES
Author(s): KOURAKIS A, MOURATIDOU M, KOKKINOS G, et al.
Source: MUTATION RESEARCH Volume: 279 Issue: 2 Pages: 145-148 Published: MAY 16
1992
Times Cited: 44
47. Title: CHLORPROMAZINE-INDUCED DAMAGE ON NUCLEIC-ACIDS - A
COMBINED CYTOGENETIC AND BIOCHEMICAL-STUDY
Author(s): LIALIARIS T, PANTAZAKI A, SIVRIDIS E, et al.
Source: MUTATION RESEARCH Volume: 265 Issue: 2 Pages: 155-163 Published: FEB 1992
Times Cited: 24
48. Title: ENHANCED GENOTOXICITY BY MELPHALAN AND
HYPERTHERMIA IN CHRONIC HEROIN-ADDICTS
Author(s): VASSILIADES N, MOURELATOS D, ELIOPOULOS P, et al.
Source: FORENSIC SCIENCE INTERNATIONAL Volume: 50 Issue: 2 Pages: 269-276
Published: SEP 1991
Times Cited: 4
49. Title: CYTOGENETIC STUDY FOR POSSIBLE MUTAGENIC ACTIVITY
INDUCED BY ICE-NUCLEATION BACTERIA OR THEIR METABOLIC PRODUCTS IN
HUMAN-LYMPHOCYTES INVITRO
Author(s): LIALIARIS T, MOURELATOS D, STERGIADOU E, et al.
Source: MUTATION RESEARCH Volume: 234 Issue: 6 Pages: 390-391 Published: DEC 1990
Times Cited: 0
50. Title: COMPARATIVE-STUDY ON CYTOGENETIC DAMAGE AND ON
ANTINEOPLASTIC EFFECTS INDUCED BY MODIFIED STEROIDAL DERIVATIVES OF
PARA-BIS(2-CHLOROETHYL)AMINOPHENYL PROPENOIC ACID IN HUMAN
LYMPOCYTES INVITRO AND IN P388 LEUKEMIA-CELLS INVIVO
Author(s): PAPAGEORGIOU A, BOUTIS L, MOURELATOS D, et al.
Source: MUTATION RESEARCH Volume: 234 Issue: 6 Pages: 396-397 Published: DEC 1990
Times Cited: 0
51. Title: CYTOGENETIC STUDY FOR POSSIBLE MUTAGENIC ACTIVITY INDUCED BY
ICE-NUCLEATION BACTERIA OR THEIR METABOLIC PRODUCTS IN HUMANLYMPHOCYTES INVITRO
Author(s): LIALIARIS T, MOURELATOS D, STERGIADOU HC, et al.
Source: MUTATION RESEARCH Volume: 242 Issue: 2 Pages: 163-168 Published: OCT 1990
Times Cited: 7
52. Title: EFFECTS OF ALKYLATING ANTINEOPLASTICS ALONE OR IN
COMBINATION WITH 3-AMINOBENZAMIDE ON GENOTOXICITY, ANTITUMORACTIVITY, AND NAD LEVELS IN HUMAN-LYMPHOCYTES INVITRO AND ON EHRLICH
ASCITES TUMOR-CELLS INVIVO
Author(s): PETROU C, MOURELATOS D, MIOGLOU E, et al.
Source: TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS Volume: 10 Issue: 4
Pages: 321-331 Published: 1990
Times Cited: 11
53. Title: SYNERGISTIC INDUCTION OF CYTOGENETIC DAMAGE BY THE
HOMO-AZA-STEROIDAL ESTER OF PARA-BIS(2-CHLORETHYL)AMINOPHENYLACETIC
ACID IN COMBINATION WITH CAFFEINE IN HUMAN-LYMPHOCYTES INVITRO AND IN
EHRLICH ASCITES TUMOR-CELLS INVIVO
Author(s): PETROU C, MOURELATOS D, DOZIVASSILIADES J, et al.
Source: MUTATION RESEARCH Volume: 243 Issue: 2 Pages: 109-113 Published: FEB 1990
Times Cited: 3
54. Title: COMPARATIVE-STUDY ON CYTOGENETIC EFFECTS BY
DIPLATINUM COMPLEXES OF THE LIGANDS OF NAPHTHAZARINE AND SQUARIC ACID
IN HUMAN-LYMPHOCYTES
Author(s): LIALIARIS T, MOURELATOS D, BOUTIS L, et al.
Source: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Volume:
251 Issue: 1 Pages: 368-371 Published: OCT 1989
Times Cited: 6
55. Title: SYNERGISTIC INDUCTION OF CYTOGENETIC DAMAGE BY ALKYLATING
ANTINEOPLASTICS AND 5-AZACYTIDINE IN HUMAN-LYMPHOCYTES
Author(s): IOANNIDOU E, LIALIARIS T, MOURELATOS D, et al.
Source: ENVIRONMENTAL AND MOLECULAR MUTAGENESIS Volume: 14 Issue: 1 Pages:
6-12 Published: 1989
Times Cited: 9
56. Title: ENHANCEMENT OF CYTOGENETIC DAMAGE BY
CHLOROPROMAZINE IN HUMAN-LYMPHOCYTES TREATED WITH ALKYLATING
ANTINEOPLASTICS AND CAFFEINE
Author(s): LIALIARIS T, MOURELATOS D, DOZIVASSILIADES J
Source: MUTATION RESEARCH Volume: 206 Issue: 3 Pages: 361-365 Published: NOV 1988
Times Cited: 15
57. Title: ENHANCEMENT OF CYTOGENETIC DAMAGE AND OF
ANTINEOPLASTIC EFFECT BY CAFFEINE IN EHRLICH ASCITES TUMOR-CELLS
TREATED WITH CYCLOPHOSPHAMIDE INVIVO
Author(s): MOURELATOS D, DOZIVASSILIADES J, KOTSIS A, et al.
Source: CANCER RESEARCH Volume: 48 Issue: 5 Pages: 1129-1131 Published: MAR 1 1988
Times Cited: 58
58. Title: CELL-DIVISION DELAYS AND SCES INDUCED BY MODIFIED STEROIDAL
DERIVATIVES OF PARA-BIS(2-CHLORO-ETHYL)AMINOPHENYL ACETIC-ACID IN
HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, PETROU C, BOUTIS L, et al.
Source: MUTATION RESEARCH Volume: 181 Issue: 2 Pages: 340-340 Published: DEC 1987
Times Cited: 0
59. Title: ENHANCEMENT AND ATTENUATION OF CYTOGENETIC
DAMAGE BY VITAMIN-C IN CULTURED HUMAN-LYMPHOCYTES EXPOSED TO
THIOTEPA OR L-ETHIONINE
Author(s): LIALIARIS T, MOURELATOS D, DOZIVASSILIADES J
Source: CYTOGENETICS AND CELL GENETICS Volume: 44 Issue: 4 Pages: 209-214
Published: 1987
Times Cited: 14
60. Title: INDUCTION OF CYTOGENETIC DAMAGE BY MODIFIED
STEROIDAL DERIVATIVES OF PARA-BIS(2-CHLOROETHYL)AMINOPHENYLACETIC
ACID IN HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, PETROU C, BOUTIS L, et al.
Source: MUTATION RESEARCH Volume: 190 Issue: 3 Pages: 205-210 Published: MAR 1987
Times Cited: 12
61. Title: ENHANCEMENT OF CYTOGENETIC DAMAGE BY INHIBITORS OF POLY(ADPRIBOSE)POLYMERASE IN HUMAN-LYMPHOCYTES EXPOSED TO ANTINEOPLASTICS
INVIVO AND INVITRO
Author(s): MOURELATOS D, KOURAKIS A, KOLIOUSKAS DE, et al.
Source: TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS Volume: 6 Issue: 6
Pages: 485-492 Published: 1986
Times Cited: 4
62. Title: INDUCTION OF SISTER-CHROMATID EXCHANGES IN HEROINCANNABIS, HEROIN AND CANNABIS ADDICTS
Author(s): VASSILIADES N, MOURELATOS D, DOZIVASSILIADES J, et al.
Source: MUTATION RESEARCH Volume: 170 Issue: 3 Pages: 125-127 Published: JUN 1986
Times Cited: 5
63. Title: INDUCTION OF SISTER-CHROMATID EXCHANGES AND CELLCYCLE DELAYS IN HUMAN-LYMPHOCYTES BY VITAMIN-A ALONE OR IN
COMBINATION WITH MELPHALAN AND CAFFEINE
Author(s): DOZIVASSILIADES J, MYRTSIOTIS A, GRANITSAS A, et al.
Source: EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY Volume: 21 Issue: 9
Pages: 1089-1092 Published: 1985
Times Cited: 15
64. Title: SYNERGISTIC INDUCTION OF SISTER-CHROMATID EXCHANGES
IN LYMPHOCYTES FROM NORMAL SUBJECTS AND FROM PATIENTS UNDER
CYTOSTATIC THERAPY BY INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE AND
ANTITUMOUR AGENTS
Author(s): MOURELATOS D, KOURAKIS A, DOZIVASSILIADES J, et al.
Source: MUTATION RESEARCH Volume: 143 Issue: 4 Pages: 225-230 Published: 1985
Times Cited: 8
65. Title: PROSTAGLANDINS ACT SYNERGISTICALLY WITH ANTITUMOUR
AGENTS ON INDUCTION OF SISTER CHROMATID EXCHANGES IN HUMANLYMPHOCYTES
Author(s): DOZIVASSILIADES J, MOURELATOS D
Source: PROSTAGLANDINS LEUKOTRIENES AND MEDICINE Volume: 17 Issue: 1 Pages:
55-59 Published: 1985
Times Cited: 4
66. Title: EFFECT OF VITAMIN-A ALONE OR IN COMBINATION WITH
MELPHALAN AND CAFFEINE ON SISTER CHROMATID EXCHANGE CELL-KINETICS AND
CYTO-TOXICITY IN HUMAN-LYMPHOCYTES
Author(s): MYRTSIOTIS A, DOZIVASSILIADES J, GRANITSAS A, et al.
Source: DERMATOLOGICA Volume: 169 Issue: 4 Pages: 227-228 Published: 1984
Times Cited: 0
67. Title: INDUCTION OF SISTER-CHROMATID EXCHANGE IN HUMANLYMPHOCYTES BY VITAMIN-B6
Author(s): DOZIVASSILIADES J, MOURELATOS D, MYRTSIOTIS A
Source: MUTATION RESEARCH Volume: 124 Issue: 2 Pages: 175-178 Published: 1983
Times Cited: 3
68. Title: ENHANCEMENT BY METHYLXANTHINES OF SISTERCHROMATID EXCHANGE FREQUENCY INDUCED BY CYTOSTATICS IN NORMAL AND
LEUKEMIC HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, DOZIVASSILIADES J, TSIGALIDOUBALLA V, et al.
Source: MUTATION RESEARCH Volume: 121 Issue: 2 Pages: 147-152 Published: 1983
Times Cited: 11
69. Title: ANTI-TUMOR AGENTS ACT SYNERGISTICALLY WITH
METHYLXANTHINES ON SISTER-CHROMATID EXCHANGE INDUCTION IN HUMANLYMPHOCYTES - INVITRO AND INVIVO INVITRO STUDIES
Author(s): MOURELATOS D, DOZIVASSILIADES J, TSIGALIDOUBALLA V, et al.
Source: MUTATION RESEARCH Volume: 113 Issue: 3-4 Pages: 283-283 Published: 1983
Times Cited: 0
70. Title: ANTI-TUMOR ALKYLATING-AGENTS ACT SYNERGISTICALLY
WITH METHYLXANTHINES ON INDUCTION OF SISTER-CHROMATID EXCHANGE IN
HUMAN-LYMPHOCYTES
Author(s): MOURELATOS D, DOZIVASSILIADES J, GRANITSAS A
Source: MUTATION RESEARCH Volume: 104 Issue: 4-5 Pages: 243-247 Published: 1982
Times Cited: 14
71. Title: PHOTOCHEMOTHERAPY AND THE RISK OF SKIN-CANCER
Author(s): MOURELATOS DC
Source: LANCET Volume: 2 Issue: 8139 Pages: 424-424 Published: 1979
Times Cited: 0
72. Title: ENHANCEMENT BY CAFFEINE OF SISTER-CHROMATID EXCHANGE
FREQUENCY INDUCED BY ANTI-NEOPLASTIC AGENTS IN HUMAN-LYMPHOCYTES
Author(s): MOURELATOS DC
Source: EXPERIENTIA Volume: 35 Issue: 6 Pages: 822-824 Published: 1979
Times Cited: 11
73. Title: ENHANCEMENT BY CAFFEINE OF SISTER-CHROMATID
EXCHANGE FREQUENCY IN LYMPHOCYTES FROM NORMAL SUBJECTS AFTER
TREATMENT BY MUTAGENS
Author(s): FAED MJW, MOURELATOS D
Source: MUTATION RESEARCH Volume: 49 Issue: 3 Pages: 437-440 Published: 1978
Times Cited: 50
74. Title: SISTER CHROMATID EXCHANGES IN LYMPHOCYTES OF
PSORIATICS AFTER TREATMENT WITH 8-METHOXYPSORALEN AND LONG WAVE
ULTRAVIOLET-RADIATION
Author(s): MOURELATOS D, FAED MJW, GOULD PW, et al.
Source: BRITISH JOURNAL OF DERMATOLOGY Volume: 97 Issue: 6 Pages: 649-654
Published: 1977
Times Cited: 34
75. Title: SISTER CHROMATID EXCHANGES IN HUMAN LYMPHOCYTES
EXPOSED TO 8-METHOXYPSORALEN AND LONG WAVE UV-RADIATION PRIOR TO
INCORPORATION OF BROMODEOXYURIDINE
Author(s): MOURELATOS D, FAED MJW, JOHNSON BE
Source: EXPERIENTIA Volume: 33 Issue: 8 Pages: 1091-1093 Published: 1977
Times Cited: 22
Φιδάνη Στυλιανή
Μέλος
1. Α. Goate, MC.Chartier-Harlin, M.Mullan, J.Brown, F.Crawford, L.Fidani, L.Giuffra,
A.Haynes, N.Irving, L.James, R.Mant, P.Newton, K.Rooke, P.Roques, C.Talbot, M.PericakVance, A.Roses, R.Williamson, M.Rossor, M.Owen, J.Hardy. Segregation of a missense
mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature
349, 704-706, 1991
2. F.Crawford, J.Hardy, M.Mullan, A.Goate, D.Hughes, L.Fidani, P.Roques, M.Rossor,
MC.Chartier-Harlin. Sequencing of exons 16 and 17 of the β-amyloid precursor protein gene
in 14 families with early onset Alzheimer’s disease fails to reveal mutations in the β-amyloid
sequence. Neuroscience Letters 133, 1-2, 1991
3. MC.Chartier-Harlin, F.Crawford, H.Houlden, A.Warren, D.Hughes, L.Fidani A.Goate,
M.Rossor, P.Roques, J.Hardy, M.Mullan. Early-onset Alzheimer’s disease caused by
mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353, 844-846, 1991
4. L.Fidani, K.Rooke, MC.Chartier-Harlin, D.Hughes, R.Tanzi, M.Mullan, P.Roques,
M.Rossor, J.Hardy, A.Goate. Screening for mutations in the open reading frame and promoter
of the β-amyloid precursor protein gene in familial Alzheimer’s disease: identification of a
further family with APP717 ValIle. Human Molecular Genetics 1, 165-168, 1992
5. K.Rooke, A.Goate, L.Fidani, M.Mullan, P.Roques, M.Rossor, J.Hardy, MC.Chartier-Harlin.
Screening of the promoter and the β-amyloid sequence of the APP gene for polymorphism in
families with late onset Alzheimer’s disease. Neurodegeneration 1, 237-240, 1992
6. M.Mullan, H.Houlden, M.Windelspecht, L.Fidani, C.Lombardi, P.Diaz, M.Rossor, R.Crook,
J.Hardy, K.Duff, F.Crawford. Α locus for familial early-onset Alzheimer’s disease on the
long arm of chromosome 14, proximal to the a1-antichymotrypsin gene. Nature Genetics 2,
340-342, 1992
7. L.Fidani, J.Hardy. Chromosome 21 and amyloid plaque proteins in Alzheimer’s disease:
genetic factors and molecular biology. Medicographia 15, 30-33, 1993
8. R.Adroer, C.Lopez-Acedo, R.Oliva, J.Hardy, L.Fidani. A novel silent variant at codon 711
and a variant at codon 708 of APP sequence detected in Spanish Alzheimer and control cases.
Neuroscience Letters 150, 33-34, 1993
9. J.Brown, S.Gydesen, SA.Sorensen, A.Brun, K.Duff, H.Houlden, L.Fidani, S.Kullkarni,
J.Cummings, A.Goate, M.Rossor, J.Hardy Exclusion mapping in familial Non-Specific
Dementia. Dementia 4, 163-166, 1993
10. A. Antoniadis, S.Alexiou-Daniel, L.Fidani, E.F.K.Bautz. Comparison of the clinical and
serologic diagnosis of haemorrhagic fever with renal syndrome (HFRS) and leptospirosis.
European Journal of Epidemiology 11, 91-92, 1994
11. J.Brown, P.L.Lantos, P.Roques, L.Fidani, M.N.Rossor. Familial dementia with swollen
achromatic and corticobasal inclusion bodies: a clinical and pathological study. Journal of
Neurological Sciences 135, 21-30, 1996
12. F. Athanassiadou, D.Catriu, M. Hatzistilianou, T.Papageorgiou, S.Fidani. Effect of GM-CSF
on TNF-a, IL-3 and Il-7 levels in vitro and in vivo in children with acute lymphoblastic
leukaemia (ALL). Haema 2, 139-144, 1999
13. M.Hatzistilianou, L.Fidani, F.Athanassiadou, T. Papageorgiou, D.Catriu. Identification of
t(12;21) and minimal residual disease detection using RT-PCR in childhood B-lineage ALL.
Haema 3, 233-235, 2000
14. F. Athanassiadou, L.Fidani, Th. Papageorgiou, M. Hatzistilianou, D.Catriu. Acute
lymphoblastic leukaemia and urticaria pigmentosa. Medical and Pediatric Oncology 34, 368369, 2000
15. L.Fidani, D. Compton, J. Hardy, R.C. Petersen, E Tangalos, V. Mirtsou, A. Goulas, F.
Wavrant De Vrieze. No association between the lipoprotein lipase S447X polymorphism and
Alzheimer’s disease. Neuroscience Letters 322, 192-194, 2002
16. L. Fidani, A. Goulas, V. Mirtsou, R. Petersen, E. Tangalos, R. Crook, J. Hardy. Interleukin1A polymorphism is not associated with late onset Alzheimer’s disease. Neuroscience Letters
323, 81-83, 2002.
17. A. Goulas, L. Fidani, A. Kotsis, V. Mirtsou, R.C. Petersen, E Tangalos, J. Hardy. An
association study of a functional catalase gene polymorphism, -262C T, and patients with
Alzheimer’s disease. Neuroscience Letters 330, 210-212, 2002.
18. F. Athanassiadou, L. Fidani, A. Stefanidis, G. Karkavelas, T. Papageorgiou. Giant cell tumor
of the rib in a 12 year-old girl: a case report. Pediatric Hematology and Oncology 20, 351355, 2003
19. L. Fidani, A. Goulas, R. Crook, R. Petersen, E. Tangalos, A. Kotsis, J. Hardy. An association
study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset
Alzheimer’s disease. Neuroscience Letters 357, 152-154, 2004
20. L. Fidani, F. Athanassiadou-Piperopoulou, A. Goulas, K. Chatzidakis, D. Koliouskas, A.
Kotsis. An association study of the tumor necrosis factor alpha C-850T polymorphism and
childhood acute lymphoblastic leukemia in a population from northern Greece. Leukemia
Research 28, 1053-1055, 2004
21. L. Fidani, A. I. Hatzitolios, A. Goulas, C. Savopoulos, C. Basayannis, A. Kotsis. Cholesteryl
ester transfer protein TaqI B and lipoprotein lipase Ser447Ter gene polymorphisms are not
associated with ischaemic stroke in Greek patients. Neuroscience Letters 384, 102-105, 2005
22. K. Chatzidakis, A.Goulas, F.Athanassiadou-Piperopoulou, L. Fidani, D. Koliouskas, V.
Mirtsou. Methylenetetrahydrofolate reductase C677T polymorphism: Association with risk
for childhood acute lymphoblastic leukemia and response during the initial phase of
chemotherapy in Greek patients. Pediatric Blood and Cancer 47, 147-151, 2006
23. L. Fidani, K. Kalinderi, S. Bostantjopoulou, J. Clarimon, A. Goulas, Z. Katsarou, J. Hardy,
A. Kotsis. Association of the Tau haplotype with Parkinson's disease in the Greek population.
Movement Disorders 21, 1036-1039, 2006
24. L. Fidani, J. Clarimon, A. Goulas, A. I. Hatzitolios, W. Evans, E. Tsirogianni, J. Hardy, A.
Kotsis. Association of phosphodiesterase 4D gene G0 haplotype and ischaemic stroke in a
Greek population. European Journal of Neurology 14, 745-749, 2007
25. K. Kalinderi, L. Fidani, S. Bostantjopoulou, Z. Katsarou, A. Kotsis. The G2019S LRRK2
mutation is uncommon amongst Greek patients with sporadic Parkinson’s disease. European
Journal of Neurology 14, 1088-1090, 2007
26. A. Goulas, M. Kosmidou, A.I. Hatzitolios, N. Raikos, D. Molyva, C. Savopoulos, S.
Giannopoulos, L. Fidani. An association study of sodium – lithium countertransport activity
with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek
dyslipidaemic patients and controls. Clinical Chemistry and Laboratory Medicine 46, 306310, 2008
27. A. Goulas, M. Kosmidou, A.I. Hatzitolios, D. Molyva, L. Fidani, S. Giannopoulos, V.
Mirtsou. Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B
polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients. Basic and
Clinical Pharmacology and Toxicology 2008, E-pub ahead of print (doi: 10.1111/j.17427843.2008.00220.x)
28. A. Tragiannidis, G. Tzouvelekis, M. Eboriadou, L. Fidani, E. Pavlou, T.Papageorgiou, F.
Athanassiadou. Septic pulmonary embolism due to staphylococcus aureus. Pediatrics
International 2008, in press
29. K. Kalinderi, L. Fidani, S. Bostantjopoulou. From 1997 to 2007: a decade journey through
the H1 haplotype on 17q21 chromosome. Parkinsonism & Related Disorders 2008, in press
30. K. Kalinderi, L. Fidani, G. Kourtesi, Z. Katsarou, E. Mioglou, S. Bostantjopoulou. No
association of the Val158Met COMT polymorphism with Parkinson’s Disease in the Greek
population. European Journal of Neurology 2008, 15(8):83
31. Κ. Kalinderi, S. Bostanjopoulou, C. Paisan-Ruiz, Z. Katsarou, J. Hardy, L.Fidani Complete
screening for glucocerebrosidase mutations in Parkinson disease patients from Greece
Neuroscience Letters 2009, 452:87-89
32. A.Xanthis, A. Hatzitolios, S.Fidani, C.Befani, G.Giannakoulas, G. Koliakos. Receptor of
advanced glycation end products (RAGE) positively regulates CD36 expression and reactive
oxygen species production in human monocytes in diabetes. Angiology 2009,
33. Kalinderi K., Fidani L., Katsarou Z., Clarimon J., Bostanjopoulou S., Kotsis A. GSK3beta
polymorphisms MAPTH1 haplotype and Parkinson’s disease in a Greek cohort.
Neurobiology of Aging 2009 Epub ahead of print
34. Dimitriadou M., Christoforidis A., Economou M., Tsatra I., Vlachaki E., Fidani L., Katzos
G., Athanassiou-Metaxa M. Elevated serum parathormone levels are associated with
myocardial iron overload in patients with beta-thalassaemia major. Eur. J. Haematol. 2009
Epub ahead of print
35. Λ.Φιδάνη. Η μοριακή γενετική της νόσου του Alzheimer. Ελληνική Ιατρική 59, 141-147,
1993
36. Α. Παπαχρίστου, Β. Αιβάζης, Π. Μητσέας, Σ. Φιδάνη, Σ. Παυλάτος, Ε. Μπουρλή.
Εκτίμηση της παχυσαρκίας από το βάρος και την πτυχή δέρματος του τρικεφάλου σε παιδιά
6-18 χρονών. Παιδιατρικά Χρονικά 23, pp181-189, 1998
37. Λ.Φιδάνη, Φ. Αθανασιάδου. Γενετικές διαταραχές στις λευχαιμίες της παιδικής ηλικίας.
Παιδιατρική Βορείου Ελλαδος 11, 77-83,1999
38. Λ. Φιδάνη-Γούλα, Φ. Αθανασιάδου-Πιπεροπούλου. Γονιδιακή προσέγγιση στους συμπαγείς
όγκους της παιδικής ηλικίας. Παιδιατρική Βορείου Ελλάδος 13, 316-323, 2001
39. Λ. Φιδανη, Γ. Καπρίνης. Η προσέγγιση της μοριακής ιατρικής στην ψυχιατρική. Ψυχιατρική
13, 17-27, 2002
40. Α. Γούλας, Λ. Φιδάνη. Φαρμακογενετική: Νεότερα δεδομένα και κλινικές εφαρμογές.
Ελληνική Ιατρική 68, 38-45, 2002
41. Κ. Παπαπολυχρονιάδης, Δ. Καιμάκης, Η. Χαραλαμπόπουλος, Β. Παπαδόπουλος, Α.
Μιχαλόπουλος, Χ. Σαρδέλλη, Λ. Φιδάνη, Ν. Χαρλαύτης. Κλειστές κακώσεις θωρακικού
τοιχώματος. Ταξινόμηση-αντιμετώπιση. Γαληνός 45, 146-153, 2003
42. Μ. Διδάγγελος, Σ. Λέββα, Λ. Φιδάνη. Γονιδιακό Doping. Επιθεώρηση Κλινικής
Φαρμακολογίας και Φαρμακοκινητικής 24, 149-157, 2006
43. Λ. Φιδάνη, Α. Γιαννόπουλος, Α. Τραγιαννίδης, Γ. Τζουβελέκης, Κ. Καλινδέρη, Α. Κώτσης,
Ι. Καβαλιώτης, Φ. Αθανασιάδου. Μελέτη του γονιδιακού πολυμορφισμού +405 G/C VEGF
και των κλινικοεργαστηριακών ευρημάτων σε παιδιά με Νόσο Kawasaki. Παιδιατρική 70,
379-384, 2007
44. Μ. Αποστολοπούλου, Α. Χατζητόλιος, Λ. Φιδάνη, Χ. Σαββόπουλος. Ο πολυμορφισμός
A1166C του υποδοχέα τύπου 1 της αγγειοτενσίνης ΙΙ στα αγγειακά εγκεφαλικά επεισόδια:
Ένας νέος γονιδιακός δείκτης πρόβλεψης; Αρτηριακή Υπέρταση, 16, 2007
45. K. Kalinderi, L. Fidani, S. Bostantjopoulou. Genetics of familial Parkinson’s disease.
Aristotle University Medical Journal 34, 9-18, 2007
Ανδρεάδης Δημήτριος
Μέλος
ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΞΕΝΟΓΛΩΣΣΑ ΠΕΡΙΟΔΙΚΑ(Citations 41)
1. Andreadis D, Nomikos A, Barbatis C. Metastatic Renal Clear Cell Carcinoma in parotid gland:
A study of immunohistochemical profile and cell adhesion molecules (CAMs) expression in two
cases. Pathol Oncol Res 2007;13(2):161-165
(IF2006): 1241)
2. Andreadis D, Gagari E, Laskaris G, Kapsokefalos P. Idiopathic Sweet’s syndrome with oral
manifestations. Report of a case and review of the literature. Acta Stomatologica Croatica
2007;41(2):152-58
3. Epivatianos A, Poulopoulos A, Dimitrakopoulos I, Andreadis D, Nomikos A, Vlachou S,
Papazoglou G, Barbatis C. Application of a-smooth muscle actin and C-KIT in the differential
diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Oral
Oncology 2007;43(1):67-76
(IF2005: 2569) (Citations: 2)
4. Andreadis D, Lorenzini G, Drakoulakos D, Belazi M, Mihailidou E, Velkos G, MourellouTsatsou O, Antoniades D. Detection of pemphigus desmoglein 1 and 3 autoantibodies and
pemphigoid BP180 autoantibodies in saliva and comparison with serum values. Eur J Oral Sci
2006;114(5):374-380
(IF2005:
1747) (Citations: 1)
5. Andreadis D, Epivatianos A, Mireas G, Nomikos A, Poulopoulos A, Yiotakis J, Barbatis C.
Immunohistochemical detection of E-cadherin in certain types of salivary gland tumors. J
Laryngol Otol 2006;120:298-304
(IF2005: 0.561) (Citations: 3)
6. Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Christidis K, Barbatis C.
Carcinosarcoma of parotid. Immunohistochemical analysis with emphasis in cell cycle mitotic
activity and cell adhesion molecules expression. Oral Oncol EXTRA 2006;42:140-143
(IF2005: 2103)
7. Andreadis D, Nomikos A, Poulopoulos A, Epivatianos A, Barbatis C. Diagnosis of a metastatic
malignant melanoma in parotid gland. Report of a case. Oral Oncol EXTRA 2006;42:137-139
(IF2005: 2103)
8. Antoniades D, Markopoulos A, Andreadis D, Balaskas I, Patrikalou E, Grekas D. Ulcerative
uremic stomatitis associated with untreated chronic renal failure: report of a case and review of
the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101(5):608-613
(IF2005: 1221) (Citations: 2)
9. Antoniades DZ, Markopoulos AK, Deligianni E, Andreadis D. Bilateral aplasia of parotid
glands correlated with accessory parotid tissue. J Laryngol Otol 2006;120:327-329
(IF2005: 0.561) (Citations: 1)
10. Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Papazoglou G, Antoniades D, Barbatis
C. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral
Oncol. 2006;42(1):57-65
(IF2005: 2103) (Citations: 7)
11. Andreadis D, Nomikos A, Epivatianos A, Poulopoulos A, Barbatis C. Basaloid Squamous
Carcinoma versus Basal Cell Adenocarcinoma of the oral cavity. Pathology 2005;37(6):560-563
(IF2005: 1471) (Citations: 3)
12. Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Christidis K, Papazoglou G,
Antoniades D, Barbatis C. Immunohistochemical detection of the expression of the cell adhesion
molecules E-cadherin, desmoglein-2, beta4-integrin, ICAM-1 and HCAM (CD44s) in Warthin's
tumour of the parotid gland. Oral Oncol. 2005;41(8):799-805
(IF2005:
2266) (Citations: 1)
13. Poulopoulos A, Andreadis D, Epivatianos A, Antoniades D. Basal cell adenocarcinoma of the
minor salivary gland: Case report and cell adhesion molecules immunocytochemical profile.
Oral Oncology EXTRA 2005;41(7):150-153
(IF2005: 2266) (Citations: 1)
14. Andreades DA, Belazi M, Antoniades DZ. Diagnosis of a maxillary brown tumor associated with
hyperparathyroidism secondary to chronic renal failure. Report of a case. Oral Health Prev
Dent 2004;2:143-147
(Citations: 1)
15. Andreadis DA, Rizos CB, Belazi M, Peneva M, Antoniades DZ. Encephalocraniocutaneous
Lipomatosis accompanied by maxillary compound odontoma and juvenile angiofibroma. Report
of a case. Birth Defects Research Part A: Clinical and Molecular Teratology 2004;70(11):889891
(IF2004: 0,910) (Citations:
3)
16. Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C,
Destouni E, Antoniades D. Oral candida isolates in patients undergoing radiotherapy for head
and neck cancer. Prevalence, azole susceptibility profile and response in antifungal treatment.
Oral Microbiol Immunol 2004;19:347-351
(IF2004:
1759) (Citations: 16)
17. Belazi M, Fleva A, Markopoulos A, Andreadis D, Drakoulakos D, Daniilidou N, Michailidou E,
Karamitsos D. Serum and saliva levels of IL-2 in children with Insulin – Dependent Diabetes
Mellitus. Balk J Stom 2004;8:240-242
18. Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Solonaki F, Hini S, Antoniades D.
In vitro susceptibility of oral candida species to antifungal agents in renal transplant recipients.
Rev Clin Pharmacol Pharmacokin Int 2004;18:94-97
ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΕΛΛΗΝΙΚΑ ΠΕΡΙΟΔΙΚΑ
19. Ανδρεάδης Δ, Νομικός Α. Μη Ειδικό Διαυγοκυτταρικό Καρκίνωμα των Σιελογόνων Αδένων.
Οδοντοστοματολογική Πρόοδος 2007;61(3):414-425
20. Μπελάζη Μ, Βελεγράκη Α, Κουσίδου-Ερεμόντι Θ, Ανδρεάδης Δ, Κόλλια Κ, ΔεβλιώτουΠαναγιωτίδου Δ. Ο ρόλος των ζυμομυκήτων στη βλεννογονίτιδα κατά τη θεραπεία ογκολογικών
ασθενών: Κλινικά και εργαστηριακά ευρήματα από ασθενείς με καρκίνο κεφαλής και τραχήλου.
Ιατρική 2004;85(6):385-393
21. Κουσίδου-Ερεμόντι Θ, Μπελάζη Μ, Ανδρεάδης Δ, Πουλόπουλος Α, Δεβλιώτου-Παναγιωτίδου Δ,
Αντωνιάδης Δ. Η αντιμετώπιση της βλεννογονίτιδας κατά την ακτινοθεραπεία ασθενών με καρκίνο
κεφαλής και τραχήλου. Στόμα 2004;1:47-53
22. Aνδρεάδης Δ, Μαρκόπουλος Α. Ψυχολογία του ασθενούς με καρκίνο στόματος. Ελλ Π Στομ
Γναθοπροσωπ Χειρ 2001;16:27-35
ΔΗΜΟΣΙΕΥΜΕΝΕΣ ΠΕΡΙΛΗΨΕΙΣ
1. Andreadis D, Poulopoulos A, Nomikos A, Epivatianos A, Christidis C, Barbatis C,
Antoniades D. Altered expression of cell adhesion molecules E-cadherin, desmoglein-2, b4integrin, CD44s(HCAM), and ICAM-1 in acinic cell and salivary ductal adenocarcinomas.
Virchows Arch 2009;455 (Suppl1):S1-482
2. Andreadis D, Poulopoulos A, Nomikos A, Epivatianos A, Christidis C, Barbatis C,
Antoniades D. Epithelial cell adhesion alterations in salivary gland neoplasms. The paradigm
of E-cadherin, desmoglein-2 and b-4 integrin. Virchows Arch 2009;455 (Suppl1):S1-482
3. Epivatianos A, Poulopoulos A, Dimitrakopoulos I, Andreadis D, Nomikos A, Vlachou S,
Papazoglou G, Barbatis C. Application of a-smooth muscle actin and C-KIT in the differential
diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Oral
Oncology Suppl May 2007;2(1):214
(IF2005: 2103)
4. Andreadis D, Laskaris G, Malamos D, Anagnostou D. Plasma-cell Mucositis of the oral
cavity presented as an irregular ulcer: report of a case. Oral Dis Suppl September
2006;12:31
(IF2005: 1445)
5. Doukas-Alexiou M, Georgakopoulou E, Gagari E, Andreadis D, Malamos D, Kapsokefalos
P, Laskaris G. Oral Pemphigus vulgaris: a clinicostatistical review of 157 cases in Greece.
Oral Dis Suppl September 2006;12:5
(IF2005: 1445)
6. Kapsokefalos P, Andreadis D, Doukas-Alexiou M, Georgakopoulou E, Gagari E, Laskaris G.
Mucous membrane pemphigoid: epidemiological findings on 149 patients with oral
involvement. Oral Dis Suppl September 2006;12:15
(IF2005:
1445)
7. Barbatis C, Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Christidis K,
Papazoglou G, Antoniades D (abstract). Expression and topographical distribution of cell
adhesion molecules E-cadherin, beta4-integrin, desmoglein-2, ICAM-1 and HCAM (CD44s)
in pleomorphic adenomas of salivary glands. Oral Oncol Suppl April 2005;1(1):135-136
(IF2005: 2266)
8. Poulopoulos A, Andreadis D, Epivatianos A, Nomikos A, Barbatis C, Antoniades D
(abstract). Intraoral basal cell adenocarcinoma. Report of a case, with regards to
histological - immunohistochemical findings and the expression of cell adhesion molecules.
Oral Oncol Suppl April 2005; 1(1): 174-175
(IF2005: 2266)
9. Andreadis DA, Markopoulos A: The psychological profile of patients with oral cancer.
(Summary). Mund Kiefer Gesichts Chir 2001;(5): 209-210
Παπαγεωργίου Αθανάσιος
Μέλος
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
«Fractionation of native and denaturated deoxyribonucleoproteins»
K. Ralchev, E. Ruseva, A. Papageorgiou.
Ann. Univ. Sof. 64, 231-245, 1972.
«Observations on the antineoplastic activity of aminimides»
L. Boutis, A. Papageorgiou, T. Toliou and J.J. Κabara.
Current Chemotherapy, 1213 - 1216, 1978.
«New antitumor compounds: Antitumor activity of 3â-hydroxy-13á-amino-13, 17-seco-5á-androstan-17oic-13, 17-lactam-p-bis (2-chloroethyl) amino phenyl butyrate»
P. Catsoulacos, D. Politis, L. Boutis and A. Papageorgiou.
Pharm. Sciences, 67, 1342-1344, 1978.
Antitumor activity of steroidal carbamate derivatives from N,N-bis (2-chloroethyl)-p-phenylenediamine»
P. Catsoulacos, D. Politis, L. Boutis and A. Papageorgiou.
Eur. J. Med. Chem., 15, 473-375, 1980.
«Interaction of homo-aza-steroidal ester of p-bis (2-chloroethyl) amino phenyl acetic acid (ASE) with the
DNA of Ehrlich ascites tumor cells».
A. Papageorgiou, I. Ivanov, G. Markov, S.I. Koliais L. Boutis, and P. Catsoulacos.
FEBS Letters, 153, 194, 1983.
«Does ASE (an alkylating ester) form interstrand cross links in the DNA of Ehrlich ascites tumor cells
(EAT)?»
A. Papageorgiou, I. Ivanov, G. Markov, L. Boutis, and P. Catsoulacos.
Anticancer Research, 4 (1), 9-12, 1984.
«Studies on the effect of homo-aza-steroidal ester of p-bis (2-chloroethyl) amino phenyl acetic acid».
A. Papageorgiou, S.I. Koliais, O. Antonoglou, P. Catsoulacos, and L. Boutis.
Methods and Finding in Experimental and Clinical Pharmacology, 6, 5-9, 1984.
«Synthesis and antitumor activity of a novel diplatinum complex of the binucleating Naphtazarinato
ligand».
V.P. Papageorgiou, M. Christianopoulou, C. Tsipis, L. Boutis and A. Papageorgiou.
Inorganica Chimica Acta, 124, 203-206, 1986.
«Further studies on the antineoplastic activity of Homo-aza-steroidal esters»
G. Pairas, P. Catsoulacos, A. Papageorgiou and L. Boutis.
Oncology, 43, 344-348, 1986.
«Induction of 2’, 5’ -oligo (A) synthetase in animals bearing Ehrlich ascites tumor cells»
G. Galactidou, A. Kortsaris, A. Papageorgiou and S.I. Koliais.
Microbiologica, 10, 143-150, 1987.
«Response of transplantable tumors in mice and macromolecular synthesis to 17β-acetamido-3-azahomo-4α-androsten-4-one»
C. Athanasiou, P. Catsoulacos, A. Papageorgiou and K. Athanasiou.
Cancer Investigation, 5, 301-307, 1987.
«Induction of cytogenetic damage by modified steroidal derivatives of p-bis (2-chloro ethyl) amino
phenyl acetic acid in human lymphocytes»
D. Mourelatos, C. Petrou, L. Boutis, A. Papageorgiou, P. Catsoulacos and J. Dozi-Vassiliades
Mutation Research, 190, 205-210, 1987. 2.065
«Potential Antitumor Agents: Steroidal Aminodoesters with an Alkylating Moiety»
A. Papageorgiou, L. Boutis, S. Nikolaropoulos and P. Catsoulacos.
Oncology, 44, 128-132, 1987.
«Increased protective activity against acid precipitation of poly (U) in the serum of tumor-bearing mice»
D. Kouretas, A. Papageorgiou and O. Antonoglou
Anticancer Research, 8, 1307-1312, 1988.
15.
16.
17.
18.
19.
20.
21.
«Comparative study on cytogenetic effects by diplatinum complexes of the ligands of naphthazarine and
squaric acid in Human lymphocytes»
Th. Lialiaris, D. Mourelatos, L. Boutis, A. Papageorgiou, M. Christianopoulou, V. Papageorgiou, J.
Dozi-Vassiliades
J. Pharmacol. Exp. Therapeutics, 251, 368-371, 1989.
«Chemical synthesis and characteristics of an hybrid phase T5-lac promoter»
I. Ivanov, J. Rommens, A. Safarova, V. Maximova, A. Usheva and A. Papageorgiou.
Microbiologica, 13, 85-90, 1990.
«A comparison of the sequences of segment A of four infectious bursal disease virus strains and
identification of a variable region in VP2»
C.D. Bayliss, U. Spies, K. Shaw, R.W. Peters, A. Papageorgiou, H. Muller, M.E. Boursnell.
J. Gen. Virology, 71 (Pt.6), 1303-12, 1990
«4-Aroyl-1 nitrosohydrasinecarboxamides: Synthesis, in vivo and in vitro antitumor activity»
R. Gugova, A. Papageorgiou, S.I. Taksirov, V.V. Topakbahian, E. Margariti, L. Boutis, D. Mourelatos, J.
Dozi-Vassiliades, E.V. Golovinsky and G.D. Demitov.
Eur. J. Med. Chem., 27, 745-750, 1992.
«Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-Activity relationships».
P. Catsoulacos, Ch. Camoutsis, A. Papageorgiou and E. Margariti.
Anticancer Research, 12, 1617-1620, 1992.
«A comparative study of the cytogenetic and antineoplastic effects induced by modified steroidal
derivatives of p-bis (2-chloroethyl) amino phenyl propionic acid in human lymphocytes in vitro and in
three transplantable tumors in vivo».
A. Papageorgiou, L. Boutis, D. Mourelatos, J. Dozi-Vassiliades and P. Catsoulacos.
J. Occup. Med. Toxicol, 1, 199-208, 1992.
«Structure-Anticancer and Structure-Genetic activity relationships of homo-aza-steroidal esters of N, Nbis (2-chloroethyl) amino cinnamic acid isomers».
P. Catsoulacos, Ch. Camoutsis, A. Papageorgiou, E. Margariti, K. Psaraki and N. Demopoulos.
Journal of Pharmaceutical Sciences, 82 (2), 204-208, 1993
22.
«On the formation of homo-aza-steroidal esters of N, N-bis (2-chloroethyl) amino benzoic acid isomers
and their antitumor activity».
A. Anastasiou, P. Catsoulacos, A. Papageorgiou and E. Margariti.
J. Heterocyclic Chemistry, 31, 367-374, 1994.
23.
«Comparison of current alkylating agents with an homo-aza-steroidal ester for antineoplastic activity».
P. Catsoulacos, A. Papageorgiou, E. Margariti, D. Mourelatos and E. Mioglou.
Oncology, 51, 74-78, 1994.
«Comparative study on cytogenetic damage induced by homo-aza-steroidal esters in human
lymphocytes»
D. Mourelatos, A. Papageorgiou, L. Boutis and P. Catsoulacos.
Mut. Res. Enviromental, 334, 19-22, 1995.
«Comparative study of SCE induction and cytogenetic effects by homo-aza-steroidal esters of N, N-bis
(2-chloroethyl) amino benzoic acid in human lymphocytes»
D. Mourelatos, E. Mylonaki, A. Papageorgiou, L. Boutis, A. Paradelis, A. Anastasiou and P. Catsoulacos.
Mut. Res. Letters, 346, 129-133, 1995.
«On the formation of estrone lactam esters of N, N-bis (2-chloroethyl) amino cinnamic acid isomers, p-N,
N-bis (2-chloroethyl) amino phenyl butyric acid and their antitumor activity».
P. Catsoulacos, G. Pairas and A. Papageorgiou.
J. Heterocyclic Chem. , 32, 1063-1065, 1995.
«Potential Antitumor Agent: Steroidal bilactam ester of p-N, N-bis (2-chloroethy) amino phenyl acetic
acid»
P. Catsoulacos, Ch. Camoutsis and A. Papageorgiou.
Anticancer Research, 15, 827-830, 1995.
«Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide
mononitrate and dinitrate».
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
E. Pipili, A. Papageorgiou, G. Sotiropoulou, T. Fotsis, G. Karakiulakis, M.E. Maragoudakis.
Br. J. Pharmacology, 116, 1829-34, 1995.
«In vivo binding of the radio iodinated peptide ΥΙGSR on B16 melanoma cells»
Q. Koliakos, G. Koliakos, A. Papageorgiou, S. Iliadis, A. Triantos, A. Dimitriadou, M. Kanellaki.
Invasion Metastasis, 16, 322-29, 1996.
«A comparative study of the cytogenetic and antineoplastic effects induced by steroidal aminodoesters of
p-N, N-bis (2-chloroethyl) amino phenyl butyric acid (Chlorambucil)».
A. Papageorgiou, P. Catsoulacos, D. Catsoulacos, D. Mourelatos, E. Mioglou-Kalouptsi, Z. IakovidouKrsitsi, L. Boutis, A. Kotsis.
The Cancer Journal, 9 (4), 203, 206, 1996.
«Palladium (II) complexes of 2-acetylpyridine N (4)-propyl, N (4)-dipropyl and 3hexamethyleneiminythiosemicarbazones with potentially interesting biological activity. Synthesis,
spectral properties, antifungal and in vitro antitumor activity».
D. Kovala-Demertzi, A. Demopoulou, A. Mavroudis, A. Papageorgiou and D.X. West.
New Palladium Complexes, 16 (20), 3625-3633, 1997.
«Antineoplastic and cytogenetic effects of complexes of Pd(II) with 4-N-substituted Derivatives of 2Acetyl-Pyridine-Thiosemicarbazone»
A. Papageorgiou, Z. Iakovidou, D. Mourelatos, E. Mioglou, L. Boutis, A. Kotsis, D. Kovala-Demertzi, A.
Demopoulou, D.X. West and M.A. Demertzis.
Anticancer Research, 17, 246-252, 1997.
«Palladium (II) complexes of 2-acetylpyridine N (4)-Methyl, N (4)-Ethyl and N (4)-PhenylThiosemicarbazones. Crystal structure of chloro (2-Acetylpyridine, N (4) Methylthiosemicaarbazonate.
Palladium (II)
Synthesis, spectral studies, in vitro and in vivo antitumor activity».
D. Kovala-Demertzi, A. Demopoulou, A. Mavroudis, G Valle and A. Papageorgiou.
Journal of Inorganic Biochemistry. 68:177-186, 1997.
«Antitumor and cytogenetic effects of esoteric (ASE) and amidic (ASA) steroidal derivative of p-bis (2chloroethyl) amino phenylacetic acid (CAPA). A comparative study».
S.S. Nikolaropoulos, E.S. Arsenou, A. Papageorgiou and D. Mourelatos.
Journal of Inorganic Biochemistry, 68: 177-186, 1997.
«Antineoplastic and Cytogenetic Effects of Platinum (II) and Palladium (II) Complexes with Pyridine-2Carboxyldehyde-Thiosemicarbazone».
D. Kovala-Demertzi, M.A. Demertzis, V. Veragi, A. Papageorgiou, D. Mourelatos, E. Mioglou, Z.
Iakovidou, A. Kotsis.
Chemotherapy, 44, 6(3) 421-426, 1998.
«Enhanced Cytogenetic and Antineoplastic Effects by the Combined Action of Two Esteric Steroidal
Derivatives of Nitrogen Mustards»
A. Papageorgiou, S.S. Nikolaropoulos, E.S. Arsenou, E. Karaberis, D. Mourelatos, A. Kotsis, E.
Chrysogelou.
Chemotherapy, 45, 1, 61-67, 1999.
«Albumin Possesses Intrinsic Enolase Activity Towards Dihydrotestosterone which can Differentiate
Benign from Malignant Breast Tumors».
Z. Dramanovic, S. Voyatzi, D. Kouretas, D. Sahpazidou, A. Papageorgiou, O. Antonoglou.
Anticancer Research, 19: 4113-4124, 1999.
«Effect of Navelbine on Inhibition of Tumor Growth Cellular Differentiation and Estrogen Receptor
Status on Lewis Lung Carcinoma».
A. Papageorgiou, P. Stravoravdi, D. Sahpazidou, K. Natsis, E. Chrysogelou, TH. Toliou.
Chemotherapy, 46: 188-194, 2000.
«Synergistic antineoplastic and cytogenetic effects by the combined action of two homo-aza-steroidal
esters of nitrogen mustards on P388 and L1210 leukemias in vivo and in vitro».
S. Nikolaropoulos, D. Tsavdaridis, E. Arsenou, A. Papageorgiou, E. Karaberis, D. Mourelatos.
Anticancer Research, 20: 2745-2752, 2000.
«Platinum (II) and Palladium (II) complexes with 2-acetyl-pyridine thiosemicarbazone: Cytogenetic and
antineoplastic effects».
Z. Iakovidou, A. Papageorgiou, MA. Demertzis, E. Mioglou, D. Mourelatos, A. Kotsis, P. Nath Yadav,
D. Kovala-Demertzi.
Anti-Cancer Drugs, 12: 65-70, 2001.
41.
«A comparative study of cytogenetic and antineoplastic effects induced by two modified steroidal
alkylating agents».
A. Papageorgiou, D. Tsavdaridis, GD. Geromichalos, Ch. Camoutsis, E. Karaberis, D. Mourelatos, E.
Chrysogelou, S. Houvartas, A. Kotsis.
Cancer Detection and Prevention, 25(3): 247-252, 2001.
42.
«Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal
esters of {p-[bis(2-chloroethyl)amino]pnehyl}butyric acid».
Ch. Camoutsis, D. Catsoulacos, V. Karayani, A. Papageorgiou, D. Mourelatos, E. Mioglou, Z. Kritsi.
Cancer Detection and Prevention, 25(6): 558-564, 2001
43.
«7-Keto hybrid steroidal esters of nitrogen nustard: cytogenetic and antineoplastic effects».
V. Karayianni, A. Papageorgiou, E. Mioglou, Z. Iakovidou, D. Mourelatos, M. Fousteris, A. Koutsourea,
E. Arsenou and S. Nikolaropoulos.
Anti-Cancer Drugs, 13: 1-8, 2002.
«Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA)».
M. Fousteris, A. Koutsourea, E. Arsenou, A. Papageorgiou, D. Mourelatos and S. Nikolaropoulos.
Anticancer Research, 22: 2293-2300, 2002.
44.
45.
«Antiidiotypic Antibodies Carrying the “Internal Image” of Peptide YIGSR Inhibit Spontaneous
Metastasis of Lewis Lung Carcinoma in Mice».
K. Kouzi-Koliakou, Z. Sapountzi, A. Papageorgiou, V. Trachana, S. Kotsinou, G. Koliakos.
In vivo, 16: 511-518, 2002.
46.
«Slowing Growth and Histology Changes in Lewis Lung Carcinoma Implanted in a Partly Denervated
Muscle».
A. Papageorgiou, Ch. Trontzos, H. Kallistratos, B. Kokkas, N. Grigoriadis, Ph. Grammatikos.
Cancer Investigation vol. 21, (6): 869-872, 2003.
47.
«Apoptotic changes and uptake of 99mTc-MIBI in Lewis lung carcinoma implanted in a partly denervated
muscle in mice».
A. Papageorgiou, B. Kokkas, N. Grigoriadis, G. Gerasimou, V. Mirtsou, I. Mylonas, P. Grammaticos.
Hell J Nucl Med, 6(2): 88-90, 2003
48.
«The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of chlorambucil’s
active metabolite».
E. Arsenou, M. A. Fousteris, A. I. Koutsourea, A. Papageorgiou, V. Karayianni, E. Mioglou, Z.
Iakovidou, D. Mourelatos, S. S. Nikolaropoulos.
Anti-Cancer Drugs, 15(10): 1-8, 2004.
49.
«Antitumor effect of a- and d- lactam androgen nitrogen mustards on non-small cell lung carcinoma».
D. T. Trafalis, C. Camoutsis, P. Dalezis, A. Papageorgiou, M. Kontos, P. Karamanakos, G. Giannakos,
A. E. Athanassiou.
Journal of BUON, 9: 275-282, 2004.
50.
«Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against
lymphoid leukemia».
D. T. Trafalis, D. Tsavdaridis, C. Camoutsis, V. Karayani, D. Mourelatos, E. Chrysogelou, P. Dalezis, A.
E. Athanassiou, G. A. Pangalis, A. Papageorgiou.
Br J Haematology, 128: 343-350, 2004.
51.
«Cytotoxic effects of a mixed ligand copper(II) chelate complex against a panel of human and murine
cancer cells in vitro. Theoretical study of the mechanism of biologic action through molecular
modeling».I
G.D. Geromichalos, G.A. Katsoulos, A. Papageorgiou, D.T. Trafalis, C.C. Hadjikostas, S.H. Voyatzi, P.
Stravoravdi.
Journal of BUON, 9: 433-441, 2004.
52.
«Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in
vivo».
D.T.P. Trafalis, E. Chrysogelou, P. Dalezis, G. Geromichalos, M. Kontos, C. Andreadis, N. Ziras, M.
Koutsilieris, A.E. Athanassiou, G.A. Pangalis, A. Papageorgiou.
Journal of BUON 10 (1): 89-94, 2005.
53.
«Synergistic interaction between a novel mixed ligand copper(II) chelate complex and a panel of
anticancer agents in T47D human breast cancer cells in vitro».
G.D. Geromichalos, G.A. Katsoulos, D.T. Trafalis, C.C. Hadjikostas, A. Papageorgiou.
Journal of BUON 10 (2): 235-240, 2005.
54.
«A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma».
Trafalis DT, Geromichalos GD, Bountouroglou N, Koumbi D, Kontos M, Sougias D, Dalezis P,
Karamanakos P, Papageorgiou A, Camoutsis C, Athanassiou AE.
Journal of BUON 10(2): 227-34, 2005.
55.
«Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with
conventional chemotherapeutics in malignant melanoma».
Trafalis DT, Camoutsis C, Papageorgiou A.
Melanoma Res. 15(4): 273-81, 2005.
56.
«In vivo anticancer, anti-inflammatory, and toxicity studies of mixed-ligand Cu(II) complexes of dien and
its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline. Crystal structure of
[Cu(dien)(Br)(2a-2tzn)](Br)(H(2)O)».
Chaviara AT, Christidis PC, Papageorgiou A, Chrysogelou E, Hadjipavlou-Litina DJ, Bolos CA.
J Inorg Biochem. 99(11): 2102-9, 2005.
57.
«Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified
steroidal esters of chlorambucil's active metabolite».
Papageorgiou A, Koutsourea AI, Arsenou ES, Fousteris MA, Mourelatos D, Nikolaropoulos SS.
Anticancer Drugs. 16(10): 1075-82, 2005.
58.
«On the formation of 4-[N,N-bis(2-chloroethyl)amino]phenyl acetic acid esters of hecogenin and azahomo-hecogenin and their antileukemic activity».
Camoutsis C, Trafalis D, Pairas G, Papageorgiou A.
Farmaco. 60(10): 826-9, 2005.
59.
«Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against
lymphoid leukaemia».
Trafalis DT, Tsavdaridis D, Camoutsis C, Karayiani V, Mourelatos D, Dalezis P, Athanassiou A,
Pangalis GA, Papageorgiou A.
Br J Haematol. 128(3): 343-50, 2005.
60.
«NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with
adriamycin (ADR) ».
Papageorgiou A, Andreadis C, Boutis A, Lialiaris TS, Mouratidou D.
Anticancer Res. 26(1A): 243-248, 2006.
61.
«Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer agents
in T47D human breast cancer cells in vitro».
Geromichalos GD, Trafalis DT, Katsoulos GA, Papageorgiou A, Dalezis P, Triandafillidis EB,
Hadjikostas CC, Athanassiou A.
J BUON.11(4): 469-76, 2006.
62.
«Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro».
Dalezis P, Geromichalos GD, Voyatzi S, Trafalis D, Athanassiou AE, Koutsilieris M, Papageorgiou A.
J BUON. 11(3): 323-7, 2006.
63.
«Cyclin-dependent kinase (CDK) inhibitor olomoucine enhances gamma-irradiation-induced apoptosis
and cell cycle arrest in Raji cells».
Boutis A, Papazisis K, Pistevou-Gompaki K, Lambropoulos A, Sofroniadis I, Papageorgiou A, Destouni
E, Kortsaris A.
Anticancer Res. 26(5A): 3493-8, 2006.
64.
«Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer».
Trafalis DT, Geromichalos GD, Koukoulitsa C, Papageorgiou A, Karamanakos P, Camoutsis C.
Breast Cancer Res Treat. 97(1): 17-31, 2006.
65.
«Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified
steroidal esters of chlorambucil».
Fousteris MA, Koutsourea AI, Arsenou ES, Papageorgiou A, Mourelatos D, Nikolaropoulos SS.
Anticancer Drugs. 17(5): 511-9, 2006.
66.
«Antileukemic and cytogenetic activity by triple administration of three modified steroidal derivatives of
nitrogen mustards».
Fousteris MA, Papageorgiou A, Arsenou ES, Koutsourea AI, Karaberis E, Mourelatos D, Onyango DO,
Nikolaropoulos SS.
Chemotherapy. 53(2): 118-26, 2007.
67.
«Synergistic Antitumor Activity of Oxaliplatin in Combination with Gemcitabine in Pancreatic TumorBearing Mice».
Moschidis A, Papageorgiou A, Atmatzidis K, Tsalis K, Moschidis E, Livanis J, Chrysogelou E,
Mourelatos D, Tsavdaridis D, Harlaftis N.
Chemotherapy. 53(3): 153-159, 2007.
68.
«Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and
antineoplastic activity».
Hussein A, Mioglou-Kalouptsi E, Papageorgiou A, Karapidaki I, Iakovidou-Kritsi Z, Lialiaris Th,
Xrysogelou E, Camoutsis Ch and Mourelatos D.
In vivo. 21: 389-396, 2007.
69.
«Adsorption of oxaliplatin by hydroxyapatite».
Betsiou M, Sikalidis C, Papageorgiou A.
Bioautomation. 8(Suppl. 1): 138-145, 2007.
70.
«Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating
steroidal esters».
Koutsourea A, Fousteris M, Arsenou E, Papageorgiou A, PairasG, Nikolaropoulos S.
Bioorganic & Medicinal Chemistry. 16: 5207-5215, 2008
71.
«Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PAN02».
Papageorgiou A, Lialiaris Th, Stergiou E, Stergiou I, Tsigris C, Kourti A, Geromichalos G, Stravoravdi
P, Trafalis D, Athanassiou A, Pitsas A, Camoutsis Ch.
Journal of BUON. 13: 235-239, 2008
72.
«Synthesis, characterization, crystal structure, in vitro and in vivo antitumor activity of palladium(II) and
zinc(II) complexes with 2-formyl and 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl
thiosemicarbazone».
Kovala-Demertzi D, Alexandratos A, Papageorgiou A, Yadav P, Dalezis P, Demetzis M.
Polyhedron. 27(13): 2731-2738, 2008.
73.
«Synthesis, in vivo antileukemic evaluation and comparative study of novel 5alpha-7-keto steroidal esters
of chlorambucil»..
Koutsourea A, Fousteris M, Arsenou E, Papageorgiou A, Pairas G, Nikolaropoulos S.
In vivo. 22(3): 345-352, 2008.
74.
«Synthesis, characterization and antileukemic activity of 7-hydroxy-8-acetylcoumarin
benzoylhydrazone».
Kotali A, Lafazanis I, Papageorgiou A, Chrysogelou E, Lialiaris Th, Sinakos Z.
Molbank, M547, 2008.
Γερομιχαλός Γεώργιος
Μέλος
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
In vitro synergistic effect of some novel Cu(II) complexes in combination with epirubicin and
mitomycin C against HeLa-S3 cervical cancer cell line. Geromichalos GD, Katsoulos GA,
Hadjikostas CC, Kortsaris AH, Kyriakidis DA. Anti-Cancer Drugs 7(4); 469-475 (1996)
Optimization of the sulforhodamine B colorimetric assay. Papazisis KT, Geromichalos GD,
Dimitriadis KA, Kortsaris AH. J Immunol Methods 208 (2); 151-158 (1997)
Antiproliferative activity of synthetic tetrapeptides, analogues of AS-I phytotoxin, towards
cancer cell lines. Liakopoulou-Kyriakides M, Stavropoulos G, Geromichalos GD, Papazisis
KT, Kortsaris AH, Kyriakidis DA. Anti-Cancer Drugs 9(2); 175-179 (1998)
In vitro combined effect of a new series of copper(II) complexes with cisplatin or epirubicin on
human breast and cervical cancer cell lines. Geromichalos GD, Katsoulos GA, Hadjikostas
CC, Kortsaris AH, Kyriakidis DA. Drugs under Experimental and Clinical Research 24 (2);
93-104 (1998)
In vitro evaluation of the cytotoxicity of three resin-based root canal sealers. Koulaouzidou
EA, Papazisis KT, Beltes P, Geromichalos GD, Kortsaris AH. Endod Dent Traumatol 14(4);
182-185 (1998)
Effects of melatonin on proliferation of cancer cell lines. Papazisis KT, Kouretas D,
Geromichalos GD, Sivridis E, Tsekreli OK, Dimitriadis K, Kortsaris AH. J Pineal Res 25(4);
211-218 (1998) & Erratum in: Cancer Lett 149(1-2) ;227 (2000).
CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to Cytosinearabinoside. Papazisis KT, Geromichalos GD, Kouretas D, Dimitriadis KA, Kortsaris AH.
Cancer Lett 138(1-2); 221-226 (1999)
Protein tyrosine kinase in hibitor, genistein, enhances apoptosis and cell cycle arrest in K562
cells treated with gamma-irradiation. Papazisis KT, Zambouli D, Kimoundri OT, Papadakis
ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH.
Cancer Lett. 160(1); 107-13 (2000)
Antitumor activity of L-asparaginase from Thermus thermophilus. Pritsa AA, Papazisis KT,
Kortsaris AH, Geromichalos GD, Kyriakidis D. Anticancer Drugs 12(2); 137-42 (2001)
A comparative study of cytogenetic and antineoplastic effects induced by two modified
steroidal alkylating agents. Papageorgiou A, Tsavdaridis D, Geromichalos GD, Camoutsis Ch,
Karaberis E, Mourelatos D, Chrysogelou E, Houvartas S, Kotsis A. Cancer Detection and
Prevention 25(4); 369-374 (2001)
The effects of EB1089 on spontaneous mammary carcinoma (SMC) of C3H/SY mice.
Sahpazidou D, Stravoravdi P, Toliou Th, Geromichalos GD. Vema of Asclipios 1(4); 1-4
(2002)
Significant experimental decrease of the hepatocellular carcinoma (HPC) incidence in C3H/SY
mice after long term administration of EB1089, a vitamin D analogue. Sahpazidou D,
Stravoravdi P, Toliou Th, Geromichalos GD, Zafiriou G, Natsis K, Gigis P. Oncol Res. 13(5);
261-268 (2003)
13.
Cytotoxic effects of a mixed ligand copper(II) chelate complex against a panel of human and
murine cancer cells in vitro. Theoretical study of the mechanism of biologic action through
molecular modelling. Geromichalos GD, Katsoulos GA, Papageorgiou A, Trafalis DT,
Hadjikostas CC, Voyatzi SH, Stravoravdi P. J BUON. 9(4); 433-41 (2004)
14.
VolSurf analysis of pharmacokinetic properties for several antifungal sesquiterpene lactones
isolated from Greek Centaurea sp. Koukoulitsa C, Geromichalos GD, Skaltsa H. J Comput
Aided Mol Des. 19(8); 617-23 (2005)
15.
The effect of an estrone D-lactam steroid ester derivative on breast cancer cells and its
predicted binding interactions with the ligand binding domain of estrogen receptor-alpha.
Kontos M, Nikolopoulou M, Trafalis DT, Geromichalos GD, Koukoulitsa C, Camoutsis JC,
Bastounis E, Karamanakos P. Oncol Res. (Incorporating Anti-Cancer Drug Design) 16(3);
129-42 (2005)
16.
Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic
leukemia in vivo. Trafalis DT, Chrysogelou E, Dalezis P, Geromichalos G, Kontos M,
Andreadis C, Ziras N, Koutsilieris M, Athanassiou AE, Pangalis GA, Papageorgiou A. J
BUON. 10(1); 89-94 (2005)
17.
A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma.
Trafalis DT, Geromichalos GD, Bountouroglou N, Koumbi D, Kontos M, Sougias D, Dalezis
P, Karamanakos P, Papageorgiou A, Camoutsis C, Athanassiou AE. J BUON. 10(2); 227-34
(2005)
18.
Synergistic interaction between a novel mixed ligand copper(II) chelate complex and a panel
of anticancer agents in T47D human breast cancer cells in vitro. Geromichalos GD, Katsoulos
GA, Trafalis DT, Hadjikostas CC, Papageorgiou A. J BUON. 10(2); 235-40 (2005)
19.
Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against
three cell lines in vitro. Papazisis KT, Kalemi TG, Zambouli D, Geromichalos GD,
Lambropoulos AF, Kotsis A, Boutis LL, Kortsaris AH. Cancer Lett. 233(2); 255-64 (2006)
20.
Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites,
isolated from Origanum vulgare L. ssp. hirtum. Koukoulitsa C, Zika C, Geromichalos GD,
Demopoulos VJ, Skaltsa H. Bioorg Med Chem. 14(5); 1653-9 (2006)
21.
Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer. Trafalis
DT, Geromichalos GD, Koukoulitsa C, Papageorgiou A, Karamanakos P, Camoutsis C. Breast
Cancer Res Treat. 97(1); 17-31(2006)
22.
A simulation study of the interaction of sulfhydryl nucleophiles with several antifungal
Sesquiterpene Lactones isolated from Greek Centaurea sp. C. Koukoulitsa, G.D.
Geromichalos, H. Skaltsa, J. Mol. Struct. (THEOCHEM) 759 (1-3); 215-224 (2006)
23.
Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro.
Dalezis P, Geromichalos GD, Voyatzi S, Trafalis D, Athanassiou AE, Koutsilieris M,
Papageorgiou A. J BUON. 11(3); 323-7 (2006)
24.
Synergistic interaction between a mixed ligand copper (II) chelate complex and two anticancer
agents in T47D human breast cancer cells in vitro. Geromichalos GD, Trafalis DT, Katsoulos
GA, Papageorgiou A, Dalezis P, Triandafillidis EB, Hadjikostas CC, Athanassiou A. J BUON.
11(4); 469-76 (2006)
25.
Inhibitory effect on soybean lipoxygenase and docking studies of some secondary metabolites,
isolated from Origanum vulgare L. ssp. hirtum. Koukoulitsa C, Hadjipavlou-Litina D,
Geromichalos GD, Skaltsa H. J Enzyme Inhib Med Chem. 22(1); 99-104 (2007)
26.
Importance of molecular computer modeling in anticancer drug development. Geromichalos
GD. J BUON. 12 Suppl 1; S101-18. Review (2007)
27.
Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib):
preparation, structural characterization, antibacterial and antiproliferative activities of [(nBu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH). Katsoulakou E, Tiliakos M,
Papaefstathiou G, Terzis A, Raptopoulou C, Geromichalos G, Papazisis K, Papi R, Pantazaki
A, Kyriakidis D, Cordopatis P, Manessi-Zoupa E. J Inorg Biochem. 102(7); 1397-405 (2008)
28.
Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma
PANO2. Papageorgiou A, Lialiaris T, Stergiou E, Stergiou I, Tsigris C, Kourti A,
Geromichalos G, Stravoravdi P, Trafalis D, Athanassiou AE, Pitsas A, Camoutsis Ch. J
BUON. 13(2); 235-9 (2008)
29.
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects
on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicity.
Karamanakos PN, Trafalis DT, Geromichalos GD, Pappas P, Harkitis P, Konstandi M,
Marselos M. Arch Toxicol. 2008 Aug 27. [Epub ahead of print]
30.
In vitro evaluation of the cytotoxicity of ProRoot MTA and MTA Angelus. Koulaouzidou EA,
Economides N, Beltes P, Geromichalos G, Papazisis K. J Oral Sci. 50(4); 397-402 (2008)
31.
Anticancer Activity and Quantitative–Structure Activity Relationship (QSAR) Studies of a
Series of Antioxidant/Anti-Inflammatory Aryl-Acetic and Hydroxamic Acids. Eleni Pontiki,
Dimitra Hadjipavlou-Litina, George Geromichalos and Athanasios Papageorgiou, Chem Biol
Drug Des 74; 266–275 (2009)
Ερευνητική Ομάδα 2
Λιαλιάρης Θεόδωρος
Υπεύθυνος Ομάδας
1) Enhancement and attenuation of cytogenetic damage by vitamin C in cultured human lymphocytes exposed
to Thiotepa and L-Ethionine. Lialiaris T., Mourelatos D., Dozi-Vassiliades J. Cytogenetic and Cell
Genetic, 44: 209-214 (1987).
2) Enhancement of cytogentic damage by chloropromazine in human lymphocytes treated with alkylating and
neoplastics and caffeine. Lialiaris T., Mourelatos D., Dozi-Vassiliades J. Mutation Res., 206: 361-365
(1988).
3) Synergistic induction of cytogenetic damage by alkylating antineoplastics and 5-Azacytidine in human
lymphocytes. Ioannidou E., Lialiaris T., Mourelatos D., Dozi-Vassiliades J. Environmental Molecular
Mutagenesis, 14: 6-12 (1989)
7) Cytogenetic study for possible mutagenic activity nduced by ice-nucleation bacteria or their metabolic
products in human lymphocytes in vitro. Lialiaris T., Mourelatos D., Stergiadou HC., Constantinidou
HA. Μutation Res. 242: 163-168 (1990).
8) Chlorpromazine-induced damage on nucleic acids: a combined cytogenetic and biochemical study. Lialiaris
Th, Pantazaki A, Sivridis E, Mourelatos D. Μutation Res. (1992) 265: 155-163.
9) Lack of mutagenicity of metabolic products of ice nucleation bacteria in S. typhipurium. Mourelatos D.,
Eliopoulos P., Lialiaris Th., Karamanoli C., Constantinidou E. Mutagenesis (1995) 10: 261-2.
10) lnduction of cytogenetic damage in human lymphocytes in vitro and of antineoplastic effeects in Ehrlich
ascites tumor cells in vίvo treated by methotrexat, hyperthermia and/or caffeine. Maskaleris T, Lialiaris
Th, Triantaphyllidis C. Mutation Research (1998) 422: 229-236.
13) Bis(acetato)bis(1-methyl-4,5-diphenylimidazole)copper(II): Preparation, characterization, crystal structure,
DNA strand breakage and cytogenetic effect. Raptopoulou CP, Paschalidou S, Pantazaki AA, Terzis A,
Perlepes S, Lialiaris Th, Bakalbassis EG, Mrozinski J, Kyriakidis DA. Journal of Inorganic
Biochemistry (1998) 71: 15-27.
14) Induction of cytogenetic damage in human lymphocytes in vitro and of antineoplastic effects in Ehrlich
ascites tumor cells in vivo treated by methotrexate, hyperthermia and/or caffeine. Maskaleris Τ, Lialiaris
Τ, Triantaphyllidis C. Mutation Research, 422, 229-236 (1998).
15) Α combined biocbemical and cytogenetic study of thioridazine-induced damage to nucleic acids. Pantazaki
AA, Lialiaris Th. Mutagenesls (1999) 14: 243-248.
19) The Angiogenetic effect of intramuscular administration of VEGF on muscle. The influence of exercise on
angiogenesis. Efthimiadou A, Asikakopoulos B, Nikolettos N, et al. In Vivo (2004) 18: 825-829
20) The angiogenetic effect of intramuscular administration of b-FGF and a-FGF on cardiac muscle: The
influence of exercise on muscle angiogenesis. Efthimiadou A, Asimakopoulos B, Nikolettos N, et al. J
Sport Sci 24 (8): 849-854 (2006).
21) Evidence of increased chromosomal instability in infertile males after exposure to mitomycin C and
caffeine. Papachristou F, Lialiaris T, Touloupidis S, et al. Asian J Androl 8 (2): 199-204 (2006)
22) NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with adriamycin
(ADR). Papageorgiou A, Andreadis C, Boutis A, et al. Anticancer Res 26 (1A): 243-247 (2006)
23) Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic
activity. Hussein A, Mioglou-Kalouptsi E, Papageorgiou A, Karapidaki I, Iakovidou-Kritsi Z, Lialiaris
T, Xrysogelou E, Camoutsis C, Mourelatos D. In Vivo. 2007 Mar-Apr;21(2):389-95.
24) Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor
induces angiogenesis in the infarcted rabbit myocardium.Bougioukas I, Didilis V, Ypsilantis P,
Giatromanolaki A, Sivridis E, Lialiaris T, Mikroulis D, Simopoulos C, Bougioukas G. Cardiovasc
Pathol. 2007 Mar-Apr;16(2):63-8.
25) The mutagenic potential of vitamin C on human lymphocytes and native nucleic acids. T.S. Lialiaris, A.A.
Pantazaki, F.E. Papachristou, E. Lyratzopoulos, K. Natsis and A.H. Kortsaris. J Biol Res (2007) 8: 189197.
26) Cytogenetic study in cultured human lymphocytes treated with three commonly used preservatives. P.
Mpountoukas, A. Vantarakis, E. Sivridis, T. Lialiaris. Food and Chemical Toxicology (2008) 46: 23902393.
27) Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A, Lialiaris T, Stergiou E, Stergiou I, Tsigris C, Kourti A, Geromichalos G, Stravoravdi
P, Trafalis D, Athanassiou AE, Pitsas A, Camoutsis Ch. J BUON. 2008;13(2):235-9.
28) Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of
melphalan.Lialiaris T, Lyratzopoulos E, Papachristou F, Simopoulou M, Mourelatos C, Nikolettos N.
Mutagenesis. 2008 Sep;23(5):347-54.
29) DNA damage and chromosomal aberrations in various types of male factor infertility. Papachristou F,
Simopoulou M, Touloupidis S, Tsalikidis C, Sofikitis N, Lialiaris T. Fertil Steril. 2008 Nov;90(5):177481.
30) Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich
ascites tumor cells in vivo. Lialiaris TS, Papachristou F, Mourelatos C, Simopoulou M. Anticancer
Drugs. 2009 Jul 6. [Epub ahead of print]
31) Cytoprotective activity of amifostine on cultured human lymphocytes exposed to irinotecan. Lialiaris TS,
Kotsiou E, Pouliliou S, Kareli D, Makrinou H, Kouskoukis A, Papachristou F, Koukourakis M Food
Chem Toxicol. 2009 Jul 3. [Epub ahead of print]
32) Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal
esters. Karapidaki I, Bakopoulou A, Papageorgiou A, Iakovidou Z, Mioglou E, Nikolaropoulos S,
Mourelatos D, Lialiaris T. Mutat Res. 2009;675:51-9.
Γιατρομανωλάκη Αλεξάνδρα
Μέλος
1: Koukourakis MI, Giatromanolaki A, Sheldon H, Buffa FM, Kouklakis G, Ragoussis
I, Sivridis E, Harris AL; Tumour and Angiogenesis Research Group. Phase I/II
trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal
cancer: vasculature-independent radiosensitizing effect of bevacizumab. Clin
Cancer Res. 2009 Nov 15;15(22):7069-76. Epub 2009 Nov 3. PubMed PMID: 19887481.
2: Koukourakis MI, Tsoutsou PG, Abatzoglou I, Soulimioti G, Sismanidou K, Liberis
V, Giatromanolaki A, Sivridis E, Galazios G. Postoperative accelerated
radiotherapy with cytoprotection followed by three-dimensional conformal boost in
patients with early endometrial/cervical cancer. Tumori. 2009
Jul-Aug;95(4):455-60. PubMed PMID: 19856656.
3: Mimidis KP, Papadopoulos VP, Baltatzidis G, Giatromanolaki A, Sivridis E,
Kartalis G. Severe acute cholestasis caused by Teucrium polium. J Gastrointestin
Liver Dis. 2009 Sep;18(3):387-8. PubMed PMID: 19795041.
4: Giatromanolaki A, Fiska A, Pitsiava D, Kartalis G, Koukourakis MI, Sivridis E.
Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and
VEGF expression. In Vivo. 2009 Sep-Oct;23(5):699-703. PubMed PMID: 19779103.
5: Sivridis E, Stamos C, Fiska A, Nikolettos N, Koukourakis MI, Giatromanolaki A.
c-erbB-2 and the "triple-state" in early breast carcinomas. Med Oncol. 2009 Jun
23. [Epub ahead of print] PubMed PMID: 19548127.
6: Polychronidis A, Tsaroucha AK, Perente S, Giatromanolaki A, Koukourakis M,
Simopoulos C. Port-site metastasis of extrahepatic bile duct carcinoma after
laparoscopic cholecystectomy without evidence of a primary tumour. Acta Chir
Belg. 2008 Nov-Dec;108(6):768-70. PubMed PMID: 19241938.
7: Koukourakis MI, Kontomanolis E, Giatromanolaki A, Sivridis E, Liberis V. Serum
and tissue LDH levels in patients with breast/gynaecological cancer and benign
diseases. Gynecol Obstet Invest. 2009;67(3):162-8. Epub 2008 Dec 16. PubMed PMID:
19088479.
8: Koukourakis MI, Tsoutsou PG, Abatzoglou IM, Sismanidou K, Giatromanolaki A,
Sivridis E. Hypofractionated and accelerated radiotherapy with subcutaneous
amifostine cytoprotection as short adjuvant regimen after breast-conserving
surgery: interim report. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1173-80.
Epub 2008 Dec 6. PubMed PMID: 19058920.
9: Koukourakis MI, Simopoulos C, Pitiakoudis M, Lyratzopoulos N, Romanidis K,
Giatromanolaki A, Polychronidis A, Kouklakis G, Sivridis E, Minopoulos G, Manolas
K. Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in
the treatment of rectal cancer: a feasibility study. Anticancer Res. 2008
Sep-Oct;28(5B):3035-40. PubMed PMID: 19031952.
10: Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris
AL, Gatter KC. Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas
is associated with hypoxia regulated proteins. Leuk Lymphoma. 2008
Nov;49(11):2181-6. PubMed PMID: 19021062.
11: Souftas V, Polychronidis A, Giatromanolaki A, Perente S, Simopoulos C.
Dermoid cyst in the hepatoduodenal ligament: report of a case. Surg Today.
2008;38(10):959-61. Epub 2008 Sep 27. PubMed PMID: 18820876.
12: Sivridis E, Giatromanolaki A. The endometrial hyperplasias revisited.
Virchows Arch. 2008 Sep;453(3):223-31. Epub 2008 Aug 23. Review. PubMed PMID:
18726114.
13: Wigfield SM, Winter SC, Giatromanolaki A, Taylor J, Koukourakis ML, Harris
AL. PDK-1 regulates lactate production in hypoxia and is associated with poor
prognosis in head and neck squamous cancer. Br J Cancer. 2008 Jun
17;98(12):1975-84. Epub 2008 Jun 10. PubMed PMID: 18542064; PubMed Central PMCID:
PMC2441961.
14: Giatromanolaki A, Bates GJ, Koukourakis MI, Sivridis E, Gatter KC, Harris AL,
Banham AH. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with
intratumoral angiogenesis in endometrial cancer. Gynecol Oncol. 2008
Aug;110(2):216-21. Epub 2008 Jun 3. PubMed PMID: 18533240.
15: Zambatis C, Skarlatos J, Koukourakis M, Kosma L, Giatromanolaki A, Beroukas
K, Yannakakis D. Concurrent hypofractionated radiotherapy and 5-Fluorouracil for
advanced sarcomas of the bone. Sarcoma. 1998;2(1):25-8. PubMed PMID: 18521229;
PubMed Central PMCID: PMC2395373.
16: Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris
AL, Gatter KC. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell
non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
Hematol Oncol. 2008 Dec;26(4):219-24. PubMed PMID: 18461646.
17: Simopoulos C, Tsaroucha AK, Asimakopoulos B, Giatromanolaki A, Gavriilidis P,
Polychronidis A, Karayiannakis A. Total and caspase-cleaved cytokeratin 18 in
chronic cholecystitis: a prospective study. BMC Gastroenterol. 2008 May 6;8:14.
PubMed PMID: 18460214; PubMed Central PMCID: PMC2396167.
18: Polychronidis A, Laftsidis P, Giatromanolaki A, Perente S, Bounovas A,
Simopoulos C. Suture-line recurrence at a jejunojejunal anastomosis after
gastrectomy for gastric cancer. Gastric Cancer. 2008;11(1):59-63. Epub 2008 Mar
29. PubMed PMID: 18373179.
19: Georgiadis GS, Lazarides MK, Tsalkidis A, Argyropoulou P, Giatromanolaki A.
Carotid body tumor in a 13-year-old child: Case report and review of the
literature. J Vasc Surg. 2008 Apr;47(4):874-880. Epub 2008 Feb 14. Review. PubMed
PMID: 18280094.
20: Giatromanolaki A, Sivridis E, Papazoglou D, Koukourakis MI, Maltezos E. Human
papillomavirus in endometrial adenocarcinomas: infectious agent or a mere
"passenger"? Infect Dis Obstet Gynecol. 2007;2007:60549. PubMed PMID: 18274613;
PubMed Central PMCID: PMC2233766.
21: Giatromanolaki A, Koukourakis MI, Pezzella F, Turley H, Sivridis E, Bouros D,
Bougioukas G, Harris AL, Gatter KC. Expression of prolyl-hydroxylases PHD-1, 2
and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates
to an activated HIF pathway. Cancer Lett. 2008 Jan 8. [Epub ahead of print]
PubMed PMID: 18187257.
22: Detorakis ET, Ioannakis K, Giatromanolaki A, Sivridis E, Drakonaki E,
Kozobolis VP. Selective removal of sebaceous gland carcinoma of the lower eyelid
with orbital infiltration. Ophthalmic Surg Lasers Imaging. 2007
Sep-Oct;38(5):413-6. PubMed PMID: 17955850.
23: Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E,
Turley H, Harris AL, Gatter KC. Activated VEGFR2/KDR pathway in tumour cells and
tumour associated vessels of colorectal cancer. Eur J Clin Invest. 2007
Nov;37(11):878-86. Epub 2007 Sep 20. PubMed PMID: 17883421.
24: Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E. Lung cancer: a
comparative study of metabolism related protein expression in cancer cells and
tumor associated stroma. Cancer Biol Ther. 2007 Sep;6(9):1476-9. Epub 2007 Jun
27. PubMed PMID: 17881895.
25: Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E. Hypoxia inducible
factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and
response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Int J Radiat Biol. 2008 Jan;84(1):47-52. PubMed PMID: 17852557.
26: Bayele HK, Peyssonnaux C, Giatromanolaki A, Arrais-Silva WW, Mohamed HS,
Collins H, Giorgio S, Koukourakis M, Johnson RS, Blackwell JM, Nizet V, Srai SK.
HIF-1 regulates heritable variation and allele expression phenotypes of the
macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite.
Blood. 2007 Oct 15;110(8):3039-48. Epub 2007 Jul 2. PubMed PMID: 17606764.
27: Giatromanolaki A, Sivridis E, Koukourakis MI. The Pathology of Tumor
Stromatogenesis. Cancer Biol Ther. 2007 Jun 26;6(6). [Epub ahead of print] PubMed
PMID: 17534144.
28: Giatromanolaki A, Koukourakis MI, Gatter KC, Harris AL, Sivridis E. BNIP3
expression in endometrial cancer relates to active hypoxia inducible factor
1alpha pathway and prognosis. J Clin Pathol. 2008 Feb;61(2):217-20. Epub 2007 May
18. PubMed PMID: 17513511.
29: Giatromanolaki A, Kotsiou S, Koukourakis MI, Sivridis E. Angiogenic factor
expression in hepatic cirrhosis. Mediators Inflamm. 2007;2007:67187. Epub 2007
Feb 28. PubMed PMID: 17497037; PubMed Central PMCID: PMC1847476.
30: Danielides V, Katotomichelakis M, Homsioglou E, Koukourakis MI,
Giatromanolaki A, Sivridis E. Squamous cell nose and a synchronous in-situ vocal
cord carcinoma: a case report. B-ENT. 2007;3(1):45-8. PubMed PMID: 17451127.
31: Anninos PA, Giatromanolaki A, Kotini A, Sivridis L, Koutlaki N, Anastasiadis
P. Magnetic field profiles in normal human breast during the menstrual cycle.
Clin Exp Obstet Gynecol. 2007;34(1):47-9. PubMed PMID: 17447638.
32: Sington J, Giatromanolaki A, Campo L, Turley H, Pezzella F, Gatter KC. BNIP3
expression in follicular lymphoma. Histopathology. 2007 Apr;50(5):555-60. PubMed
PMID: 17394490.
33: Bougioukas I, Didilis V, Ypsilantis P, Giatromanolaki A, Sivridis E,
Lialiaris T, Mikroulis D, Simopoulos C, Bougioukas G. Intramyocardial injection
of low-dose basic fibroblast growth factor or vascular endothelial growth factor
induces angiogenesis in the infarcted rabbit myocardium. Cardiovasc Pathol. 2007
Mar-Apr;16(2):63-8. PubMed PMID: 17317537.
34: Giatromanolaki A, Koukourakis MI, Simopoulos C, Sivridis E. Metastatic cancer
cells from c-erbB-2 negative primary breast cancer maintain the original
c-erbB-2/HIF1alpha phenotype. Cancer Biol Ther. 2007 Feb;6(2):153-5. Epub 2007
Feb 26. PubMed PMID: 17224643.
35: Kambouri K, Gardikis S, Giatromanolaki A, Efstathiou E, Pitiakoudis M,
Ipsilantis P, Botaitis S, Perente S, Antypas S, Polychronidis A, Sivridis E,
Simopoulos C. Comparison of angiogenic activity after urethral reconstruction
using free grafts and pedicle flap: an experimental study. Eur J Pediatr Surg.
2006 Oct;16(5):323-8. PubMed PMID: 17160776.
36: Papanas N, Giatromanolaki A, Galazios G, Maltezos E, Sivridis E. Endometrial
carcinoma and diabetes revisited. Eur J Gynaecol Oncol. 2006;27(5):505-8. PubMed
PMID: 17139988.
37: Koukourakis MI, Pitiakoudis M, Giatromanolaki A, Tsarouha A, Polychronidis A,
Sivridis E, Simopoulos C. Oxygen and glucose consumption in gastrointestinal
adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic
glycolysis. Cancer Sci. 2006 Oct;97(10):1056-60. PubMed PMID: 16984378.
38: Giatromanolaki A, Sivridis E, Simopoulos C, Polychronidis A, Gatter KC,
Harris AL, Koukourakis MI. Hypoxia inducible factors 1alpha and 2alpha are
associated with VEGF expression and angiogenesis in gallbladder carcinomas. J
Surg Oncol. 2006 Sep 1;94(3):242-7. PubMed PMID: 16900513.
39: Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL; Tumour
Angiogenesis Research Group. Lactate dehydrogenase 5 expression in operable
colorectal cancer: strong association with survival and activated vascular
endothelial growth factor pathway--a report of the Tumour Angiogenesis Research
Group. J Clin Oncol. 2006 Sep 10;24(26):4301-8. Epub 2006 Aug 8. PubMed PMID:
16896001.
40: Kazakos CJ, Galanis VG, Giatromanolaki A, Verettas DA, Sivridis E. Clear cell
sarcoma of the scapula. A case report and review of the literature. World J Surg
Oncol. 2006 Aug 7;4:48. PubMed PMID: 16893467; PubMed Central PMCID: PMC1555585.
41: Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal
cancer: prognostic and therapeutic implications. Am J Clin Oncol. 2006
Aug;29(4):408-17. Review. PubMed PMID: 16891872.
42: Touloupidis S, Fatles G, Kalaitzis C, Giatromanolaki A, Sivridis E,
Simopoulos K, Rombis V. The significance of p53 and bcl-2 overexpression and
other prognostic factors in transitional cell carcinoma of the bladder. Int Urol
Nephrol. 2006;38(2):231-6. PubMed PMID: 16868688.
43: Koukourakis MI, Papazoglou D, Giatromanolaki A, Panagopoulos I, Maltezos E,
Harris AL, Gatter KC, Sivridis E. C2028T polymorphism in exon 12 and dinucleotide
repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein
expression in non-small cell lung cancer. Lung Cancer. 2006 Sep;53(3):257-62.
Epub 2006 Jul 11. PubMed PMID: 16837101.
44: Giatromanolaki A, Sivridis E, Gatter KC, Turley H, Harris AL, Koukourakis MI;
for the Tumour and Angiogenesis Research Group. Lactate dehydrogenase 5 (LDH-5)
expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR)
pathway and prognosis. Gynecol Oncol. 2006 Dec;103(3):912-8. Epub 2006 Jul 11.
PubMed PMID: 16837029.
45: Koukourakis MI, Giatromanolaki A, Polychronidis A, Simopoulos C, Gatter KC,
Harris AL, Sivridis E. Endogenous markers of hypoxia/anaerobic metabolism and
anemia in primary colorectal cancer. Cancer Sci. 2006 Jul;97(7):582-8. PubMed
PMID: 16827797.
46: Efthimiadou A, Asimakopoulos B, Nikolettos N, Giatromanolaki A, Sivridis E,
Lialiaris TS, Papachristou DN, Kontoleon E. The angiogenetic effect of
intramuscular administration of b-FGF and a-FGF on cardiac muscle: the influence
of exercise on muscle angiogenesis. J Sports Sci. 2006 Aug;24(8):849-54. PubMed
PMID: 16815779.
47: Giatromanolaki A, Koukourakis MI, Turley H, Sivridis E, Harris AL, Gatter KC;
Tumour and Angiogenesis Research Group. Phosphorylated KDR expression in
endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable
prognosis. Mod Pathol. 2006 May;19(5):701-7. PubMed PMID: 16557278.
48: Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI. Hypoxia-inducible
factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl
Immunohistochem Mol Morphol. 2006 Mar;14(1):78-82. PubMed PMID: 16540735.
49: Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of
metabolic pathways between cancer cells and stromal cells in colorectal
carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res.
2006 Jan 15;66(2):632-7. PubMed PMID: 16423989.
50: Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders
MI, Dische S, Sivridis E, Harris AL. Endogenous markers of two separate hypoxia
response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are
associated with radiotherapy failure in head and neck cancer patients recruited
in the CHART randomized trial. J Clin Oncol. 2006 Feb 10;24(5):727-35. Epub 2006
Jan 17. PubMed PMID: 16418497.
51: Efthimiadou A, Asimakopoulos B, Nikolettos N, Giatromanolaki A, Sivridis E,
Papachristou DN, Kontoleon E. Angiogenic effect of intramuscular administration
of basic and acidic fibroblast growth factor on skeletal muscles and influence of
exercise on muscle angiogenesis. Br J Sports Med. 2006 Jan;40(1):35-9; discussion
35-9. PubMed PMID: 16371488; PubMed Central PMCID: PMC2491924.
52: Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL; Tumour
and Angiogenesis Research Group. Inclusion of vasculature-related variables in
the Dukes staging system of colon cancer. Clin Cancer Res. 2005 Dec 15;11(24 Pt
1):8653-60. PubMed PMID: 16361550.
53: Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham
AH. Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead
transcription factor are common events in early endometrial cancer: relationship
with estrogen receptors and HIF-1alpha expression. Mod Pathol. 2006
Jan;19(1):9-16. PubMed PMID: 16258506.
54: Koukourakis MI, Manavis J, Simopoulos C, Liberis V, Giatromanolaki A,
Sivridis E. Hypofractionated accelerated radiotherapy with cytoprotection
combined with trastuzumab, liposomal doxorubicine, and docetaxel in
c-erbB-2-positive breast cancer. Am J Clin Oncol. 2005 Oct;28(5):495-500. PubMed
PMID: 16199990.
55: Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at
the invading tumour edge of colorectal adenocarcinomas are associated with
endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol. 2005
Oct;58(10):1033-8. PubMed PMID: 16189147; PubMed Central PMCID: PMC1770734.
56: Sivridis E, Giatromanolaki A, Galazios G, Koukourakis MI. Node-related
factors and survival in node-positive breast carcinomas. Breast. 2006
Jun;15(3):382-9. Epub 2005 Aug 30. PubMed PMID: 16135406.
57: Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E.
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor
pathway and metastasis in colorectal cancer. Clin Exp Metastasis.
2005;22(1):25-30. PubMed PMID: 16132575.
58: Giatromanolaki A, Arvanitidou V, Hatzimichael A, Simopoulos C, Sivridis E.
The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas.
Pathology. 2005 Apr;37(2):149-51. PubMed PMID: 16028843.
59: Sivridis E, Giatromanolaki A, Koutlaki N, Anastasiadis P. Malignant female
adnexal tumour of probable Wolffian origin: criteria of malignancy.
Histopathology. 2005 Jun;46(6):716-8. PubMed PMID: 15910610.
60: Mimidis K, Giatromanolaki A, Sivridis E, Papadopoulos V, Ritis K, Kartalis G.
Thymidine phosphorylase expression in patients with chronic viral hepatitis. Rom
J Gastroenterol. 2005 Mar;14(1):27-31. PubMed PMID: 15800690.
61: Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL; Tumor and
Angiogenesis Research Group. Pyruvate dehydrogenase and pyruvate dehydrogenase
kinase expression in non small cell lung cancer and tumor-associated stroma.
Neoplasia. 2005 Jan;7(1):1-6. PubMed PMID: 15736311; PubMed Central PMCID:
PMC1490315.
62: Gardikis S, Giatromanolaki A, Ypsilantis P, Botaitis S, Perente S, Kambouri
A, Efstathiou E, Antypas S, Polychronidis A, Touloupidis S, Sivridis E,
Simopoulos C. Comparison of angiogenic activities after urethral reconstruction
using free grafts in rabbits. Eur Urol. 2005 Mar;47(3):417-21. Epub 2004 Dec 2.
PubMed PMID: 15716210.
63: Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Gatter KC, Harris
AL, Jackson DG. LYVE-1 immunohistochemical assessment of lymphangiogenesis in
endometrial and lung cancer. J Clin Pathol. 2005 Feb;58(2):202-6. PubMed PMID:
15677543; PubMed Central PMCID: PMC1770560.
64: Efthimiadou A, Asimakopoulos B, Nikolettos N, Giatromanolaki A, Sivridis E,
Lialiaris TS, Papachristou DN, Kontoleon E. The angiogenetic effect of
intramuscular administration of VEGF on muscle. The influence of exercise on
angiogenesis. In Vivo. 2004 Nov-Dec;18(6):825-9. PubMed PMID: 15646828.
65: Gatopoulou A, Mimidis K, Giatromanolaki A, Papadopoulos V, Polychronidis A,
Lyratzopoulos N, Sivridis E, Minopoulos G. Impact of hiatal hernia on
histological pattern of non-erosive reflux disease. BMC Gastroenterol. 2005 Jan
9;5:2. PubMed PMID: 15638947; PubMed Central PMCID: PMC546187.
66: Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Gatter KC,
Harris AL, Sivridis E. c-erbB-2 related aggressiveness in breast cancer is
hypoxia inducible factor-1alpha dependent. Clin Cancer Res. 2004 Dec
1;10(23):7972-7. PubMed PMID: 15585632.
67: Sivridis E, Giatromanolaki A. Endometrial adenocarcinoma: an apostasy from
early views. Gynecol Oncol. 2004 Dec;95(3):772-3. PubMed PMID: 15582004.
68: Giatromanolaki A, Sivridis E, Koukourakis MI. Tumour angiogenesis: vascular
growth and survival. APMIS. 2004 Jul-Aug;112(7-8):431-40. Review. PubMed PMID:
15563307.
69: Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E,
Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and
angiogenic activity in non-small cell lung cancer. Lung Cancer. 2004
Dec;46(3):293-8. Erratum in: Lung Cancer. 2005 May;48(2):297. Siviridis,
Efthimios [corrected to Sivridis, Efthimios]. PubMed PMID: 15541813.
70: Giatromanolaki A, Sivridis E, Tsikouras P, Manavis I, Maroulis G, Koukourakis
MI. Angiogenesis and vascular survival ability in ovarian adenocarcinomas.
Virchows Arch. 2004 Nov;445(5):521-6. Epub 2004 Sep 9. PubMed PMID: 15365829.
71: Giatromanolaki A, Koukourakis MI, Sowter HM, Sivridis E, Gibson S, Gatter KC,
Harris AL. BNIP3 expression is linked with hypoxia-regulated protein expression
and with poor prognosis in non-small cell lung cancer. Clin Cancer Res. 2004 Aug
15;10(16):5566-71. PubMed PMID: 15328198.
72: Sivridis E, Giatromanolaki A. Proliferative activity in postmenopausal
endometrium: the lurking potential for giving rise to an endometrial
adenocarcinoma. J Clin Pathol. 2004 Aug;57(8):840-4. PubMed PMID: 15280405;
PubMed Central PMCID: PMC1770392.
73: Sivridis E, Giatromanolaki A. Endometrial adenocarcinoma: beliefs and
scepticism. Int J Surg Pathol. 2004 Apr;12(2):99-105. Review. PubMed PMID:
15173914.
74: Giatromanolaki A, Koukourakis MI, Ritis K, Mimidis K, Sivridis E. Interferon
regulatory factor-1 (IRF-1) suppression and derepression during endometrial
tumorigenesis and cancer progression. Cytokine. 2004 May 21;26(4):164-8. PubMed
PMID: 15149633.
75: Koukourakis MI, Giatromanolaki A, Sivridis E, Pastorek J, Karapantzos I,
Gatter KC, Harris AL; Tumour and Angiogenesis Research Group. Hypoxia-activated
tumor pathways of angiogenesis and pH regulation independent of anemia in
head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):67-71.
PubMed PMID: 15093900.
76: Pitiakoudis M, Giatromanolaki A, Iliopoulos I, Tsaroucha AK, Simopoulos C,
Piperidou C. Phenytoin-induced lymphocytic chemotaxis, angiogenesis and
accelerated healing of decubitus ulcer in a patient with stroke. J Int Med Res.
2004 Mar-Apr;32(2):201-5. PubMed PMID: 15080024.
77: Gatopoulou A, Mimidis K, Giatromanolaki A, Polichronidis A, Lirantzopoulos N,
Sivridis E, Minopoulos G. Impact of Helicobacter pylori infection on histological
changes in non-erosive reflux disease. World J Gastroenterol. 2004 Apr
15;10(8):1180-2. PubMed PMID: 15069722.
78: Sivridis E, Giatromanolaki A. New insights into the normal menstrual
cycle-regulatory molecules. Histol Histopathol. 2004 Apr;19(2):511-6. Review.
PubMed PMID: 15024712.
79: Pitiakoudis M, Koukourakis M, Giatromanolaki A, Tsaroucha AK, Polychronidis
A, Simopoulos C. Phytobezoars as a cause of small bowel obstruction associated
with a carcinoid tumor of the ileocecal area. Acta Chir Iugosl. 2003;50(2):131-3.
PubMed PMID: 14994580.
80: Papadopoulos I, Giatromanolaki A, Koukourakis MI, Sivridis E. Tumour
angiogenic activity and vascular survival ability in bladder carcinoma. J Clin
Pathol. 2004 Mar;57(3):250-5. PubMed PMID: 14990594; PubMed Central PMCID:
PMC1770238.
81: Sivridis E, Giatromanolaki A, Koukourakis MI. "Stromatogenesis" and tumor
progression. Int J Surg Pathol. 2004 Jan;12(1):1-9. PubMed PMID: 14765266.
82: Giatromanolaki A, Koukourakis MI, Kakolyris S, Mavroudis D, Kouroussis C,
Mavroudi C, Perraki M, Sivridis E, Georgoulias V. Assessment of highly angiogenic
and disseminated in the peripheral blood disease in breast cancer patients
predicts for resistance to adjuvant chemotherapy and early relapse. Int J Cancer.
2004 Feb 10;108(4):620-7. PubMed PMID: 14696130.
83: Koukourakis MI, Giatromanolaki A, Sivridis E; Tumour and Angiogenesis
Research Group. Lactate dehydrogenase isoenzymes 1 and 5: differential expression
by neoplastic and stromal cells in non-small cell lung cancer and other
epithelial malignant tumors. Tumour Biol. 2003 Aug-Sep;24(4):199-202. PubMed
PMID: 14654714.
84: Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Sivridis E.
Vascular endothelial growth factor (VEGF) expression in operable gallbladder
carcinomas. Eur J Surg Oncol. 2003 Dec;29(10):879-83. PubMed PMID: 14624781.
85: Papalambros E, Sigala F, Georgopoulos S, Menekakos C, Giatromanolaki A,
Bastounis E, Sivridis E. Immunohistochemical expression of metalloproteinases
MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and
aortic diameter. Int J Mol Med. 2003 Dec;12(6):965-8. PubMed PMID: 14612975.
86: Koukourakis MI, Giatromanolaki A, Chong W, Simopoulos C, Polychronidis A,
Sivridis E, Harris AL. Amifostine induces anaerobic metabolism and
hypoxia-inducible factor 1 alpha. Cancer Chemother Pharmacol. 2004
Jan;53(1):8-14. Epub 2003 Oct 22. PubMed PMID: 14574457.
87: Sivridis E, Giatromanolaki A, Koukourakis MI. The vascular network of
tumours--what is it not for? J Pathol. 2003 Oct;201(2):173-80. Review. PubMed
PMID: 14517833.
88: Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis
MI. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular
endothelial growth factor expression and a poorer prognosis in nodular malignant
melanomas of the skin. Melanoma Res. 2003 Oct;13(5):493-501. PubMed PMID:
14512791.
89: Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris
AL, Sage EH. Enhanced expression of SPARC/osteonectin in the tumor-associated
stroma of non-small cell lung cancer is correlated with markers of
hypoxia/acidity and with poor prognosis of patients. Cancer Res. 2003 Sep
1;63(17):5376-80. PubMed PMID: 14500371.
90: Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter
KC, Harris AL; Tumour and Angiogenesis Research Group. Lactate dehydrogenase-5
(LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour
hypoxia, angiogenic factor production and poor prognosis. Br J Cancer. 2003 Sep
1;89(5):877-85. PubMed PMID: 12942121; PubMed Central PMCID: PMC2394471.
91: Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter
KC, Harris AL, Koukourakis MI. Upregulated hypoxia inducible factor-1alpha and
-2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther.
2003;5(4):R193-201. Epub 2003 Apr 29. PubMed PMID: 12823854; PubMed Central
PMCID: PMC165055.
92: Koukourakis MI, Simopoulos C, Polychronidis A, Perente S, Botaitis S,
Giatromanolaki A, Sivridis E. The effect of trastuzumab/docatexel combination on
breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF
pre-treatment status? Anticancer Res. 2003 Mar-Apr;23(2C):1673-80. PubMed PMID:
12820439.
93: Kapsoritakis A, Sfiridaki A, Maltezos E, Simopoulos K, Giatromanolaki A,
Sivridis E, Koukourakis MI. Vascular endothelial growth factor in inflammatory
bowel disease. Int J Colorectal Dis. 2003 Sep;18(5):418-22. Epub 2003 May 22.
PubMed PMID: 12761641.
94: Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC,
Harris AL. DEC1 (STRA13) protein expression relates to hypoxia- inducible factor
1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J
Pathol. 2003 Jun;200(2):222-8. PubMed PMID: 12754744.
95: Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Perifolliculitis
capitis abscedens et suffodiens successfully controlled with topical
isotretinoin. Eur J Dermatol. 2003 Mar-Apr;13(2):192-5. PubMed PMID: 12695138.
96: Koukourakis MI, Giatromanolaki A, Galazios G, Sivridis E. Molecular analysis
of local relapse in high-risk breast cancer patients: can radiotherapy
fractionation and time factors make a difference? Br J Cancer. 2003 Mar
10;88(5):711-7. PubMed PMID: 12618880; PubMed Central PMCID: PMC2376345.
97: Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter
KC, Harris AL, Koukourakis MI. Hypoxia inducible factor 1alpha and 2alpha
overexpression in inflammatory bowel disease. J Clin Pathol. 2003
Mar;56(3):209-13. PubMed PMID: 12610101; PubMed Central PMCID: PMC1769899.
98: Koukourakis MI, Manolas C, Minopoulos G, Giatromanolaki A, Sivridis E.
Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and
early relapse in node-negative ductal carcinoma of the breast. Int J Surg Pathol.
2003 Jan;11(1):29-34. PubMed PMID: 12598915.
99: Giatromanolaki A, Sivridis E, Maltezos E, Koukourakis MI. Down-regulation of
intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides
a strong basis for explaining amifostine selectivity. Semin Oncol. 2002 Dec;29(6
Suppl 19):14-21. PubMed PMID: 12577238.
100: Giatromanolaki A, Sivridis E, Simopoulos C, Polychronidis A, Gatter KC,
Harris AL, Koukourakis MI. Differential assessment of angiogenic activity and of
vascular survival ability (VSA) in breast cancer. Clin Exp Metastasis.
2002;19(8):673-9. PubMed PMID: 12553372.
101: Koukourakis MI, Giatromanolaki A, Liberis V, Sivridis E. Hypoxia inducible
factor 1 alpha and 2 alpha expression is independent of anemia in patients with
stage I endometrial cancer. Anticancer Res. 2002 Nov-Dec;22(6C):4137-40. PubMed
PMID: 12553044.
102: Sivridis E, Giatromanolaki A, Touloupidis S, Pasadakis P, Vargemezis V.
Platelet endothelial cell adhesion molecule-1 and angiogenic factor expression in
idiopathic membranous nephropathy. Am J Kidney Dis. 2003 Feb;41(2):360-5. PubMed
PMID: 12552497.
103: Sivridis E, Touloupidis S, Giatromanolaki A. Immunopathological prognostic
and predictive factors in prostate cancer. Int Urol Nephrol. 2002;34(1):63-71.
Review. PubMed PMID: 12549642.
104: Tsamis I, Giatromanolaki A, Tamiolakis D, Georgiou L, Manavis J, Alexiadis
G, Thomaidis V, Sivridis E. Fine needle aspiration cytology in ameloblastoma of
the mandible. Cytopathology. 2002 Dec;13(6):375-8. PubMed PMID: 12485174.
105: O'Byrne KJ, Goddard J, Giatromanolaki A, Koukourakis MI. Vascular
endothelial growth factor expression in non-small cell lung cancer. Methods Mol
Med. 2003;74:357-73. PubMed PMID: 12415708.
106: Maltezos ES, Sivridis EL, Giatromanolaki AN, Simopoulos CE. Human
subcutaneous dirofilariasis: a report of three cases manifesting as breast or
axillary nodules. Scott Med J. 2002 Aug;47(4):86-8. PubMed PMID: 12235915.
107: Giatromanolaki A, Sivridis E, Simopoulos C, Polychronidis A, Gatter KC,
Harris AL, Koukourakis MI. Thymidine phosphorylase expression in gallbladder
adenocarcinomas. Int J Surg Pathol. 2002 Jul;10(3):181-8. PubMed PMID: 12232571.
108: Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI; Tumor
and Angiogenesis Research Group. Association of hypoxia-inducible factors 1alpha
and 2alpha with activated angiogenic pathways and prognosis in patients with
endometrial carcinoma. Cancer. 2002 Sep 1;95(5):1055-63. PubMed PMID: 12209691.
109: Sivridis E, Giatromanolaki A, Androulakis I, Hatzimichael A, Anastasiadis P.
Sirenomelia in uneventful pregnancy. Clin Exp Obstet Gynecol. 2002;29(2):140-2.
PubMed PMID: 12171318.
110: Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Turley H, Talks
K, Gatter KC, Harris AL. Hypoxia-inducible factor (HIF1A and HIF2A),
angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck
cancer. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1192-202. PubMed PMID:
12128120.
111: Argyropoulou PI, Sivridis E, Giatromanolaki A, Verettas D, Manavis I,
Argyropoulou MI. Malignant haemangiopericytoma of the knee joint: MR findings. Br
J Radiol. 2002 Jun;75(894):539-42. PubMed PMID: 12124243.
112: Giatromanolaki A, Sivridis E, Minopoulos G, Polychronidis A, Manolas C,
Simopoulos C, Koukourakis MI. Differential assessment of vascular survival
ability and tumor angiogenic activity in colorectal cancer. Clin Cancer Res. 2002
May;8(5):1185-91. PubMed PMID: 12006536.
113: Sivridis E, Giatromanolaki A, Papadopoulos I, Gatter KC, Harris AL,
Koukourakis MI. Thymidine phosphorylase expression in normal, hyperplastic and
neoplastic prostates: correlation with tumour associated macrophages,
infiltrating lymphocytes, and angiogenesis. Br J Cancer. 2002 May
6;86(9):1465-71. PubMed PMID: 11986782; PubMed Central PMCID: PMC2375369.
114: Sivridis E, Giatromanolaki A, Anastasiadis P, Georgiou L, Gatter KC, Harris
AL, Bicknell R, Koukourakis MI; Tumour and Angiogenesis Research Group.
Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J
Pathol. 2002 Apr;196(4):416-22. PubMed PMID: 11920737.
115: Giatromanolaki A. Prognostic role of angiogenesis in non-small cell lung
cancer. Anticancer Res. 2001 Nov-Dec;21(6B):4373-82. Review. PubMed PMID:
11908693.
116: Giatromanolaki A, Harris AL. Tumour hypoxia, hypoxia signaling pathways and
hypoxia inducible factor expression in human cancer. Anticancer Res. 2001
Nov-Dec;21(6B):4317-24. Review. PubMed PMID: 11908686.
117: Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kouroussis CH,
Bozionelou V, Georgoulias V, Gatter KC, Harris AL. Assessment of vascular
maturation in lung and breast carcinomas using a novel basement membrane
component, LH39. Anticancer Res. 2001 Nov-Dec;21(6B):4311-6. PubMed PMID:
11908685.
118: Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pissakas G,
Gatter KC, Harris AL. Squamous cell head and neck cancer: evidence of angiogenic
regeneration during radiotherapy. Anticancer Res. 2001 Nov-Dec;21(6B):4301-9.
PubMed PMID: 11908684.
119: Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P.
Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic
relevance. Histopathology. 2002 Jan;40(1):92-100. PubMed PMID: 11903603.
120: Giatromanolaki A, Sivridis E, Koukourakis MI, Polychronidis A, Simopoulos C.
Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J
Clin Oncol. 2002 Feb;25(1):38-41. PubMed PMID: 11823693.
121: Koukourakis MI, Giatromanolaki A, Kouroussis C, Kakolyris S, Sivridis E,
Frangiadaki C, Retalis G, Georgoulias V; Tumor and Angiogenesis Research Group.
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a
short, safe, and effective postoperative regimen for high-risk breast cancer
patients. Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):144-55. PubMed PMID:
11777632.
122: Manavis J, Alexiadis G, Lambropoulou M, Deftereos S, Argyropoulou P,
Giatromanolaki A, Sivridis E. Extragonadal retroperitoneal endodermal sinus tumor
in an eight-month-old female infant. Eur J Gynaecol Oncol. 2001;22(5):345-6.
PubMed PMID: 11766736.
123: Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter
KC, Harris AL, Koukourakis MI; Tumour and Angiogenesis Research Group. The
angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in
patients with endometrial carcinoma: prognostic and therapeutic implications.
Cancer. 2001 Nov 15;92(10):2569-77. PubMed PMID: 11745191.
124: O'Byrne KJ, Cox G, Swinson D, Richardson D, Edwards JG, Lolljee J, Andi A,
Koukourakis MI, Giatromanolaki A, Gatter K, Harris AL, Waller D, Jones JL.
Towards a biological staging model for operable non-small cell lung cancer. Lung
Cancer. 2001 Dec;34 Suppl 2:S83-9. PubMed PMID: 11720747.
125: Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos K, Pastorek J,
Wykoff CC, Gatter KC, Harris AL. Hypoxia-regulated carbonic anhydrase-9 (CA9)
relates to poor vascularization and resistance of squamous cell head and neck
cancer to chemoradiotherapy. Clin Cancer Res. 2001 Nov;7(11):3399-403. PubMed
PMID: 11705854.
126: Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter
KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to
angiogenic pathways and independently to poor outcome in non-small cell lung
cancer. Cancer Res. 2001 Nov 1;61(21):7992-8. PubMed PMID: 11691824.
127: Kakolyris S, Giatromanolaki A, Koukourakis M, Powis G, Souglakos J, Sivridis
E, Georgoulias V, Gatter KC, Harris AL. Thioredoxin expression is associated with
lymph node status and prognosis in early operable non-small cell lung cancer.
Clin Cancer Res. 2001 Oct;7(10):3087-91. PubMed PMID: 11595699.
128: Sivridis E, Giatromanolaki A. Prognostic aspects on endometrial hyperplasia
and neoplasia. Virchows Arch. 2001 Aug;439(2):118-26. Review. PubMed PMID:
11561751.
129: Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F,
Gatter KC, Harris AL. Relation of hypoxia inducible factor 1 alpha and 2 alpha in
operable non-small cell lung cancer to angiogenic/molecular profile of tumours
and survival. Br J Cancer. 2001 Sep 14;85(6):881-90. PubMed PMID: 11556841;
PubMed Central PMCID: PMC2375073.
130: Sivridis E, Anninos P, Giatromanolaki A, Kotini A, Adamopoulos A,
Anastasiadis P. Biomagnetic activity in the female breast at various
physiological states. Clin Exp Obstet Gynecol. 2001;28(3):196-9. PubMed PMID:
11530874.
131: Sivridis E, Giatromanolaki A, Agnantis N, Anastasiadis P. Mast cell
distribution and density in the normal uterus--metachromatic staining using
lectins. Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):109-13. PubMed PMID:
11516809.
132: Alexiadis G, Lambropoulou M, Deftereos S, Giatromanolaki A, Sivridis E,
Manavis J. Abdominal wall endometriosis--ultrasound research: a diagnostic
problem. Clin Exp Obstet Gynecol. 2001;28(2):121-2. PubMed PMID: 11491372.
133: Giatromanolaki A, Koukourakis MI, Sivridis E, Thorpe PE, Brekken RA,
Konstantinos S, Fountzilas G, Gatter KC, Harris AL. Tumor specific activation of
the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell
head and neck carcinomas. Clin Exp Metastasis. 2000;18(4):313-9. PubMed PMID:
11448062.
134: Papadopoulos I, Sivridis E, Giatromanolaki A, Koukourakis MI. Tumor
angiogenesis is associated with MUC1 overexpression and loss of prostate-specific
antigen expression in prostate cancer. Clin Cancer Res. 2001 Jun;7(6):1533-8.
PubMed PMID: 11410487.
135: Giatromanolaki A, Stathopoulos GP, Koukourakis MI, Rigatos S, Vrettou E,
Kittas C, Fountzilas G, Sivridis E. Angiogenesis and apoptosis-related protein
(p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to
paclitaxel and carboplatin chemotherapy. Am J Clin Oncol. 2001 Jun;24(3):222-6.
PubMed PMID: 11404489.
136: Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial
carcinoma: association of steroid hormone receptor expression with low
angiogenesis and bcl-2 expression. Virchows Arch. 2001 May;438(5):470-7. PubMed
PMID: 11407475.
137: Kakolyris SA, Kaklamanis LG, Koukourakis MJ, Giatromanolaki A,
Rousomoustakaki M, Souglakos JC, Reppa DK, Georgoulias VA, Gatter KC, Harris AL.
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence.
Oncol Res. 2000;12(4):203-8. PubMed PMID: 11341470.
138: Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA,
Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI. The angiogenic pathway
"vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis
and osteoarthritis. J Pathol. 2001 May;194(1):101-8. PubMed PMID: 11329148.
139: Koukourakis MI, Giatromanolaki A, Kakolyris S, Sivridis E, Georgoulias V,
Funtzilas G, Hickson ID, Gatter KC, Harris AL. Nuclear expression of human
apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is
associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat
Oncol Biol Phys. 2001 May 1;50(1):27-36. PubMed PMID: 11316543.
140: Koukourakis MI, Corti L, Skarlatos J, Giatromanolaki A, Krammer B,
Blandamura S, Piazza M, Verwanger T, Schnitzhofer G, Kostandelos J, Beroukas K.
Clinical and experimental evidence of Bcl-2 involvement in the response to
photodynamic therapy. Anticancer Res. 2001 Jan-Feb;21(1B):663-8. PubMed PMID:
11299823.
141: Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP,
Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
Bax protein expression in colorectal cancer: association with p53, bcl-2 and
patterns of relapse. Anticancer Res. 2001 Jan-Feb;21(1A):253-9. PubMed PMID:
11299743.
142: Koukourakis MI, Giatromanolaki A, Skarlatos J, Corti L, Blandamura S, Piazza
M, Gatter KC, Harris AL. Hypoxia inducible factor (HIF-1a and HIF-2a) expression
in early esophageal cancer and response to photodynamic therapy and radiotherapy.
Cancer Res. 2001 Mar 1;61(5):1830-2. PubMed PMID: 11280732.
143: Giatromanolaki A, Koukourakis MI, Stathopoulos GP, Kapsoritakis A, Paspatis
G, Kakolyris S, Sivridis E, Georgoulias V, Harris AL, Gatter KC. Angiogenic
interactions of vascular endothelial growth factor, of thymidine phosphorylase,
and of p53 protein expression in locally advanced gastric cancer. Oncol Res.
2000;12(1):33-41. PubMed PMID: 11061344.
144: Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter
KC. Thymidine phosphorylase expression in normal and hyperplastic endometrium. J
Clin Pathol. 2000 Sep;53(9):704-8. PubMed PMID: 11041061; PubMed Central PMCID:
PMC1731246.
145: Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Gatter KC, Harris
AL. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay
between angiogenic and vascular survival factors defines the clinical behaviour
of non-small cell lung cancer. J Pathol. 2000 Oct;192(2):140-9. PubMed PMID:
11004689.
146: Koukourakis MI, Giatromanolaki A, Sivridis E, Fezoulidis I. Cancer
vascularization: implications in radiotherapy? Int J Radiat Oncol Biol Phys. 2000
Sep 1;48(2):545-53. PubMed PMID: 10974475.
147: Giatromanolaki A. Differential expression of angiogenic and of vascular
survival factors in non-small cell lung cancer (NSCLC). Adv Exp Med Biol.
2000;476:291-5. PubMed PMID: 10949673.
148: Koukourakis MI, Giatromanolaki A, Kakolyris S, Froudarakis M, Georgoulias V,
Retalis G, Bahlitzanakis N. Phase I/II dose escalation study of docetaxel and
carboplatin combination supported with amifostine and GM-CSF in patients with
incomplete response following docetaxel chemo-radiotherapy: additional
chemotherapy enhances regression of residual cancer. Med Oncol. 2000
May;17(2):135-43. PubMed PMID: 10871820.
149: Koukourakis MI, Koukouraki S, Giatromanolaki A, Kakolyris S, Georgoulias V,
Velidaki A, Archimandritis S, Karkavitsas NN. High intratumoral accumulation of
stealth liposomal doxorubicin in sarcomas--rationale for combination with
radiotherapy. Acta Oncol. 2000;39(2):207-11. PubMed PMID: 10859012.
150: Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Cox J, Krammer B, Gatter KC,
Harris AL. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and
of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Clin Exp Metastasis. 1999;17(7):545-54. PubMed PMID: 10845553.
151: Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E,
Kakolyris S, Georgoulias V, Gatter KC, Harris AL. Vascular endothelial growth
factor/KDR activated microvessel density versus CD31 standard microvessel density
in non-small cell lung cancer. Cancer Res. 2000 Jun 1;60(11):3088-95. PubMed
PMID: 10850461.
152: Koukourakis MI, Kyrias G, Kakolyris S, Kouroussis C, Frangiadaki C,
Giatromanolaki A, Retalis G, Georgoulias V. Subcutaneous administration of
amifostine during fractionated radiotherapy: a randomized phase II study. J Clin
Oncol. 2000 Jun;18(11):2226-33. PubMed PMID: 10829042.
153: Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE,
Gatter KC, Harris AL. Coexpression of MUC1 glycoprotein with multiple angiogenic
factors in non-small cell lung cancer suggests coactivation of angiogenic and
migration pathways. Clin Cancer Res. 2000 May;6(5):1917-21. PubMed PMID:
10815916.
154: Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G. c-erbB-2
oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of
the head and neck, but is not associated with response to cytotoxic therapy or
survival. Anticancer Res. 2000 Mar-Apr;20(2A):997-1004. PubMed PMID: 10810387.
155: Corti L, Skarlatos J, Boso C, Cardin F, Kosma L, Koukourakis MI,
Giatromanolaki A, Norberto L, Shaffer M, Beroukas K. Outcome of patients
receiving photodynamic therapy for early esophageal cancer. Int J Radiat Oncol
Biol Phys. 2000 May 1;47(2):419-24. PubMed PMID: 10802369.
156: O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP,
Gatter K, Harris AL. Vascular endothelial growth factor, platelet-derived
endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br
J Cancer. 2000 Apr;82(8):1427-32. PubMed PMID: 10780522; PubMed Central PMCID:
PMC2363365.
157: Kakolyris S, Fox SB, Koukourakis M, Giatromanolaki A, Brown N, Leek RD,
Taylor M, Leigh IM, Gatter KC, Harris AL. Relationship of vascular maturation in
breast cancer blood vessels to vascular density and metastasis, assessed by
expression of a novel basement membrane component, LH39. Br J Cancer. 2000
Feb;82(4):844-51. PubMed PMID: 10732757; PubMed Central PMCID: PMC2374391.
158: Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC,
Harris AL. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell
head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res. 2000
Feb;6(2):381-9. PubMed PMID: 10690514.
159: Koukourakis MI, Giatromanolaki A, Guddo F, Kaklamanis L, Vignola M,
Kakolyris S, Turley H, Georgoulias V, Bonsignore G, Gatter KC, Harris AL.
c-erbB-2 and episialin challenge host immune response by HLA class I expression
in human non-small-cell lung cancer. J Immunother. 2000 Jan;23(1):104-14. PubMed
PMID: 10687143.
160: Sivridis E, Giatromanolaki A, Koukourakis M, Agnantis N. Lectin-binding
patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value
of concanavalin A. Virchows Arch. 2000 Jan;436(1):52-8. PubMed PMID: 10664162.
161: Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter
KC. Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp
Metastasis. 1999 Jul;17(5):445-50. PubMed PMID: 10651312.
162: Koukourakis MI, Flordellis CS, Giatromanolaki A, Koukouraki S, Kapsoritakis
A, Potamianos S, Retalis G, Sivridis E, Salsaa B, Harris AL, Maragoudakis MI.
Oral administration of recombinant human granulocyte macrophage
colony-stimulating factor in the management of radiotherapy-induced esophagitis.
Clin Cancer Res. 1999 Dec;5(12):3970-6. PubMed PMID: 10632327.
163: Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V,
Kanavaros P, Sivridis E, Gatter KC, Harris AL. Assessment of vascular maturation
in non-small cell lung cancer using a novel basement membrane component, LH39:
correlation with p53 and angiogenic factor expression. Cancer Res. 1999 Nov
1;59(21):5602-7. PubMed PMID: 10554041.
164: Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC,
Harris AL. Intratumoral angiogenesis: a new prognostic indicator for stage I
endometrial adenocarcinomas? Oncol Res. 1999;11(4):205-12. PubMed PMID: 10566619.
165: Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kanavaros P,
Hickson ID, Barzilay G, Georgoulias V, Gatter KC, Harris AL. Nuclear localization
of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early
operable non-small cell lung cancer (NSCLC). J Pathol. 1999 Nov;189(3):351-7.
PubMed PMID: 10547596.
166: Koukourakis MI, Koukouraki S, Giatromanolaki A, Archimandritis SC, Skarlatos
J, Beroukas K, Bizakis JG, Retalis G, Karkavitsas N, Helidonis ES. Liposomal
doxorubicin and conventionally fractionated radiotherapy in the treatment of
locally advanced non-small-cell lung cancer and head and neck cancer. J Clin
Oncol. 1999 Nov;17(11):3512-21. PubMed PMID: 10550149.
167: Giatromanolaki A, Stathopoulos GP, Tsiompanou E, Papadimitriou C,
Georgoulias V, Gatter KC, Harris AL, Koukourakis MI. Combined role of tumor
angiogenesis, bcl-2, and p53 expression in the prognosis of patients with
colorectal carcinoma. Cancer. 1999 Oct 15;86(8):1421-30. Erratum in: Cancer. 2009
Sept 1;115(17):4040. Tsiobanou, E [corrected to Tsiompanou, E]. PubMed PMID:
10526268.
168: Koukourakis MI, Bizakis JG, Skoulakis CE, Kyrmizakis D, Giatromanolaki A,
Papadakis CE, Prokopakis E, Amanakis Z, Hellidonis ES. Combined irinotecan,
docetaxel and conventionally fractionated radiotherapy in locally advanced head
and neck cancer. A phase I dose escalation study. Anticancer Res. 1999
May-Jun;19(3B):2305-9. PubMed PMID: 10472349.
169: Koukourakis MI, Bahlitzanakis N, Froudarakis M, Giatromanolaki A,
Georgoulias V, Koumiotaki S, Christodoulou M, Kyrias G, Skarlatos J, Kostantelos
J, Beroukas K. Concurrent conventionally factionated radiotherapy and weekly
docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma. Br J
Cancer. 1999 Aug;80(11):1792-6. PubMed PMID: 10468298; PubMed Central PMCID:
PMC2363119.
170: Arapandoni-Dadioti P, Giatromanolaki A, Trihia H, Harris AL, Koukourakis MI.
Angiogenesis in ductal breast carcinoma. Comparison of microvessel density
between primary tumour and lymph node metastasis. Cancer Lett. 1999 Apr
1;137(2):145-50. PubMed PMID: 10374835.
171: Giatromanolaki A, Koukourakis MI, Georgoulias V, Gatter KC, Harris AL,
Fountzilas G. Angiogenesis vs. response after combined chemoradiotherapy of
squamous cell head and neck cancer. Int J Cancer. 1999 Mar 15;80(6):810-7. PubMed
PMID: 10074911.
172: Koukourakis MI, Giatromanolaki A, Schiza S, Kakolyris S, Georgoulias V.
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with
immunological toxicity evaluation. Int J Radiat Oncol Biol Phys. 1999 Jan
1;43(1):107-14. PubMed PMID: 9989521.
173: Giatromanolaki A, Fountzilas G, Koukourakis MI, Arapandoni P, Theologi V,
Kakolyris S, Georgoulias V, Harris AL, Gatter KC. Neo-angiogenesis in locally
advanced squamous cell head and neck cancer correlates with thymidine
phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin Exp
Metastasis. 1998 Oct;16(7):665-72. PubMed PMID: 9932613.
174: Guddo F, Giatromanolaki A, Koukourakis MI, Reina C, Vignola AM, Chlouverakis
G, Hilkens J, Gatter KC, Harris AL, Bonsignore G. MUC1 (episialin) expression in
non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and
correlates with poor survival in node positive patients. J Clin Pathol. 1998
Sep;51(9):667-71. PubMed PMID: 9930070; PubMed Central PMCID: PMC500903.
175: Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P,
Georgoulias V, Fountzilas G. p53 and bcl-2 expression in locally advanced
squamous cell head-neck cancer treated with platinum based chemotherapy and
radiotherapy. Anticancer Res. 1998 Nov-Dec;18(6B):4685-92. PubMed PMID: 9891541.
176: Kakolyris S, Kaklamanis L, Giatromanolaki A, Koukourakis M, Hickson ID,
Barzilay G, Turley H, Leek RD, Kanavaros P, Georgoulias V, Gatter KC, Harris AL.
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1)
protein: a basis for its role in human disease. Histopathology. 1998
Dec;33(6):561-9. PubMed PMID: 9870152.
177: Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott
PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC. Vascular endothelial growth
factor, wild-type p53, and angiogenesis in early operable non-small cell lung
cancer. Clin Cancer Res. 1998 Dec;4(12):3017-24. PubMed PMID: 9865915.
178: Koukourakis MI, Stefanaki I, Giatromanolaki A, Frangiadaki C, Armenaki A,
Georgoulias V, Koumandakis E, Kranidis A, Helidonis E. Fractionated carboplatin
radiosensitization: a phase I dose-escalation study. Am J Clin Oncol. 1998
Dec;21(6):595-601. PubMed PMID: 9856662.
179: Giatromanolaki A, Sivridis E, Koukourakis MI, Harris AL, Gatter KC. Bcl-2
and p53 expression in stage I endometrial carcinoma. Anticancer Res. 1998
Sep-Oct;18(5B):3689-93. PubMed PMID: 9854478.
180: Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K,
Harris AL, Gatter KC. Comparative evaluation of angiogenesis assessment with
anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin
Cancer Res. 1997 Dec;3(12 Pt 1):2485-92. PubMed PMID: 9815651.
181: Koukourakis MI, Kourousis C, Kamilaki M, Koukouraki S, Giatromanolaki A,
Kakolyris S, Kotsakis A, Androulakis N, Bahlitzanakis N, Georgoulias V. Weekly
docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A
phase I/II dose escalation trial. Eur J Cancer. 1998 May;34(6):838-44. PubMed
PMID: 9797695.
182: Guddo F, Giatromanolaki A, Patriarca C, Hilkens J, Reina C, Alfano RM,
Vignola AM, Koukourakis MI, Gambacorta M, Pruneri G, Coggi G, Bonsignore G.
Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is
associated with tumor progression. Anticancer Res. 1998 May-Jun;18(3B):1915-20.
PubMed PMID: 9677444.
183: Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne KJ, Apostolikas N,
Skarlatos J, Gatter KC, Harris AL. Different patterns of stromal and cancer cell
thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on
tumour neoangiogenesis and survival. Br J Cancer. 1998 May;77(10):1696-703.
PubMed PMID: 9635852; PubMed Central PMCID: PMC2150048.
184: Giatromanolaki A, Koukourakis MI, Kakolyris S, Kaklamanis L, Barbatis K,
O'Byrne KJ, Theodosssiou D, Harris AL, Gatter KC. Focal expression of thymidine
phosphorylase associates with CD31 positive lymphocytic aggregation and local
neo-angiogenesis in non-small cell lung cancer. Anticancer Res. 1998
Jan-Feb;18(1A):71-6. PubMed PMID: 9568058.
185: Giatromanolaki A, Koukourakis MI. p53 and angiogenesis in non-small-cell
lung cancer. Br J Cancer. 1998 Mar;77(5):850-2. PubMed PMID: 9514069; PubMed
Central PMCID: PMC2149961.
186: Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Whitehouse RM, Talbot DC,
Gatter KC, Harris AL. Potential role of bcl-2 as a suppressor of tumour
angiogenesis in non-small-cell lung cancer. Int J Cancer. 1997 Dec
19;74(6):565-70. PubMed PMID: 9421349.
187: Koukourakis MI, Koukouraki S, Giatromanolaki A, Skarlatos J, Georgoulias V,
Karkavitsas N. Non-small cell lung cancer functional imaging: increased
hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance
to cytotoxic treatment. Clin Cancer Res. 1997 May;3(5):749-54. PubMed PMID:
9815745.
188: Giatromanolaki A, Koukourakis MI, Comley M, Kaklamanis L, Turley H, O'Byrne
K, Harris AL, Gatter KC. Platelet-derived endothelial cell growth factor
(thymidine phosphorylase) expression in lung cancer. J Pathol. 1997
Feb;181(2):196-9. PubMed PMID: 9120725.
189: Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM,
Talbot DC, Gatter KC, Harris AL. Platelet-derived endothelial cell growth factor
expression correlates with tumour angiogenesis and prognosis in non-small-cell
lung cancer. Br J Cancer. 1997;75(4):477-81. PubMed PMID: 9052396; PubMed Central
PMCID: PMC2063312.
190: Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C,
Trichia E, Whitehouse R, Harris AL, Gatter KC. Non-small cell lung cancer:
c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
Anticancer Res. 1996 Nov-Dec;16(6B):3819-25. PubMed PMID: 9042264.
191: Koukouraki S, Damilakis J, Giatromanolaki A, Androulakis E, Karkavitsas N,
Koukourakis M. Functional imaging of tumours with 99Tcm-sestamibi pinhole
scintigraphy. Nucl Med Commun. 1996 Nov;17(11):943-51. PubMed PMID: 8971865.
192: Chetty R, Biddolph S, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A,
Gatter K. bcl-2 protein is strongly expressed in post-transplant
lymphoproliferative disorders. J Pathol. 1996 Nov;180(3):254-8. PubMed PMID:
8958801.
193: Kaklamanis L, Koukourakis MI, Leek R, Giatromanolaki A, Ritter M, Whitehouse
R, Gatter KC, Harris AL. Loss of interleukin 4 receptor-associated molecule
gp200-MR6 in human breast cancer: prognostic significance. Br J Cancer. 1996
Nov;74(10):1627-31. PubMed PMID: 8932345; PubMed Central PMCID: PMC2074844.
194: Koukourakis MI, Whitehouse RM, Giatromanolaki A, Saunders M, Kaklamanis L.
Predicting distant failure in nasopharyngeal cancer. Laryngoscope. 1996
Jun;106(6):765-71. PubMed PMID: 8656965.
195: Giatromanolaki A, Koukourakis M, O'Byrne K, Fox S, Whitehouse R, Talbot DC,
Harris AL, Gatter KC. Prognostic value of angiogenesis in operable non-small cell
lung cancer. J Pathol. 1996 May;179(1):80-8. PubMed PMID: 8691350.
196: Chetty R, Biddolph SC, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A,
Gatter KC. EBV latent membrane protein (LMP-1) and bcl-2 protein expression in
Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders.
Histopathology. 1996 Mar;28(3):257-60. PubMed PMID: 8729046.
197: Giatromanolaki A, Gorgoulis V, Chetty R, Koukourakis MI, Whitehouse R,
Kittas C, Veslemes M, Gatter KC, Iordanoglou I. C-erbB-2 oncoprotein expression
in operable non-small cell lung cancer. Anticancer Res. 1996
Mar-Apr;16(2):987-93. PubMed PMID: 8687165.
198: Koukourakis M, Hlouverakis G, Kosma L, Skarlatos J, Damilakis J,
Giatromanolaki A, Yannakakis D. The impact of overall treatment time on the
results of radiotherapy for nonsmall cell lung carcinoma. Int J Radiat Oncol Biol
Phys. 1996 Jan 15;34(2):315-22. PubMed PMID: 8567332.
199: Chetty R, Biddolph S, Kaklamanis L, Giatromanolaki A, Gatter K. Relationship
of EBV and bcl-2 in Hodgkin's disease. Histopathology. 1995 Oct;27(4):392-3.
PubMed PMID: 8847076.
200: Chetty R, Cerroni L, Pulford K, Giatromanolaki A, Biddolph S, Kaklamanis L,
Gatter K. TAL1 gene deletions and TAL1 protein expression in sporadic melanoma.
Melanoma Res. 1995 Aug;5(4):251-4. PubMed PMID: 7496160.
201: Koukourakis M, Skarlatos J, Kosma L, Giatromanolaki A, Yannakakis D.
Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free
survival and patterns of failure. Acta Oncol. 1995;34(4):525-30. PubMed PMID:
7605662.
202: Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C, Kittas
C. Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia:
possible correlation with human papillomavirus infection and clinicopathological
findings. Virchows Arch. 1994;425(5):481-9. Review. PubMed PMID: 7850072.
203: Gorgoulis V, Giatromanolaki A, Iliopoulos A, Kanavaros P, Aninos D,
Ioakeimidis D, Kontomerkos T, Karameris A. EGF and EGF-r immunoexpression in
Sjögren's syndrome secondary to rheumatoid arthritis. Correlation with EBV
expression? Clin Exp Rheumatol. 1993 Nov-Dec;11(6):623-7. PubMed PMID: 8299253.
204: Gorgoulis V, Giatromanolaki A, Karameris A, Tsatsanis C, Aninos D, Ozanne B,
Veslemes M, Jordanoglou J, Trigidou R, Papastamatiou H, et al. Epidermal growth
factor receptor expression in squamous cell lung carcinomas: an
immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded
material. Virchows Arch A Pathol Anat Histopathol. 1993;423(4):295-302. PubMed
PMID: 8236825.
Ερευνητική Ομάδα 3
Νικολαρόπουλος Σωτήριος
Υπεύθυνος Ομάδας
1.
A. Papageorgiou, L. Boutis, S. Nikolaropoulos and P. Catsoulacos: Potential Antitumor Agents:
Steroidal Amidoesters with an Alkylating Moiety, Oncology 1987, 44, 128-132.
[IF=2.684]
2.
C. Camoutsis, S. Nikolaropoulos and P.Catsoulacos: Steroidal Pyrazoline and Pyrazole,
Journal Of Chemical & Engineering Data 1987, 32, 478.
[IF=0.885]
3.
G. Pairas, S. Nikolaropoulos and P.Catsoulacos: Stereochemical Investigation of Steroidal
Ketoximes, Pharmakeftiki 1988, 1, 17-20.
[IF= -]
4.
S. Nikolaropoulos and P. Catsoulacos: Steroidal Imidazopyridines and Lactam Imidazopyridines, J. Heterocyclic Chem. 1988, 25, 1607.
[IF=0.859]
5.
S. Nikolaropoulos and P. Catsoulacos: Formation of Acetamido-Aza-Steroids, J. Heterocyclic
Chem. 1990, 27, 1997.
[IF=0.887]
6.
M. Pelecanou and S. Pelecanou: On the Synthesis of D-Homoandrostanes
Z. Naturforsch. 1993, 48b, 1305.
[IF=0.864]
7.
S. Nikolaropoulos, E. Arvanitopoulou and N. Katsanos: Diffusion Coefficients in Liquids by
HPLC and the respective Calibration Factors, Fresen J. Anal. Chem, 1995, 352, 639-642.
[IF=1.924]
8.
A. Papageorgiou, S. Nikolaropoulos, P. Catsoulacos, D. Mourelatos, Z. Iacovidou-Kritsi, E.
Mioglou- Kalouptsi, A. Kotsis: Enhacement of antineoplastic effects by stereoisomers of
steroidal derivatives of p-N,N -bis(2-chloroethyl)aminophenylacetate,
Biochemistry and Biophysics Newsletter, 1996, 41, 64-65.
[IF=1.213]
9.
S.Nikolaropoulos, E.S.Arsenou, A.Papageorgiou and D.Mourelatos:
Antitumor and Cytogenetic Effects of Esteric (ASE) and Amidic (ASA) Steroidal Derivative of pbis(2-Chloroethyl)amino phenylacetic Acid (CAPA). A Comparative Study.
Anticancer Research, 1997, 17, 4525-4530.
[IF=1.045]
10. Ch. Camoutsis and S.Nikolaropoulos: Steroidal isoxazoles, isoxazolines and isoxazolidines
J. Heterocyclic Chem., 1998, 35(4), 731-759.
[IF=0.696]
11. A.Papageorgiou, S.Nikolaropoulos, E.S Arsenou, E.Karaberis, D.Mourelatos, A.Kotsis,
E.Chryssogelou: Enhanced Cytogenetic and Antineoplastic Effects by the Combined Action of
Two Esteric Steroidal Derivatives of Nitrogen Mustards, Chemotherapy, 1999, 45, 61-67.
[IF=0.797]
12. E. Arvanitopoulou , S. Nikolaropoulos, F. Bazoti and N.A. Katsanos: Physicochemical
measurements in liquids by simple HPLC instrumentation, J. Liq. Chrom. & Rel. Technol., 2000,
23(19), 2911-2928.
[IF=0.844]
13. S.Nikolaropoulos, D.Tsavdaridis, E.Arsenou, A.Papageorgiou, E.Karaberis and
D.Mourelatos: Synergistic Antineoplastic and Cytogenetic Effects by the Combined Action of
Two Homo-aza-Steroidal Esters of Nitrogen Mustards on P388 and L1210 Leukaemias in Vivo
and in Vitro, Anticancer Research, 2000, 20, 2745-2752.
[IF=1.331]
14. Ch. Camoutsis, D. Catsoulacos, V. Karayianni, A.Papageorgiou, D.Mourelatos, E. Mioglou, Z.
Kritsi and S.Nikolaropoulos: Comprative Study of Sister Chromatid Exchange Induction and
Antitumor Effects by Homo-aza-steroidal Esters of {p-[bis(2-chloroethyl)amino]phenyl}butyric
Acid, Cancer Detection and Prevention, 25(6):558-564 (2001).
[IF=1.324]
15. Manolis A. Fousteris, Anna I. Koutsourea, Evagelia S. Arsenou, Athanasios Papageorgiou,
Dionisis Mourelatos and Sotiris S. Nikolaropoulos:
Antileukemic and Cytogenetic Effects of Modified and non-Modified Esteric Steroidal
Derivatives of 4-Methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA),
Anticancer Research, 2002, 22(4), 2293-2300.
[IF=1.447]
16. Venetia Karayianni, Athanasios Papageorgiou, Eleftheria Mioglou, Zafeiroula Iakovidou,
Dionysios Mourelatos, Manolis Fousteris, Anna Koutsourea, Evaggelia Arsenou, and Sotiris
Nikolaropoulos: 7-keto Hybrid steroidal esters of nitrogen mustard: cytogenetic and
antineoplastic effects,
Anticancer Drugs, 2002, 13(6), 637-643.
[IF=2.013]
17. A. Kapou, T. Mavromoustakos, S.G. Grdadolnik and S. Nikolaropoulos:
Synthesis and conformational analysis of steroidal carriers of alkylating agents with the use of
two-dimentional nuclear magnetic resonance,
Drug Discovery and Design: Medical Aspects, IOS Press, 2002, 167-173.
[IF= -]
18. Venetia Karayanni, Eleftheria Mioglou, Zafiroula Iakovidou, Dionysios Mourelatos, Manolis
Fousteris, Anna Koutsourea, Evaggelia Arsenou, Sotiris Nikolaropoulos:
A new approach for evaluating in vivo antileukemic activity using the SCE assay. An application
on three newly synthesized anti-tumor steroidal esters,
Mutation Research/Genetic Toxicology and Enviromental Mutagenesis, 2003, 535, 79-86.
[IF=1.748]
19. E.S. Arsenou, M.A. Fousteris, A.I. Koutsourea and S.S. Nikolaropoulos:
7-keto-Δ5-steroids: Key-molecules owning particular biological and chemical interest
Mini Reviews in Medicinal Chemistry, 2003, 3(6), 557-567.
[IF= 3.163]
20. Evaggelia S. Arsenou, Anna I. Koutsourea, Manolis A. Fousteris and S.S. Nikolaropoulos:
Optimization of the allylic oxidation in the synthesis of 7-keto-Δ5-steroidal substrates,
Steroids, 2003, 68, 407-414.
[IF=2.444]
21. Anna I. Koutsourea, Evaggelia S. Arsenou, Manolis A. Fousteris and S.S. Nikolaropoulos:
Synthetic approaches for the synthesis of a cytostatic steroidal B-D bilactam
Steroids, 2003, 68, 659-666.
[IF=2.444]
22. D. Mourelatos, Z. Iakovidou, E. Mioglou, E. Karapidaki, A. Koutsourea, E. Arsenou, M.
Fousteris, S. Nikolaropoulos: SCEs and PRIs as indicators of structure-biological activity
relationship of newly synthesized steroidal esters, Epitheorese Klinikes Farmakologias kai
Farmakokinetikes, International Edition 2004, 18(1), 52-54.
[IF=-]
23. Manolis A. Fousteris, Anna I. Koutsourea, Evaggelia S. Arsenou, Leondios Leondiadis,
Sotiris S. Nikolaropoulos and Ioannis K. Stamos: Pyrrolocarbazole Analogs of Aromatic
Skeleton of Indolocarbazole Natural Products, J. Heterocyclic Chem., 2004, 41, 349-353.
[IF=0.814]
24. Evaggelia S. Arsenou, Manolis A. Fousteris, Anna I. Koutsourea, Athanasios Papageorgiou,
Venetia Karayianni, Eleftheria Mioglou, Zafiria Iakovidou, Dionysios Mourelatos and Sotiris S.
Nikolaropoulos: The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic
potency of chlorambucil’s active metabolite steroidal esters
Anticancer Drugs, 2004, 15, 983-990.
[IF=2.052]
25. Asimina Kouloumenta, Georgia Stephanou, Nikos A. Demopoulos, and Sotiris S.
Nikolaropoulos: Genetic effects caused by potent antileukemic steroidal esters of chlorambucil’s
active metabolite,
Anticancer Drugs, 2005, 16:67-75.
[IF=1.907]
26. Agnes Kapou, Sotiris Nikolaropoulos and Thomas Mavromoustakos: Effects of steroidal carriers
of alkylating agents on the phase transition in DPPC membrane bilayers.
Thermochimica Acta, 2005, 429, 53-56.
[IF=1.230]
27. Evaggelia S. Arsenou, Evaggelia P. Papadimitriou, Eleni Kliafa, Maria Hountala and Sotiris S.
Nikolaropoulos: Effects of retinoic acid steroidal analogues on human leukemic HL60 cell
proliferation in vitro and on angiogenesis in vivo.
Anticancer Drugs, 2005, 16:151-158.
[IF=1.907]
28. Agnes Kapou, Manolis A. Fousteris, Sotiris Nikolaropoulos, Maria Zervou, Simona G.
Grdadolnik, Panagiotis Zoumboulakis, Ioanna Kyrikou and Thomas Mavromoustakos:
2D NMR and Conformational Analysis of a Prototype Antitumour Steroidal Ester,
Journal of Pharmaceutical and Biomedical Analysis, 2005, 38, 428-434.
[IF=1.889]
29. Athanasios Papageorgiou, Anna I. Koutsourea, Evagelia S. Arsenou, Manolis A. Fousteris,
Dionysios Mourelatos and Sotiris S. Nikolaropoulos: Srtucture-antileukemic activity relationship
study of B and D-ring modified and non-modified steroidal esters of chlorambucil’s active
metabolite,
Anticancer Drugs, 2005, 16, 1075-1082.
[IF=1.907]
30. Manolis A. Fousteris, Anna I. Koutsourea, Sotiris S. Nikolaropoulos, Abdelkhalek Riahi and
Jacques Muzart: Improved chromium-catalyzed allylic oxidation of Δ5-steroids with tert-butyl
hydroperoxide, Journal of Molecular Catalysis A: Chemical, 2006, 250, 70–74.
[IF=2.511]
31. Dima Eleni, Mioglou Eleftheria, Iakovidou Zafeiroula, Spyridonidou Katerina, Nikolaropoulos
Sotiris, Mourelatos Dionysios: Cytogenic efficacy by modified steroidal esters of N-acetyl
melphalan,
Epitheorese Klinikes Farmakologias kai Farmakokinetikes, International Edition, 2006, 20(2),
85-87.
[IF=-]
32. Manolis A. Fousteris, Anna I. Koutsourea, Evaggelia S. Arsenou, Athanasios Papageorgiou,
Dionysios Mourelatos, and Sotiris S. Nikolaropoulos:
Structure-anti-leukemic activity relationship study of B- and D-ring modified and non-modified
steroidal esters of chlorambucil,
Anticancer Drugs, 2006, 17, 511-519.
[IF=2.245]
33. M. A. Fousteris, A. I. Koutsourea, N. P. Lagonikakos, E. S. Arsenou, C. Spyridonidou, D.
Mourelatos, S. S. Nikolaropoulos: Rational design, synthesis and in vitro evaluation of three
new alkylating steroidal esters, Medicinal Chemistry, 2006, 2, 569-576. [IF=-]
34. Agnes Kapou, Nikolas P. Benetis, Nikos Avlonitis, Theodora Calogeropoulou, Maria Koufaki,
Efi Scoulica, Sotiris S. Nikolaropoulos and Thomas Mavromoustakos: 3D-Quantitative
structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.
Bioorganic and Medicinal Chemistry, 2007, 15, 1252-1265. [IF=2.662]
35. M. A. Fousteris, A. Papageorgiou, E. S. Arsenou, A. I. Koutsourea, E. Karaberis, D. Mourelatos,
D. O. Onyango and S. S. Nikolaropoulos: Antileukemic and Cytogenetic Activity by Triple
Administration of Three Modified Steroidal Derivatives of Nitrogen Mustards
Chemotherapy, 2007, 53, 118-126.
[IF=1.503]
36. M. Efthimiou, C. Andrianopoulos, G. Stephanou, N. A. Demopoulos and S. S. Nikolaropoulos:
Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N,Nbis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro
Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis, 2007, 617, 125137.
[IF=4.159]
37. Manolis A. Fousteris, Anna I. Koutsourea, Evagelia S. Arsenou, Athanasios Papageorgiou,
Dionysios Mourelatos and Sotiris S. Nikolaropoulos: Structure-antileukemic activity
relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3N,N-bis(2-chloroethyl)amino benzoic acid: A comparative study
Anti-Cancer Drugs, 2007, 18, 997-1004.
[IF=2.357]
38. Charalabos Camoutsis, Manolis A. Fousteris and S. S Nikolaropoulos: Azepine-2,5-diones and
derivatives of them as precursors in synthesis of fused heterocyclic ring systems
Trends in Heterocyclic Chemistry, 2007, 12, 83-115.
[IF=-]
39. Manolis A. Fousteris, Athanasios Papakyriakou, Anna Koutsourea, Maria Manioudaki, Evgenia
Lampropoulou, Evangelia Papadimitriou, Georgios A. Spyroulias and Sotiris S. Nikolaropoulos:
Pyrrolo[2,3-a]carbazoles as Potential Cyclin Dependent Kinase 1 (CDK1) Inhibitors. Synthesis,
Biological Evaluation, and Binding Mode through Docking Simulations
Journal of Medicinal Chemistry, 2008, 51, 1048-1052.
[IF=4.895]
40. Anna I. Koutsourea, Manolis A. Fousteris, Evagelia S. Arsenou, Athanasios Papageorgiou,
George N. Pairas and Sotiris S. Nikolaropoulos: Rational design, synthesis, and in vivo
evaluation of the antileukemic activity of six new alkylating steroidal esters,
Bioorganic & Medicinal Chemistry, 2008, 16, 5207-5215.
[IF=2.662]
41. Anna I. Koutsourea, Manolis A. Fousteris, Evagelia S. Arsenou, Athanasios Papageorgiou,
George N. Pairas and Sotiris S. Nikolaropoulos: Synthesis, in vivo antileukemic evaluation and
comparative study of novel 5α-7-keto steroidal esters of chlorambucil and its active metabolite,
In Vivo, 2008, 22, 345-352.
[IF=1.143]
42. Agnes Kapou, Nikolas-P. Benetis, Serdar Durdagi, Sotiris Nikolaropoulos and Thomas
Mavromoustakos: 3D QSAR/CoMFA and CoMSIA Studies on Antileukemic Steroidal Esters
Coupled with Conformationally Flexible Nitrogen Mustards
Journal of Chemical Information and Modeling, 2008, 48, 2254-2264.
[IF=2.986]
43. I. Karapidaki, A. Bakopoulou, A. Papageorgiou, Z. Iakovidou, E. Mioglou, S. Nikolaropoulos, D.
Mourelatos, T. Lialiaris: Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly
synthesized antitumour steroidal esters,
Mutation Research - Genetic Toxicology and Environmental Mutagenesis 2009, 675, 51-59.
[IF=2.278]
44. Katerina Spyridonidou, Manolis Fousteris, Marazioti Antonia, Athanasia Chatzianastasiou,
Andreas Papapetropoulos, Sotiris Nikolaropoulos: Tricyclic indole and dihydroindole derivatives
as new inhibitors of soluble guanylate cyclise,
Bioorganic & Medicinal Chemistry Letters, 2009, 19, 4810-4813.
[IF=2.531]
Φουστέρης Μανώλης
Μέλος
1.
Manolis A. Fousteris, Anna I. Koutsourea, Evagelia S. Arsenou, Athanasios Papageorgiou,
Dionisis Mourelatos and Sotiris S. Nikolaropoulos:
Antileukemic and Cytogenetic Effects of Modified and non-Modified Esteric Steroidal
Derivatives of 4-Methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA)
Anticancer Research, 22, 2293-2300 (2002).
2.
Venetia Karayianni, Athanasios Papageorgiou, Eleftheria Mioglou, Zafeiroula Iakovidou,
Dionysios Mourelatos, Manolis Fousteris, Anna Koutsourea, Evaggelia Arsenou and Sotiris
Nikolaropoulos:
7-Keto hybrid steroidal esters of nitrogen mustard: cytogenetic and antineoplastic effects
Anticancer Drugs, 13, 637-643 (2002).
3.
Evaggelia S. Arsenou, Anna I. Koutsourea, Manolis A. Fousteris and Sotiris S.
Nikolaropoulos:
Optimization of the allylic oxidation in the synthesis of 7-keto-Δ5-steroidal substrates
Steroids, 68, 407-414 (2003).
4.
Venetia Karayanni, Eleftheria Mioglou, Zafeiroula Iakovidou, Dionisis Mourelatos, Manolis
Fousteris, Anna Koutsourea, Evaggelia Arsenou and Sotiris Nikolaropoulos:
A new approach for evaluating in vivo anti leukemic activity using the SCE assay: An
application of three newly synthesised anti-tumour steroidal esters
Mutation Research/Genetic Toxicology and Enviromental Mutagenesis, 535(1), 79-86 (2003).
5.
Anna I. Koutsourea, Evaggelia S. Arsenou, Manolis A. Fousteris and Sotiris S.
Nikolaropoulos:
Synthetic approaches for the synthesis of a cytostatic steroidal B-D bilactam
Steroids, 68, 659-666 (2003).
6.
E.S. Arsenou, M.A. Fousteris, A.I. Koutsourea and S.S. Nikolaropoulos:
7-Keto-.Δ5-Steroids: Key-Molecules Owning Particular Biological and Chemical Interest
Mini Reviews in Medicinal Chemistry, 3(6), 557-567 (2003).
7.
Manolis A. Fousteris, Anna I. Koutsourea, Evaggelia S. Arsenou, Leondios Leondiadis,
Sotiris S. Nikolaropoulos and Ioannis K. Stamos:
Pyrrolocarbazole analogs of aromatic skeleton of indolocarbazole natural products
Journal of Heterocyclic Chemistry, 41, 349-353 (2004).
8.
Evaggelia S. Arsenou, Manolis A. Fousteris, Anna I. Koutsourea, Athanasios Papageorgiou,
Venetia Karayianni, Eleftheria Mioglou, Zafiria Iakovidou, Dionysios Mourelatos and Sotiris
S. Nikolaropoulos:
The allylic 7-ketone at the steroidal skeleton is crucial for the antileukemic potency of
chlorambucil’s active metabolite steroidal esters
Anticancer Drugs, 15, 983-990 (2004).
9.
Agnes Kapou, Manolis A. Fousteris, Sotiris S. Nikolaropoulos, Maria Zervou, Simona G.
Grdadolnikc, Panagiotis Zoumpoulakis, Ioanna Kyrikou, Thomas Mavromoustakos:
2D NMR and conformational analysis of a prototype anti-tumour steroidal ester
Journal of Pharmaceutical and Biomedical Analysis, 38(3), 428-434 (2005).
10.
Athanasios Papageorgiou, Anna I. Koutsourea, Evagelia S. Arsenou, Manolis A. Fousteris,
Dionysios Mourelatos and Sotiris S. Nikolaropoulos:
Srtucture-antileukemic activity relationship study of B and D-ring modified and non-modified
steroidal esters of chlorambucil’s active metabolite
Anticancer Drugs, 16, 1075-1082, (2005).
11.
Manolis A. Fousteris, Anna I. Koutsourea, Sotiris S.Nikolaropoulos, Abdelkhalek Riahi,
Jacques Muzart:
Improved chromium-catalyzed allylic oxidation of Δ5-steroids with t-butyl hydroperoxide
Journal of Molecular Catalysis A: Chemical, 250, 70-74 (2006).
12.
Manolis A. Fousteris, Anna I. Koutsourea, Evaggelia S. Arsenou, Athanasios Papageorgiou,
Dionysios Mourelatos, Sotiris S.Nikolaropoulos:
Structure-anti-leukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of chlorambucil
Anti-Cancer Drugs, 17, 511-519 (2006).
13.
Manolis Fousteris, Carole Chevrin, Jean Le Bras and Jacques Muzart:
Water-promoted iodocyclisation of 2-allylphenols
Green Chemistry, 8, 1–3 (2006).
14.
M.A. Fousteris, A.I. Koutsourea, E.S. Arsenou, C. Spyridonidou, D. Mourelatos and S.S.
Nikolaropoulos:
Rational design, synthesis and in vitro evaluation of three new alkylating steroidal esters
Medicinal Chemistry, 2, 569-576 (2006).
15.
M. A.Fousteris, A.Papageorgiou, E. S. Arsenou, A. I. Koutsourea, E. Karaberis, D.Mourelatos,
D. O. Onyango, S. S. Nikolaropoulos:
Antileukemic and Cytogenetic Activity by Triple Administration of Three Modified Steroidal
Derivatives of Nitrogen Mustards.
Chemotherapy, 53, 118-126 (2007).
16.
M. A. Fousteris, A. Papageorgiou, E. S. Arsenou, A. I. Koutsourea, D.Mourelatos, S. S.
Nikolaropoulos:
Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified
steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative study.
Anti-Cancer Drugs, 18, 997-1004 (2007).
17.
Charalabos Camoutsis, Manolis A. Fousteris and S. S Nikolaropoulos:
“Azepine-2,5-diones and derivatives of them as precursors in synthesis of fused heterocyclic
ring systems”
Trends in Heterocyclic Chemistry 12, 83-115 (2007)
18.
Manolis A. Fousteris, Athanasios Papakyriakou, Anna Koutsourea, Maria Manioudaki, Evgenia
Lampropoulou, Evangelia Papadimitriou, Georgios A. Spyroulias, Sotiris S Nikolaropoulos:
Pyrrolo[2,3-a]carbazoles as Potential Cyclin Dependent Kinase 1 (CDK1) Inhibitors. Synthesis,
Biological Evaluation, and Binding Mode through Docking Simulations.
Journal of Medicinal Chemistry, 51, 1048-1052 (2008).
19.
Anna I. Koutsourea, Manolis A. Fousteris, Evagelia S. Arsenou, Athanasios Papageorgiou,
George N. Pairas, Sotiris S. Nikolaropoulos.
Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new
alkylating steroidal esters.
Bioorganic & Medicinal Chemistry, 16, 5207-5215 (2008).
20.
Anna I. Koutsourea, Manolis A. Fousteris, Evagelia S. Arsenou, Athanasios Papageorgiou,
George N. Pairas, Sotiris S. Nikolaropoulos:
Synthesis, in vivo antileukemic evaluation and comparative study of novel 5α-7-keto steroidal
esters of chlorambucil and its metabolite
In vivo, 22, 345-352 (2008).
21.
Katerina Spyridonidou, Manolis Fousteris, Marazioti Antonia, Athanasia Chatzianastasiou,
Andreas Papapetropoulos, Sotiris Nikolaropoulos :
Tricyclic indole and dihydroindole derivatives as new inhibitors of soluble guanylate cyclase
Bioorganic & Medicinal Chemistry Letters, 19, 4810-4813(2009).
MΕΤΑΚΑΛΟΥΜΕΝΟΙ ΕΡΕΥΝΗΤΕΣ
Ivan Ivanov
1. Vlahov, R., Ivanov, I.G., Ognyanov, I. and Ivanov, D. Sur la composition de l’essence de lavande
bulgare cohobee. Parf. Cosm. Savons 13 (1970) 542-544.
2. Vlahov, R., Ivanov, I.G. and Ivanov, D. Hydrocarbures sesquiterpeniques dans l’huile essentiele bulgare
de Salvia sclarea. Parf. Cosm. Savons 13 (1970) 600-602.
3. Markov, G. and Ivanov, I.G. Hydroxylapatite column chromatography in procerures for isolation of
purified DNA. Analyt. Biochem. 59 (1974) 555-565.
4. Ivanov, I.G. and Markov, G. Heterogeneity of mouse unique deoxy-ribonucleic acid. FEBS Letters 47
(1974) 323-326.
5. Markov, G., Ivanov, I.G. and Pashev, I.G. Fractionation of chromatin by thermal precipitation in
phosphate buffer. J. Mol. Biol. 93 (1975) 405-413.
6. Ivanov, I.G. and Markov, G.G. RNA-DNA hybridization on membrane filters with fragmented
mammalian DNA. Biochim. Biophys. Acta 383 (1975) 123-130.
7. Ivanov, I.G., Venkov, P. and Markov, G. Isolation of DNA from yeast by chromatography on
hydroxylapatite. Prep. Biochem. 5 (1975) 219-228.
8. Markov, G.G. and Ivanov, I.G. DNA and tumor progression. Compt. Rend. Acad. Bulg. Sci. 28 (1975)
1261-1264.
9. Ivanov, I.G. and Markov, G.G. Purification of RNA preparations from DNA and low molecular weight
contaminants by hydroxylapatite chromatography. Compt. Rend. Acad. Bulg. Sci. 28 (1975) 811-812.
10. Ivanov, I.G., Zlateva, B. and Markov, G. Transcription of mouse DNA. Compt. Rend. Acad. Bulg. Sci.
28 (1975) 813-816.
11. Ivanov, I. G. Heterogeneity and transcriptional activity of DNA of some eukaryotic organisms. Ph.D.
Thesis, 1975, Sofia, Bulgaria Иванов, И. „Хетерогенност и транскрипционна активност на ДНК от
някои еукариотни организми”, Дисертация (за кбн), 1975 г.
12. Markov, G.G. and Ivanov, I.G. Comparative investigation of DNA from mouse and Ehrlich ascites
tumor cells. Neoplasma 24 (1977) 497-506.
13. Antonov, P., Ivanov, I.G. and Markov, G.G. Heterogeneity of Streptomyces DNA. FEBS Lett. 79 (1977)
151-154.
14. Ivanov, I.G. and Markov, G.G. On the heterogeneity of the slow reassociating (“unique”) DNA. Mol.
Cell. Biochem. 20 (1978) 111-118.
15. Ivanov, I.G., Antonov, P., Markova, N. and Markov, G. Maturation of DNA duplexes. Mol. Biol. Rep. 4
(1978) 67-71.
16. Antonov, P., Ivanov, I.G., Markov, G. and Benigni, R. Reassociation of DNA in studying the genome
size of Streptomyces. Studia Biophysica 69 (1978) 67-74.
17. Markova, N., Ivanov, I.G. and Markov, G.G. Influence of Ag and Hg cations on hydroxylapatite
chromatography of DNA. Analyt. Biochem. 84 (1978) 633-637.
18. Ivanov, I.G. and Markov, G.G. Conservatism of mouse satellite DNA in transplantable tumors. In:
DNA: Recombination, Interaction and Repair (Zadrazil, S. and Sponar, J., eds.), Pergamon Press, 1980, pp.
341-348.
19. Markov, G.G., Yaneva, J., Markova, N. and Ivanov, I.G. Specificity of transcription of single-copy DNA
in different rat tissues. In: DNA: Recombination, Interaction and Repair (Zadrazil, S. and Sponar, J., eds.),
Pergamon Press, 1980, pp. 349-358.
20. Ivanov, I.G., Markova, N., Venkov, P. and Markov, G.G. Repetitive sequences in nuclear
deoxyribonucleic acid of Saccharomyces cerevisiae. Curr. Microbiol. 4 (1980) 313-316.
21. Venkov, P., Ivanov, I.G. and Petrov, P. High-molecular weight mRNA in polysomes of osmotic
dependent Saccharomyces cerevisiae mutants. Int. J. Biochem. 13 (1980) 83-90.
22. Markov, G.G., Yaneva, J., Markova, N. and Ivanov, I.G. Specificity of transcription of single-copy DNA
in different rat tissues. Int. J. Biochem. 13 (1980) 121-124.
23. Yaneva, J., Ivanov, I.G., Bardarov, S. and Markov, G.G. EcoRII activity in E. coli B strains. Compt.
Rend. Acad. Bulg. Sci. 37 (1981) 1017-1020.
24. Yanev, N., Tsancova, I., Yaneva, J. and Ivanov, I.G. Combinatorial and statistical study on the
structure and organization of DNA. Proc. Symp. “Organization and Automation of the Experimental
Studies”, Russe, May 27-30, 1981 (in Russion), pp. 250-254.
25. Georgieva, E., Nosikov, V., Ivanov, I.G. and Pashev, I.G. Fractionation of liver chromatin after mild
micrococcal digestion. (in Russian) Molek. Biol. 16 (1982) 392-396.
26. Raikova, E., Ivanov, I.G., Kaffalieva, D., Demirov, G. and Raikov, Z. Spin-labelling of DNA with
hydrazine mustard spin-label. Int. J. Biochem. 14 (1882) 41-46.
27. Raikova, E., Kaffalieva, D., Ivanov, I.G., Zakhariev, S. and Golovinski, E. EPR study on the interaction
of spin-labelled hydrazine mustard derivatives with DNA. Biochem. Pharmacol. 32 (1983) 587-592.
28. Ivanov, I.G., Raikova, E., Raikov, Z., Yaneva, J. and Kaffalieva, D. Alkilating spin-labels for spinlabelling of DNA. Int. J. Biochem. 15 (1983) 433-437.
29. Ivanov, I.G., Raikova, E., Kaffalieva, D., Raikov, Z. and Yaneva, J. Purification of spin-labelled DNA
by hydroxylapatite chromatography. J. Chromatogr. 260 (1983) 177-181.
30. Markova, N., Ivanov, I.G. and Markov, G.G. Unusual genome organization of the marine invertebrate
Rapana thomasiana Grosse (Gastropoda). Chromosoma 88 (1983) 124-132.
31. Pashev, I., Dimitrov, S., Ivanov, I.G. and Markov, I.G. Histon acetylation in chromatin containing
mouse satellite DNA. Eur. J. Biochem.133 (1983) 379-382.
32. Bachvarov, D. and Ivanov, I.G. Large scale purification of plasmid DNA. Prep. Biochem. 13 (1983)
161-166.
33. Bachvarov, D. and Ivanov, I.G. Hydroxylapatite chromatography in procedures for purification of
bacterial plasmids. Compt. Rend. Acad. Bulg. Sci. 36 (1983) 671-672.
34. Bachvarov, D., Ivanov, I.G. and Markov, I.G. Concentration (Co) dependence of the thermal stability
of DNA duplexes. Compt. Rend. Acad. Bulg. Sci. 36 (1983) 667-670.
35. Yanev, N., Nikolova, V., Tzankova, I., Yaneva, J. and Ivanov, I.G. Approximation of the nucleotide
sequence in DNA with Markov chains. Mathematics and Education in Mathematics: Proc. 20th Spring
Conference of the Union of Bulgarian Mathematicians, 6-9 April, 1983, pp. 268-270.
36. Papageourgiou, A., Ivanov, I.G., Markov, G., Koliais, S., Boutis, L. and Catsoulakos, P. Interaction of
mono aza-steroidal ester of p-bis-(2-chloroethyl)-aminophenyl acetic acid (ASE) with DNA of Erlich
ascites tumor cells. FEBS Letters 153 (1983) 194-198.
37. Ivanov, I. G. Study of the DNA primary structure. (in Bulgarian; Abstracts in English and Russian).
Progr. Mol. Biol. 1 (1983) 18-36.
38. Papageourgiou, A., Ivanov, I.G., Markov, G., , Boutis, L. and Catsoulakos, P. Does ASE (an alkylating
ester)form interstrand cross-links in the DNA of Erlich ascites tumor? Anticancer Res. 4 (1984) 223-226.
39. Bachvarov, D., Ivanov, I.G. and Markov, G. Does the concentration of DNA (Co) and the time of
incubation (t) as parameters of Cot influence the thermal stability of DNA duplexes? Mol. Biol. Rep. 9
(1984) 223-226.
40. Tzankova, I., Yaneva, J., Ivanov, I.G. and Yanev, N. Identification of nucleotide sequences common
for the genes of multiple gene families. Proc. Internat. Confer. On Computer Based Research, Plovdiv, 1520 October, 1984, v.2, pp. 597-601.
41. Markov, G. G. and Ivanov, I. G. Molecular hybridization of nucleic acids. (in Bulgarian; Abstracts in
Russian and English), Progr. Mol. Biol. 2 (1984) 57-101.
42. Antonov, A., Pancheva, R. and Ivanov, I.G. Radioiodination of naturally occurring phospholipides.
Biochim. Biophys. Acta 835 (1985) 408-410.
43. Ivanov, I.G. and Gigova, L. Isolation of lambda phage DNA by hydroxylapatite chromatography.
Analyt. Biochem. 146 (1985) 379-382.
44. Alexciev, K. and Ivanov, I. G. Chemical synthesis of DNA. (in Bulgarian; Abstracts in Russian and
English), Progr. Mol. Biol. 4 (1985) 3-27.
45. Ivanov, I.G. and Gigova, L. RNA colony hybridization method. Gene 46 (1986) 287-290.
46. Bachvarov, D., Ivanov, I.G. and Markov, G.G. Study on the heterogeneity of the human alphoid
satellite DNA. Compt. Rend. Acad. Bulg. Sci. 39 (1986) 77-80.
47. Bachvarov, D., Markov, G.G. and Ivanov, I.G. Sequence heterogeneity of the human satellite DNA and
thermal stability of mismatched alphoid DNA duplexes. Int. J. Biochem. 19 (1987) 963-971.
48. Ivanov, I.G. and Bachvarov, D. Determination of plasmid copy-number by the “boiling” method.
Analyt. Biochem. 165 (1987) 137-141.
49. Ivanov, I.G., Tam, J., Wishart, P. and Jay, E. Chemical synthesis and expression of the human
calcitonin gene. Gene 59 (1987) 223-230.
50. Ivanov, I.G., Gigova, L. and Jay, E. Chemical synthesis and expression in E. coli of a human Val8calcitonin gene by fusion to a synthetic human interferon gamma gene. FEBS Letters 210 (1987) 56-60.
51. Ivanov, I.G. and Jay, E. Human calcitonin gene: Chemical synthesis and expression in E. coli.
Biotechnology & Biotechnics 2 (1987) 6-13.
52. Petrov, P., Jay, E. and Ivanov, I.G. Inclusion bodies in recombinant E. coli cells producing human
calcitonin tetramer as visualized by immuno-gold electron microscopy. Biol. Cell 61 (1987) 963-971.
53. Ivanov, I.G., Yavachev, L., Gigova, L., Alexciev, K. and Christov, C. A conditional high-copy number
plasmid derivative of pBR322. Microbiologica 11 (1988) 95-99.
54. Yavachev, L. and Ivanov, I.G. What does the homology between E. coli tRNA and RNAs controlling
ColE1 plasmid replication means? J. Theoret. Biol. 131 (1988) 235-241.
55. Ivanov, I.G., Markova, N., Bachvarov, D., Alexciev, K., Saraffova, A., Maximova, V., Tsaneva, I. And
Markov, G. Constitutive expression of a native human interferon-1 gene in E. coli. Int. J. Biochem. 21
(1989) 983-985.
56. Alexciev, K., Usheva, A. and Ivanov, I.G. Expression in E. coli K12 strains of two synthetic human
calcitonin genes differing in codon composition. Curr. Microbiol. 18 (1989) 5-9.
57. Alexciev, K., Usheva, A., Pavlova, M. and Ivanov, I.G. Expression of synthetic human calcitonin genes
in plasmid vectors containing tandemly repeated non-overlapping ribosome binding sites. Int. J. Biochem.
21 (1989) 987-996.
58. Gigova, L., Wishart, P., Usheva, A., Ivanova, M., Bardarov, S., Jay, E. and Ivanov, I.G. Expression of
repetitive human calcitonin genes in Escherichia coli. Biotechnol. Appl. Biochemistry 11 (1989) 1-12.
59. Angelov, I. and Ivanov, I. Amplification of bacterial plasmids without blocking protein biosynthesis.
Plasmid 22 (1989) 160-162.
60. Christov, C., Alexciev, K. and Ivanov, I.G. A shotgun method for oligomerization of synthetic genes.
Proc. 5th Symp. Bioterchnol., Balaton, 4-8 Sept., 1989, pp. 18-19.
61. Bachvarov, D., Usheva, A. and Ivanov, I.G. Constitutive expression of a hybrid CAT-hCT gene in E.
coli. Proc. 5th Symp. Bioterchnol., Balaton, 4-8 Sept., 1989, pp. 20-21.
62. Angelov, I. and Ivanov, I.G. Increased production of recombinant proteins in E. coli by supplementing
the growth media with ferichloride. Proc. 5th Symp. Bioterchnol., Balaton, 4-8 Sept., 1989, pp. 320-321.
63. Ivanov, I. G. and Alexciev, K. Genetic code and gene expression. (in Bulgarian; Abstracts in Russian
and English), Progr. Mol. Biol. 8 (1989) 3-21.
64. Иванав, И. „Химичен синтез и хетероложна експресия на човешки гени”, Дисертация (за дбн),
1989 г.
65. Bachvarov, D., Wishart, P., Usheva, A., Ivanov, I.G. and Jay, E. Expression in E. coli of a human Val8calcitonin gene by fusion to the gene of chloramphenicol acetyltransferase (CAT) gene. Biol. Zent. Bl. 109
(1990) 113-117.
66. Ivanov, I.G. Shotgun concatenation of synthetic genes: Construction of concatemeric human calcitonin
genes. Analyt. Biochem. 189 (1990) 213-216.
67. Ivanov, I.G., Christov, C. and Alexciev, K. Two methods for assembly and oligomerization of synthetic
genes: Construction of human calcitonin encoding sequences. Gene 95 (1990) 295-299.
68. Ivanov, I.G., Rommens, J., Saraffova, A., Maximova, V., Usheva, A., Bardarov, S., Papageourgiou, A.
and Jay, E. Chemical synthesis and characteristics of a hybrid phage T5-lac promoter. Microbiologica 13
(1990) 85-90.
69. Bachvarov, D., Jay, E. and Ivanov, I.G. Construction of a ColE1 plasmid bearing inducible highcopynnumber phenotype. Folia Microbiol. 35 (1990) 177-182.
70. Ivanov, I.G., Mironova, R., Philipova, D. and Venkov, P. Detection of specific RNA sequences in yeast
by in situ colony hybridization. Yeast 6 (1990) 31-34.
71. Mironova, R., Philipova, D., Marekov, L., Venkov, P. and Ivanov, I.G. Secretion of oligomeric Val8calcitonin by Saccharomyces cerevisiae. FEMS Microbiol. Letters 83 (1991) 23-28.
72. Antonov, P., Alexandrova, R. and Ivanov, I. Electroporation of the plasmid pECT4 into Pseudomonas
putida. Compt. Rend. Acad. Bulg. Sci. 44 (1991) 81-83.
73. Mironova, R., Philipova, D. and Ivanov, I.G. Saccharomyces cerevisiae as a host for the secretion of
human calcitonins with different molecular mass. Compt. Rend. Acad. Bulg. Sci. 44 (1991) 107-109.
74. Ivanov, I.G., Alexandrova, R., Dragulev, B., Saraffova, A. and Abou Haidar, M. G. Effect of tandemly
repeated AGG triplets on the translation of CAT mRNA in E. coli. FEBS Letters 307 (1992) 173-176.
75. Ivanov, I.G., Alexandrova, R., Dragulev, B., Leclerc, D., Saraffova, A., Maximova, V. and
AbouHaidar, M. G. Efficiency of the 5’-terminal sequence (omega) of tobacco mosaic virus RNA for the
initiation of eukaryotic gene translation in E. coli. Eur. J. Biochem. 209 (1992) 151-156.
76. Ivanov, I.G. and AbouHaidar, M.G. Effect of formaldehyde on the efficiency of hybridization of DNA
immobilized on nitrocellulose filters. Analyt. Biochem. 206 (1992) 414-418.
77. Alexandrova, R., Saraffova, A., Dragulev, B. and Ivanov, I.G. Omega sequence as a translational
initiator of foreign genes in E. coli. Compt. Rend. Acad. Bulg. Sci. 45 (1992) 117-119.
78. Angelov, I. and Ivanov, I.G. Instability of pBR322-derived plasmids is accompanied by changes in
concentration of RNA I. Compt. Rend. Acad. Bulg. Sci. 45 (1992) 57-59.
79. Angelov, I. and Ivanov, I.G. Dependence of plasmid supercoiling on the hydrophobicity of the
translated recombinant protein. Compt. Rend. Acad. Bulg. Sci. 45 (1992) 87-89.
80. Sehgal, O.P., Sinha, R.C., Gellatly, D., Ivanov, I.G. and AbouHaidar, M.G. Replication and
encapsidation of of the viroid-like satellite RNA of LTSV are supported in different hosts by cockfoot mottle
virus in turnip rosette virus. J. Gen. Virol. 74 (1993) 785-788.
81. Ivanov, I.G., Saraffova, A., Alexandrova, R. and AbouHaidar, M.G. Expression of human alpha 1
interferon genes in vectors containing tandemly located promoters recognized by two different RNA
polymerases (E. coli and T7). FEMS Microbiol. Letters 108 (1993) 231-236.
82. Ivanov, I.G., Dragulev, B. and AbouHaidar, M.G. Nucleic acids hybridization on nitrocellulose filters
of vacuum spotted Escherichia coli bacterial cells. J. Microbiol. Methods 17 (1993) 305-310.
83. Saraffova, A., Alexandrova, R., AbouHaidar, M.G., and Ivanov, I.G. Expression of the human alpha 1
interferon gene in E. coli under the control of a dual (P1T7) promoter. Compt. Rend. Acad. Bulg. Sci. 46
(1993) 105-108.
84. Sehgal, O.P., AbouHaidar, M.G., Gellatly, D., Ivanov, I.G. and Thottappilly, G. An associated small
RNA in rice yellow mottle sobemovirus homologous to the satellite RNA of lucerne transient streak
sobemovirus. Phytophathology (Mol. Plant. Pathology) 83 (1993) 1309-1312.
85. Alexandrova, R., Eweida, M., Georges, F., Dragulev, B., AbouHaidar, M.G. and Ivanov, I.G. Domains
of human interferon alpha 1 genecontaining tandems of arginine codons AGG play the role of translational
initiators in E. coli. Int. J. Biochem. Cell Biol. 27 (1995) 469-473.
86. Ivanov, I.G., Alexandrova, R., Dragulev, B. and AbouHaidar, M.G. A second putative mRNA binding
site on the E. coli ribosome. Gene 160 (1995) 75-79.
87. Ivanov, I.G. and AbouHaidar, M.G. Thermal stability of oligonucleotide duplexes bound to
nitrocellulose filters. Analyt. Biochem. 232 (1995)249-251.
88. Saraffova, A., Maximova, V., Ivanov, I.G. and AbouHaidar, M.G. Comparative study on the effect of
signal peptide codons and arginine codons on the expression of human interferon alpha 1 gene in
Escherichia coli. J. Interf. Cytok. Res. 16 (1996) 745-749.
89. Ivanov, I.G., Saraffova, A. and AbouHaidar, M.G. Unusual effect of clusters of rare arginine (AGG)
codons on the expression of human interferon alpha 1 gene in Escherichia coli. Int. J. Biochem. Cell Biol.
29 (1997) 659-666.
90. Kaloyanova, D., Xu, J., Ivanov, I.G. and AbouHaidar, M.G. Gene expression evidence indicating that
nucleotides 507-513 and 1430-1440 in 16S rRNA are organized in close proximity on the Escherichia coli
30S ribosomal subunit. Eur. J. Biochem. 248 (1997) 10-14.
91. Golshani, A., Golomehova, V., Mironova, R., Ivanov, I.G. and AbouHaidar, M.G. Does the epsilon
sequence of phage T7 function as an initiator of translation of CAT mRNA in Escherichia coli? Biochem.
Biophys. Res. Communicat. 236 (1997) 253-256.

92. Dineva, M.A., Ivanov, I.G. and Petkov, D.D. P -methyldeoxynucleoside triphosphates as substrates for
E. coli DNA polymerase I in a template-directed synthesis of DNA. Nucleosides & Nucleotides 16 (1997)
1875-1882.
93. Kaloyanova, D., Xu, J., AbouHaidar, M.G. and Ivanov, I.G. Constitutive expression of a Phytolacca
americana antiviral protein gene in Escherichia coli. Turkish J. Biochem. 22 (1997) 3-7.
94. Timcheva, I., Maximova, V., Deligeorgiev, T., Gadjev, N., Sabnis, R. and Ivanov,I.G. Fluorescence
spectral characteristics of novel asymmetric monomethine cyanine dyes in nucleic acid solutions. FEBS
Letters 405 (1997) 141-144.
95. Xu, J., Kaloyanova, D., Ivanov, I.G., and AbouHaidar, M.G. The low expression level of pokeweed
antiviral protein (PAP) gene in E. coli by the inducible lac promoter is due to inefficient transcription and
translation and not to the toxicity of the PAP. Arch. Biochem. Biophys. 35 (1997) 82-88.
96. Odjakova, M., Golshani, A., Ivanov, G., AbouHaidar, M. and Ivanov, I.G. The low level expression of
chloramphenicol acetyltransferase (CAT) mRNA in Escherichia coli is not dependent on either ShineDalgarno or the downstream boxes in the CAT gene. Microbiol. Res. 153 (1998) 173-178.
97. Xu, J., Meng, A., Hefferon, K., Ivanov, I.G. and AbouHaidar, M.G. Effect of N-terminal deletions on
the activity of pokeweed antiviral protein expressed in E. coli. Biochemie 80 (1998) 1069-1076.
98. Xu, J., Mironova, R., Ivanov, I.G. and AbouHaidar, M.G. A polylinker-derived sequence, PL, highly
increased translation efficiency in Escherichia coli. J. Basic Microbiol. 39 (1999) 51-60.
99. Ofoghi, H., Mironova, R., Moazami, N., Domonski, N. and Ivanov, I.G. Comparative study on the
expression of a human calcitonin tetrameric gene in yeast cells and transgenic potato plants. Biotechnol.
Biotechnol. Equipm. 13(1999)20-24.
100. Vassileva, A., Mironova, R., Nacheva, G. and Ivanov, I.G. N-terminal methionine in recombinant
proteins expressed in two different Escherichia coli strains. J. Biotechnol. 69 (1999) 63-67.
101. Mironova, R., Xu, J., AbouHaidar, M. and Ivanov, I.G. Efficiency of a novel non-Shine-Dalgarno and
a Shine-Dalgarno consensus sequence to initiate translation in Esherichia coli of genes with different
downstream box composition. Microbiol. Res. 154 (1999) 35-41.
102. AbouHaidar, M.G. and Ivanov, I.G. Non-enzymatic RNA hydrolysis promoted by the combined
catalytic activity of buffers and magnesium ions. Zeitschr. Naturforsh. 54c (1999) 542-548.
103. Kaloyanova, D., Kyurkchiev, S., Xu, J., AbouHaidar, M. and Ivanov, I.G. Mouse monoclonal
antibodies against Phytolacca americana antiviral protein PAP I. Hybridoma 18 (1999) 367-370.
104. Timcheva, I., Maximova, V., Deligeorgiev, T., Zaneva, D. and Ivanov, I.G. New asymetric
monomethine cyanine dyes for nucleic acids labelling: Absorption and fluorescence spectral
characteristics. J. Photochem. Photobiol. A Chem. 130 (2000) 7-11.
105. Andreeva, A.E., Borissova, E., Mironova, R., Glycos, M., Kotsifaki, D., Ivanov, I., Krysteva, M. and
Kokkinidis, M. Crystalization of type I chloramphenicol acetyltransferase: an approach based on the
concept of ionic strength reducers. Acta Crystal. D56 (2000) 101-103.
106. Vassileva, A., Niwa, T., Mironova, R., and Ivanov, I.G. Mass-spectral ESI-MS analysis of human
interferon- and chloramphenicol acetyltransferase I produced in two Escherichia coli strains. J.
Biotechnol. 78 (2000) 61-67.
107. Golshani, A., Kolev, V., Mironova, R., AbouHaidar, M.G. and Ivanov, I.G. Enhancing Activity of 
in Escherichia coli and Agrobacterium tumefaciens cells. Biochem. Biophys. Res. Comm. 269 (2000) 508512.
108. Golshani, A., Kolev, V., AbouHaidar, M.G. and Ivanov, I.G. Epsilon as an Initiator of Translation of
CAT mRNA in Escherichia coli. Biochem. Biophys. Res. Comm. 269 (2000) 528-531.
109. Ofoghi, H., Moazami, N., Domonsky, N.N. and Ivanov, I. Cloning and expression of human calcitonin
genes in transgenic potato plants. Biotechnol. Lett. 22 (2000) 611-615.
110. Йотова, Л., Добрев, И., Иванов, И. Практикум по биохимия, Част І, Диагнозис Прес, София,
2000 г.
111. Tsanev, R. and Ivanov, I. (2001) Immune Interferon: Properties and Clinical Applications. (a book),
CRC Press, Bocka Raton, USA.
112. Mironova, R., Niwa, T., Hayashi, H, Dimitrova, R. and Ivanov, I. Evidence for non-enzymatic
glycosylation in Escherichia coli. Mol. Microbiol. 39(2001)1061-68.
113. Altobelli G., Nacheva G., Todorova K., Ivanov I., Karshikoff A. Role of the C-terminal chain in
human interferon gamma stability: An electrostatic study. Proteins: Str., Func., Genet. 43 (2001) 125-133.
114. Kolev, V., Berzal, A. and Ivanov, I. Self Initiation of Translation in Escherichia coli of mRNAs Devoid
of Translational Initiators. Folia Biologica 47 (2001) 171-175.
115. Golshani, A., Xu, J., Kolev, V., AbouHaidar, M. and Ivanov, I. Inability of Agrobacterium
tumefaciens ribosome to translate in vivo mRNAs containing non-Shine-Dalgarno translational initiators.
Zeitschr. Naturforsh. 57c (2002) 307-312.
116. Boyanova, M., Tsanev, R. and Ivanov, I. A modified kynurenine bioassay for quantitative
determination of human interferon gamma. Analyt. Biochem. 308 (2002) 178-181.
117. Boycheva, S. and Ivanov, I. Missing codon pairs in the genome of Escherichia coli. Biotechnol.
Biotechnol. Equipm. 16 (2002) 142-144.
118. Todorova, K., Nacheva, G. and Ivanov, I. Isolation of plasmid DNA by adsorption on glass fibers.
Biotechnol. Biotechnol. Equipm. 16 (2002) 145-147.
119. Nacheva, G., Boyanova, M., Todorova, K., Kyurkchiev, S. and Ivanov, I. Characterization of
functional domains of human interferon gamma by specific monoclonal antibodies. Folia Biologica 48
(2002) 96-101.
120. Ivanov, I. Alternative initiation and enhancement of translation in Escherichia coli. ICGEB Annual
Activity Report 2002, pp. 150-151.
121. Nacheva, G., Todorova, K., Boycheva, M., Berzal-Herranz, A., Karshikov, A. and Ivanov, I. Human
interferon-gamma: Significance of the C-terminal flexible domain for its biological activity. Arch.
Biochem. Biophys. 413 (2003) 91-98.
122. Boycheva, S., Shkodrov, G. and Ivanov, I. Codon pairs in the genome of Escherichia coli.
Bioinformatics 29 (2003) 987-998.
123. Kolev, V., Ivanov, I., Berzal-Herranz, A. and Ivanov, I. Non-Shine-Dalgarno initiators of translation
selected from a combinatorial DNA library. J. Mol. Microbiol. Biotechnol. 5 (2003) 154-160.
124. Atanassova, A., Sugita, M., Sugiura, M., Pajpanova, T. and Ivanov, I. Molecular cloning, expression
and characterization of three distinctive genes encoding methionine aminopeptidases in cyanobacterium
Synechocystis sp., strainPCC6803. Arch. Microbiol. 180 (2003) 185-193.
125. Mironova, R., Niwa, T., Dimitrova, R., Boyanova, M. and Ivanov, I. Glycation and post-translational
processing of human interferon-gamma expressed in Escherichia coli. J. Biol. Chem. 278 (2003) 5106851074.
126. Миронова, Р., Димитрова, Р., Боянова, М., Иванов, И. Неензимно гликозилиране на човешки
интерферон-гама в Еscherichia coli. (Сборник доклади от научна конференция с международно
участие, Ст. Загора, 5-6 Юни, 2003 г.) Хуманна и ветеринарна медицина т. 3 (2003) 74-78.
127. Димитрова, Р., Калпазанова, М., Миронова, Р., Иванов, И. Неензимно гликозилиране на
тотален белтък в Еscherichia coli. (Сборник доклади от научна конференция с международно
участие, Ст. Загора, 5-6 Юни, 2003 г.) Хуманна и ветеринарна медицина т. 3 (2003) 79-84.
128. Стойнев, Г., Сребрева, Л., Иванов, И. Използване на лизин-богати хистони като моделни
белтъци за изследване процеса на неензимно гликозилиране в Е. coli. (Сборник доклади от научна
конференция с международно участие, Ст. Загора, 5-6 Юни, 2003 г.) Хуманна и ветеринарна
медицина т. 3 (2003) 85-89.
129. Ханджийски, Й., Стефанова, В., Миронова, Р., Иванов, И. Неензимно гликозилиране на ДНК в
Еscherichia coli. (Сборник доклади от научна конференция с международно участие, Ст. Загора, 5-6
Юни, 2003 г.) Хуманна и ветеринарна медицина т. 3 (2003) 90-94.
130. Boycheva, S., Bachvarov, B., Berzal-Heranz, A. and Ivanov, I.G. Effect of 3’terminal codon pairs with
different frequency of occurrence on the expression of cat gene in Escherichia coli. Curr. Microbiol. 48
(2004) 97-101.
131. Golshani, A., Xu, J., Pacal, M., Yang, X., Ganoza, M., Ivanov, I. and AbouHaidar, M.
Computationally identified and experimentally proven strong ribosome binding sites in the Escherichia coli
genome. Biochem. Biophys. Res. Comm 316 (2004) 978-983.
132. Стойнев, Г., Сребрева, Л., Иванов, И. In vitro и in vivo инхибиране на неензимното
гликозилиране в Еscherichia coli. (Сборник доклади от научна конференция с международно участие,
Ст. Загора, 3-4 Юни, 2004 г.) Хуманна и ветеринарна медицина т. 4 (2004) 90-95.
133. Димитрова, Р., Миронова, Р., Иванов, И. Образуване на 3-деоксиглюкозон в Еscherichia coli.
(Сборник доклади от научна конференция с международно участие, Ст. Загора, 3-4 Юни, 2004 г.)
Хуманна и ветеринарна медицина т. 4 (2004) 96-100.
134. Боянова, М., Цанев, Р., Иванов, И. Рекомбинантен човешки интерферон-гама: Влияние на
някои физични фактори върху биологичната му активност. (Сборник доклади от научна
конференция с международно участие, Ст. Загора, 3-4 Юни, 2004 г.) Хуманна и ветеринарна
медицина т. 4 (2004)101-105.
135. Бойчева, С., Иванов, И. Как може да се повиши експресията на човешкия калцитонинов ген в
Еscherichia coli. (Сборник доклади от научна конференция с международно участие, Ст. Загора, 3-4
Юни, 2004 г.) Хуманна и ветеринарна медицина т. 4 (2004) 106-110.
136. Бъчваров, Б., Иванов, И. Липсващи двойки кодони в прокариоти. (Сборник доклади от научна
конференция с международно участие, Ст. Загора, 3-4 Юни, 2004 г.) Хуманна и ветеринарна
медицина т. 4 (2004)111-115.
137. Stoynev, G., Srebreva, L. and Ivanov, I.G. Histone H1 as a reporter protein to investigate glycation in
bacteria. Curr. Microbiol. 49 (2004) 423-427.
138. Dimitrova, R., Mironova, R. and Ivanov, I.G. Glycation of proteins in Escherichia coli: Interference of
strain diversity and growth conditions with glycation. Compt. Rend. Bulg. Acad. Sci. 57 (2004) 71-75.
139. Stoynev, G., Dimitrova, R., Srebreva, L., Mironova, R. and Ivanov, I.G. Glycation of proteins in
Escherichia coli: Detection of glycating compounds using histone H1 as a substrate. Compt. Rend. Bulg.
Acad. Sci. 57 (2004) 77-82.
140. Ivanov, I.V. and Ivanov, I.G. Enhancing activity of the epsilon () sequence is independent of its
binding to domain 17 in 16S rRNA. Compt. Rend. Bulg. Acad. Sci. 57 (2004) 89-92.
141. Dimitrova, R., Mironova, R. and Ivanov, I.G. Glycation of proteins in Escherichia coli: Effect of
nutrient broth ingredients on glycation. Biotechnol. Biotechnol. Equipm. 18 (2004) 99-103.
142. Иванов, И., Максимова, В. (2005) Молекулярна биология на прионите и прионните
болести. В: “Прионови болести” (Редактори: И. Велчева и Д. Стоянов), Мед. Изд. АРСО,
София.
143. Mironova, R., Niwa, T., Handzhiyski, Y., Sredovska, A., and Ivanov, I. Evidence for non-enzymatic
glycosylation of Escherichia coli chromosomal DNA. Mol. Microbiol. 55 (2005) 1801-1811.
144. Tsoncheva, V., Todorova, K., Maximova, V. and Ivanov, I.G. Spontaneous transfection of mammalian
cells with plasmid DNA. Z. Naturforsch. 60c (2005) 644-648.
145. Butland G, Krogan NJ, Xu J, Yang WH, Aoki H, Li JS, Krogan N, Menendez J, Cagney G, Kiani GC,
Jessulat MG, Datta N, Ivanov I, Abouhaidar MG, Emili A, Greenblatt J, Ganoza MC, Golshani A.
Investigating the in vivo activity of the DeaD protein using protein-protein interactions and the
translational activity of structured chloramphenicol acetyltransferase mRNAs. J. Cell. Biochem. 100
(2006) 642-652.
146. Handzhiyski, J., Mironova, R., Rusev, D. and Ivanov, I. Effect of pyridoxal-5-phosphate on glycation
and mutability of E. coli. Trakia J. Sci. 5 (2007) 5-10.
147. Bachvarov, B. and Ivanov, I. Codon usage and gene expression in prokaryotes. Trakia J. Sci. 5 (2007)
51-55.
148. Tsanev, R., Boyanova, M. and Ivanov, I. Effect of some physical factors on fluorescence and
biological activity of human interferon gamma. Biotech. Biotechnol. Equipm. 21 (2007) 177-181.
149. Tsanev, R., Boyanova, M. and Ivanov, I. Fluorescent analysis of interferon-gamma. Biotech.
Biotechnol. Equipm. 21 (2007) 215-219.
150. Ivanov, I. Pharmaceutical and medical biotechnology. Biotechnol. Biotechnol. Equip. 21 (2007) 7479.
151. Todorova, K.A., Tsoncheva, V.L., Mitev, V., Ivanov, I.G. and Maximova, V.A. Modulation the effect
of interferon by diverse protein kinase inhibitors. Biotech. Biotechnol. Equipm. 21 (2007) 478-483.
152. Boyanova, M, Mironova, R., Niwa, T. and Ivanov, I. (2008) Post-translational processing of human
interferon-gamma produced in Escherichia coli and approaches for its prevention. In: NIH Frontiers in
Research, Vol. 1, Chapter 40, pp. 365-373, Humana Press, Totowa, NJ.
153. Tsoncheva V.L., Todorova K.A., Ivanov I.G. and Maximova V.A. Influence of Interferons on the
Repair of UV-Damaged DNA. Z. Naturforsch. 63c (2008) 303-307.
154. Stoynev, G., Srebreva, L., Gugova, R., Golovinski, E. and Ivanov I. Inhibitory effect of some acetyl
esters and acetamides on glycation of the histone H1. Z. Naturforsch. 63c (2008) 526-532.
155. Mironova, R., Sredovska, A., Ivanov, I. and Niwa, T. Maillard reaction products in the Escherichia
coli derived therapeutic protein interferon Alfacon-1. Ann. N.Y. Acad. Sci. 1126 (2008) 181-184.
156. Bachvarov, B., Kirilov, K. and Ivanov, I. Codon usage in prokaryotes. Biotech. Biotechnol. Equipm.
22 (2008) 669-682.
157. Bachvarov, B and Ivanov, I. Genetic code and gene expression in bacteria. In: Bacterial DNA, Nova
Science Publishers, NY, USA (Invited chapter, in press).
158. Mironova, R., Handzhiyski, Y., Niwa, T., Berzal-Heranz, A., Datsenko, K., Wanner, B. and Ivanov,
I.G. Maillard Reaction and Spontaneous Mutagenesis in Escherichia coli. In: Bacterial DNA, Nova
Science Publishers, NY, USA (Invited chapter, in press).
159. Petrov, S., Boyanova, M., Berzal-Herranz, A., Karshikoff, A., Nacheva, G. and Ivanov, I. Significance
of the putative upstream polybasic nuclear localisation sequence for the biological activity of human
interferon-gamma. Biotech. Biotechnol. Equipm. 23 (2009) 1058-1062.
160. Petrov, S., Ivanova, E., Chakarova, D., Posheva, V., Redzheb, M., Nacheva, G. and Ivanov, I. A new
approach for purification of recombinant interferon-gamma expressed in Escherichia coli. Biotech.
Biotechnol. Equipm. 23 (2009) 1101-1102.
161. Handzhiyski, J., Mironova, R., Rusev, D. and Ivanov, I. Effect of acetylsalicylic acid on glycation and
mutability of Escherichia coli chromosomal DNA. Biotech. Biotechnol. Equipm. 23 (2009) 1079-1083.
162. Tsekovska, R., Boyanova, M., Mironova, R. and Ivanov, I. Effect of arginine on glycation and
stability of recombinant human interferon-gamma. Biotech. Biotechnol. Equipm. 23 (2009) 1063-1067.
163. Srebreva, L. N., Stoynev, G. A. and Ivanov, I. G. Evidence for excretion of glycation agents from
Escherichia coli cells during growth. Biotech. Biotechnol. Equipm. 23 (2009) 1068-1071.
164.
ПАТЕНТИ И АВТОРСКИ СВИДЕТЕЛСТВА
P1. Ivanov, I.G., Ivanov, V. P., Ivanova, V. S., Marekov, L. N., Vassileva, R. A., Sarafova, A. A., Tsanev,
R. G. Method for producing of recombinant human cysteinless gamma-interferon free of methionine at Nterminal. European Patent 0 446 582 B1; C12N 15/23 (Date of publication: 04.01.1995; Appl. No
91100777.1; Date of filing: 22.01.91).
P2. Ivanov, I., Tsanev, R., Nacheva, G., Grigoleit, H. and Gunther, R. Inhibitors of endogenous human
interferon-gamma. International Patent WO2006/099701 A1 (International Publication Date: 28.09.2006;
Appl. No PCT/BG2005/000013; Priority Date: 21.03.2005).
P3. Ivanov, I., Nacheva, G., Petrov, S. and Grigoleit, H. Suppressors of the endogenous interferon-gamma.
International Patent Appl. № РСТ/BG2008/000025.
P4. Иванов, И. Метод за химичен синтез и експресия на гена на човешкия безцистеинов интерферон. Патент BG 52178A; C12N 15/00 (Дата на публикуване: Бюлетин №6/30.06.98; Рег. No
75781/18.07.1986).
P5. Мареков, Л., Василева, Р., Иванов, В., Сарафова, А., Цанев, Р., Иванов, И., Иванова, В. Метод за
получаване на рекомбинантен човешки безцистеинов -интерферон, свободен от N-краен
метионин. Патент BG 52073 A; C12P 21/06 (Дата на публикуване: Бюлетин № 4/30.04.96; Рег. No
91006/23.07.1993).
P6. Цанев, Р., Рашков, И., Панайотов, И., Иванов, И. Гел за лечение на кожни вирусни инфекции.
Патент BG 52099 A; A61K (Дата на публикуване: Бюлетин № 12/31.12.96; Рег. No 92888/26.07.1993).
P7. Сарафова, A., Максимова, В., Марков, Г., Бъчваров, Д., Иванов, И., Aлексиев, К., Маркова, Н.,
Цанева, И. Метод за конститутивна експресия на гена на интерферон алфа-1 в E. coli. Авт.
Свидетелство: BG 47116 A; (Дата на публикуване: Бюлетин № 5/15.05.90; Рег. № 86498/20.12.1988).
P8. Иванов, И., Бъчваров, Д., Алексиев, К., Сарафова, A., Максимова, В., Христов, Х. Метод за
полусинтез на гена на човешкия алфа 1-интерферон. Авт. Свидетелство: BG 47871 A; C12N 15/00
(Дата на публикуване: Бюлетин № 10/15.10.90; Рег. № 87610/10.03.1989).
P9. Сарафова , А., Максимова, В., Иванов, И., Вейко, В., Шехтер, И. Метод за конструиране на ген
на човешки алфа 1-интерферон свободен от кодоните на сигналната последователност. Авт.
Свидетелство: BG 47872 А; C12N 15/00 (Дата на публикуване: Бюлетин № 10/15.10.90; Рег. №
87661/10.03.1989).
P10. Сарафова, А., Иванов, И., Максимова, В., Козлов, Ю., Циганков, Ю., Чистосердов, А., Стеркин,
В. Метод за експресия на гена на човешкия алфа 1-интерферон в псевдомонади. Авт. Свидетелство:
BG 47873 А; C12N 15/00 (Дата на публикуване: Бюлетин № 10/15.10.90; Рег. № 87662/10.03.1989).
P11. Иванов, И. Метод за химична синтеза и експресия на гена на човешкия калцитонин. Авт.
Свидетелство: BG 40238 А; C12N 15/00 (Дата на публикуване: Бюлетин № 11/14.11.86; Рег. №
71131/18.07.1985).
P12. Иванов, И. Метод за химична синтеза и експресия на олигомерни гени, кодиращи човешкия
калцитонин. Авт. Свидетелство: BG 40576 А; C12N 15/00 (Дата на публикуване: Бюлетин №
1/15.01.87; Рег. № 71822/18.07.1985).
P13. Миронова, Р., Иванов, И., Филипова, Д., Венков, П. Метод за секретируиема експресия на
олигомерни гени, кодиращи човешки калцитонин в дрожди. Авт. Свидетелство: BG 50905A; C12N
15/00 (Дата на публикуване: Бюлетин № 12/15.12.92; Рег. № 92773/30.08.90).
P14.
Бъчваров,
Д.,
Иванов,
И.
Метод
за
изолиране
на
векторни
ДНК.
Авт. Свидетелство: BG 34687 A; C12N 15/00 (Дата на публикуване: Бюлетин № 11/15.11.83; Рег. №
56806/28.05.82).
P15. Иванов, И., Гигова, Л. Метод за получаване на ДНК от бактериофаги. Авт. Свидетелство: BG
38095 A; C12N 15/00 (Дата на публикуване: Бюлетин № 10/15.10.85; Рег. № 65342/05.05.84).
P16.
Иванов,
И.,
Гигова,
Л.
Метод
за
колонийна
РНК
хибридизация.
Авт. Свидетелство: BG 41921 A; C12N 15/00 (Дата на публикуване: Бюлетин № 9/15.09.87; Рег. №
74101/18.03.1986).
P17. Антонов, П., Панчева, Р., Иванов, И. Метод за радиоизотопно йодиране на фосфолипиди. Авт.
Свидетелство: BG 38400 A; C07Р 9/10 (Дата на публикуване: Бюлетин № 12/16.12.85; Рег. №
66187/11.07.1984).
P18. Иванов, И., Алексиев, К., Христов, Х. Метод за конструиране на синтетични гени. Авт.
Свидетелство: BG 47115 A; C12N 15/00 (Дата на публикуване: Бюлетин № 5/15.05.90; Рег. №
86497/20.12.1988).
P19. Иванов, И., Христов, Х., Алексиев, К. Метод за олигомеризация на синтетични гени. Авт.
Свидетелство: BG 47741 A; C12N 15/00 (Дата на публикуване: Бюлетин № 9/14.09.90; Рег. №
87609/10.03.1989).
P20. Миронова, Р., Филипова, Д., Венков, П., Иванов, И. Метод за изследване транскрипцията на
гени в дрожди. Авт. Свидетелство: BG 47740 A; C12N 15/00 (Дата на публикуване: Бюлетин №
9/14.09.90; Рег. № 87608/10.03.1989).
P21. Ангелов, И., Иванов, И. Метод за повишаване продуктивността на рекомбинантни бактерии.
Авт. Свидетелство: BG 47874 A; C12N 15/00 (Дата на публикуване: Бюлетин № 10/15.10.90; Рег. №
87613/10.03.1989).
P22. Бърдаров, С., Иванов, И. Метод за стабилизация на експресионни плазмиди. Авт.
Свидетелство: BG 47875 A; C12N 15/00 (Дата на публикуване: Бюлетин № 10/15.10.90; Рег. №
87614/10.03.1989).
10.12.2008 г.
Maximova-Todorova VA
Maximova-Todorova V.A. Persistence of live virus vaccines in animals. (PhD thesis)1978.(Russian)
Gorshunova, L.P., Maximova-Todorova, V.A., Romanov, V.A., Vanag, K.A., Nabokov, A.V.
Localization of specific antigen in the organs of animals immunized by different batches of live
measles vaccine. Bull. Exper. Biol. Med.(Russian) 5, 567-569, 1978
Gorshunova L.P., Maximova-Todorova V.A., Kiyzhnyakova T.M. Nabokova A.V., Vanag K.A.
Localization of specific antigen in the organs of the newborn animals inoculated with liva smallpox
vaccine. Bull.Exper.Biol.Med. .(Russian) 11, 566-568, 1978
Vanag K.A., Bychkova E.N., Shubladze A.K., Maximova V.A. Pathomorphological features of an
experimental infection in animals inoculated with viruses of the rabies antigenic group. Vopr. Virus.
.(Russian) 1, 77-83, 1979
Manolova, N., Uzunova, A., Maximova-Todorova, V. Influenza in humans and animals.Veterinar.Sci.
(Bulgarian)ХVI, 9, 103-108, 1980
Gorshunova L.P., Maximova-Todorova V.A., Vanag K.A., Nabokova A.V., Sadogurskaya E.M. On
persistence of attenuated poliomyelitis virus in the organs of vaccinated animals.Vopr. Virus.
(Russian) 3, 338-341, 1980
Nabi, N., Maximova-Todorova, V., Gegova, G., Manolova, N.. Biological features ofselected strains
of influenza viruses in the process of their adaptation to the lung of mice. I. Study on the influenza
virus H3N2. Acta microbiologica bulgarica (Bulgarian) 6, 42-47, 1980
Maximova-Todorova V. Persistence of vaccine virus in rabbits. Acta microbiologica bulgarica
(Bulgarian) 6, 48-51, 1980
Maximova-Todorova, V. Vaccination complications after immunization with some viral vaccines.
Chronicles HES (Bulgarian) ХII, 6, 130-140, 1980
Maximova-Todorova, V. Towards the question of the persistence of some live virus vaccines.
Chronicles HES (Bulgarian) ХII, 7, 142-149, 1980
Maximova, V., Gegova, G., Manolova, N., Nabi, N.. Biological properties of selected influenza virus
strains in the process of their adjustment to mouse lungs. II. Astudy of different influenza virus strains
type A (H2N1, H1N1, H3N2) and B. Epid., Microb. and Inf. Diseases. (Bulgarian) ХVIII, 3, 227-233,
1981
Pancheva S., Manolova, N., Gagov, Il., Maximova, V. Antiviral action of some natural rotenoids and
their derivatives. Acta microbiologica bulgarica (Bulgarian) 10, 11-13, 1982
Dzeguze, D.R., Indulen, M.K., Manolova, N., Gegova, G., Maximova, V., Dryanovska-Noninska, L.,
Naidenov, E. Anti-virus activity of drug HL isolated from the bulgarian medicinal plant. In.
Remantadin and other inhibitors of viruses. 192-197, Riga, Zinatne, 1982 (Russian).
Dzeguze, D.R, Indulen, M.K., Manolova, N., Gegova, G., Maximova, V., Uzunov, S., DryanovskaNoninska, L. Naidenova, E. On the antiviral activity of helenine. Uspehi Prom. Infec. Microbiol. S.,
BAS (Bulgarian) 206-209, 1984
Manolova, N., Maximova-Todorova, V., Gegova, G., Uzunov, S., Ivancheva S., Yankulov, Y.
Antiviral activity of the Bulgarian medicinal plant “MB”. Uspehi Prom. Infec. Microbiol. S., BAS
(Bulgarian) 210-213, 1984
Manolova N., Maximova-Todorova, V. Higher plants as sources of antiviral agents. Magazine of BAS
(Bulgarian) 5, 43-51, 1984
Manolova, N.H., Maximova, V.A., Gegova, G.A., Serkedjieva, Y.P., Uzunov, S.T., Marekov, N.Y.,
Bankova, V.S. On the antiinfluenza action on fractions from propolis. Comp. Rend. Acad. Bulg. Sci.
38, 6, 735-738, 1985
Maximova-Todorova, V., Manolova, N., Gegova, G., Serkedzieva, J., Uzunov S., Pancheva S.,
Marekov N., Bankova V. Antiviral effect of some fractions isolated from propolis. Acta
microbiologica bulgarica (Bulgarian) 17, 79-85, 1985
Manolova, N., Gegova, G., Serkedzieva, J., Maximova-Todorova, V., Uzunov, S., Ivancheva S. A
study of the antiviral action of polyphenol complex isolated from the medicinal plant Geranium
sanguineum L. I. Inhibitory effect on the reproduction of the influenza virus. Acta microbiologica
bulgarica (Bulgarian) 18, 73-77, 1986
Serkedzieva, J., Manolova, N., Gegova, G., Maximova-Todorova, V., Ivancheva S. A study of the
antiviral action of polyphenol complex isolated from the medicinal plant Geranium sanguineum L. II.
Inactivating effect on the influenza virus. Acta microbiologica bulgarica (Bulgarian) 18, 78-81, 1986
Serkedzieva, J., Manolova, N., Maximova-Todorova, V., Gegova, G. Combined effect of selected
antiviral substances of natural and synthetic origin. I. Anti-influenza action of a combination of
polyphenol complex isolated from Geranium sanguineum L and rimantadine in vitro and in ovo. Acta
microbiologica bulgarica (Bulgarian) 19, 18-21, 1986
Ivancheva, S.V., Maximova, V.A., Manolova, N.Ch., Serkedjieva, Y.P., Gegova, G.A.
Chromatographic characteristics of a polyphenolic complex with antiviral activity isolated from
Geranium sanguineum L Comp. Rend. Acad. Sci. 40, 7, 95-97, 1987
Manolova, N., Maximova, V., Manolova, Z., Stoilova,I., Korczak, E., Denis, A. Immunostimulating
action of propolis. I Effect on cellular immunity. Acta microbiologica bulgarica (Bulgarian) 21, 76-81,
1987
Bankova V., Popov, S., Marekov, N., Manolova, N., Maximova, V., Gegova, G., Serkedzhieva, J.,
Uzunov. C. On the chemical composition of some propolis fractions with antiviral effect. Acta
microbiologica bulgarica (Bulgarian) 23, 52-57, 1988
Nadya Manolova, Vera Maximova MEDICAL PLANTS – VIRAL INHIBITORS Publishing Hous of
Bul. Acad. Sci., Sofia, 1988
Ivanov, I., Markova, N., Bachvarov, D., Alexciev, K., Saraffova, A., Maximova, V., Tsaneva, I.,
Markov, G. Constitutive expression of a native human interferon-alpha 1 gene in Escherichia coli.
Int. J. Biochem. 21, 9, 983-985, 1989
Ivanov, I. G., Rommens, J., Saraffova, A., Maximova, V., Usheva, A., Bardarov, S., Papageourgion,
A., Jay, E. Chemical synthesis and characteristics of a hybrid phage T5-lac promoter. Microbiologica
13, 85-89, 1990
Pantcheva, S., Gegova, G., Maximova, V., Manolova, N. Ativiral effect of rimantadine and
izoprinozine used in combination in mice.Acta microbiologica bulgarica (Bulgarian) 26, 26-29, 1990
Ivanov I.G, Alexandrova, R., Dragulev, B., Leclerc, D., Saraffova, A., Maximova, V., Abouhaidar,
M.G. Efficiency of the 5’-terminal sequence () of tobacco mosaic virus RNA for the initiation of
eucariotic translation in Escherichia coli. Eur. J. Biochem. 209, 151-156, 1992
Gegova, G., Manolova, N., Serkedjieva, J., Maximova, V., Uzunov, S., Dzeguze, D., Indulen, M.
Combined effect of selected antiviral substances of natural and synthetic origin. II. Anti-influenza
activity of a combination of a polyphenolic complex isolated from Geranium sanguineum L. and
rimantadine in vivo. Acta microbiol. bulg. (Bulgarian) 30, 37-40, 1993
Manolova, N., Baranovsky, V., Rashkov, I., and Maximova, V. Preparation, properties and
complexation ability of polyoxyethylene - Bis -Anaesthesine. Eur. Polym. J. 29, 5, 721-726, 1993
Antonov P., Maximova, V., Pancheva, R. Heat shock and osmotically dependent stres by DNA
uptake after E.coli electroporation. Biochim. Biophys. Acta 1216, 286-288, 1993
Angelova, N., Manolova, N., Rashkov, I., Maximova, V., Bogdanova, S., Domard. A. Praparation
and properties of modified chitosan films for drug release. J. Bioactive and Compatible Polymers 10,
4, 285-298, 1995
Saraffova A., Maximova, V., Ivanov, I.G. and Abouhaidar, M.G. Comparative study on the effect of
signal peptide codons and arginine codons on the expression of human interferon alpha 1 gene in
Escherichia coli. J Interferon and Cytocine Research 16, 745-749, 1996
Timcheva, I.I., Maximova, V.A., Deligeorgiev, T.G., Gadjev, N.I., Sabnis, W. and Ivanov, I.G.
Fluorescence spectral characteristics of novel asymmetrical monomethine cyanine dyes in nucleic
acid solutions. FEBS Lett. 405, 141-144, 1997
Stankova, I. G., M. Simeonov, M. F., Maximova V., Galabov, A. S. and Golovinsky, E. V. Synthesis
and anti-virus activity of some nucleoside analogues. Zeitschrift fur Naturforschung. 54:1-2, 75-83,
1999
Deligeorgiev T. G., Gadjev N. I., Timcheva I. I., Maximova V. A., Katerinopolos E., Fonkanaki E.
Synthesis of homodimeric monomethine cyanine dyes as noncovalent nucleic acid labels and their
absorption and fluorescence spectral characteristics. Dye and Pigments 44, 131-134, 1999.
Timcheva, I., V. Maximova, V. Deligeorgiev,T., Zaneva, D., Ivanov, I. New asymmetric
monomethine cyanine dyes for nucleic acid labeling: absorption and fluorescence spectral
characteristics. J. Photochemistry and Photobiology A: Chemistry 130, 7-11, 2000
Deligeorgiev, T. G., Gadjev, N. I., Timcheva, I. I., Maximova , V. A., Katerinopolos, E., Fonkanaki,
E. Synthesis of homodimeric monomethine cyanine dyes as noncovalent nucleic acid labels and their
absorption and fluorescence spectral characteristics. Dye and Pigments 44, 2, 131-136, 2000
Timcheva, I. Maximova, V., Deligeorgiev, T., N. Gadjev, N., Drexhage, K. H., Petkova I.
Homodimeric monomethine cyanine dyes as fluorescent probes of biopolymers. J. Photochemistry and
Photobiology. B: Biology 58, 2-3, 130-135, 2000.
Deligeorgiev T., Tincheva I., Maximova V., Gadjev N., Drexhage K.-H. Fluorescence characteristics
of variously charged asymetric monomethine cyanine dyes in the presence of nucleic acids. J.
Fluorescence 12, 2, 225-229, June 2000 (2002)
Gadjev N.I., Deligeorgiev T.G., Tincheva I., Maximova V. Synthesis and properties of YOYO-1-type
homodimeric monometine cyanine dyes as noncovalent nucleic acid labels. Dyes and Pigments 57,
161-164, 2003
Deligeorgiev T.G., Gadjev N.I., Tincheva I.I., Maximova V.A. Synthesis and properties ofnovel
asymmetric monomethine cyanine dyes as non-covalent labels for nucleic acids. 3rd International
conference. Instrumental methods of analysis modern trenda and applications. 23-27 September 2003,
Thessaloniki, Greece. Conference proceedings, 255-258
Deligeorgiev T., Tincheva I., Maximova V., Gadjev N., Vassilev A., Jacobsen J.-P., Drexhage K.-H.
Homodimeric monomethine cyanine dyes SOSO-1 and TOTO-1-6C – synthesis and fluorescence
properties in the presence of nucleic acids. Dyes and Pigments 61, 1, 79-84, 2004
Tsoncheva, V., Todorova, K., Ivanov, I., Maxomova, V. Spontaneous transfection of mammalian
cells with DNA. Z. Naturforsch. 60c, 7-8,644-648, 2005
Maximova, V., Ivanov, I. Molecular biology of prions and prion diseases. In. "Prionovi Diseases"
(Ed. I. Velcheva and D. Stoyanov), Med. Publ. APCO Sofia, 2005.
Ivanovska, N., Tchorbanov, A., Prechl, J., Maximova, V., Voynova, E., Vassilev, Tch. L.
Immunization with a DNA chimeric molecule encoding a hemaglutinin peptide and a scFv CD21specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus. Vaccine,
24, 11, 1830-1837, 2006
Yancheva E, Paneva D, Maximova V, Mespouille L, Dubois P, Manolova N, Rashkov I.
Polyelectrolyte Complexes between (Cross-linked) N-Carboxyethylchitosan and (Quaternized)
Poly[2-(dimethylamino)ethyl methacrylate]: Preparation, Characterization, and Antibacterial
Properties.
Biomacromolecules. 2007, 8, 976-984
Deligeorgiev, T.G., Gadjev, N.I., Vasilev, A.A., Maximova, V.A., Timcheva, I.I., Katerinopoulos,
H.E., Tsikalas, G.K. Synthesis and properties of novel asymmetric monomethine cyanine dyes as noncovalent labels for nucleic acids. Dyes and Pigments 75 (2), 466-473, 2007
Todorova K. A., Tsoncheva V. L., Mitev V., Ivanov I. G., Maximova V. A.
Modulation the effect of interferon by diverse protein kinase inhibitors. Biotech. Biotech. Eq. 21, 4,
478-483, 2007
Tsoncheva V. L., Todorova K. A., Ivanov I. G., Maximova V. A.
Influence of Interferons on the Repair of UV-Damaged DNA. Z. Naturforsh. Z Naturforsch [C]. 63, 34, 303-307, 2008.
Tsoncheva V. L., Todorova K. A., Maximova V. A. Decreased DNA repair capacity of UV-irradiated
cells following interferon treatment. Z.Naturforsh. 63c, 605-611, 2008.